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We can't solve problems by using the same kind of thinking we used when we 
created them – Albert Einstein 
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During pregnancy, the maternal body needs to adapt to a fast growing, 
highly active, new organ: the placenta. To meet its demands, it reversibly presses 
the maternal body to its metabolic and cardiovascular limits. Women with a 
good cardiometabolic health will have no problem to handle this pressure. If, 
however cardiometabolic health is already compromised and fetal demands 
cannot be met, it will push women beyond their limits into a state of physical 
‘overdrive’, leading to cardiometabolic complicated pregnancy (figure 1). Well 
known phenotypes of cardiovascular complicated pregnancies are preeclampsia 
and fetal growth restriction. An example of metabolic complicated pregnancy is 
gestational diabetes mellitus. 
In 2002 Sattar and Greer were the first to postulate the hypothesis that 
pregnancy is a stress-test for cardiometabolic health1 (figure 1.1). If complicated 
pregnancy occurs, it flags for decreased cardiometabolic health. These women 
are at increased risk for future cardiometabolic disease. It is unclear whether 
having had the complicated pregnancy contributes to the increased risk. 
Cardiovascular complications of pregnancy 
Cardiovascular complications of pregnancy are gestational hypertension, 
preeclampsia, eclampsia, placental abruption, and fetal growth restriction. For 
gestational hypertension, preeclampsia and fetal growth restriction an increased 
risk for future cardiovascular disease has been shown2 3.  
Preeclampsia complicates 2-8% of pregnancies4. It is characterized by 
hypertension and proteinuria above the 20th week of gestation5. Preeclampsia 
can occur as different phenotypes. Common phenotypes are early (<34 weeks of 
gestation) or late (>=34 weeks of gestation) onset, with or without HELLP 
syndrome (hemolysis, elevated liver enzymes and low platelets) and with or 
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without fetal growth restriction. Clinically preeclampsia is differentiated in 
severe (severe hypertension, fetal growth restriction, HELLP syndrome, early 
onset) and mild (mild hypertension, appropriate fetal growth, no HELLP 
syndrome, late onset) preeclampsia. 
Already in 1976 Chelsey observed an increased mortality in former 
eclamptic women6. More recent studies show a 2-fold increased risk for future 
cardiovascular disease up to 30 years after preeclampsia2 3 7-16. More severe 
preeclampsia is associated with an even higher risk. If preeclampsia is combined 
with fetal growth restriction, the increase is 4-fold10. When fetal growth 
restriction is accompanied with premature birth, the risk is increased 16-fold10. 
As shown by Ray et al, this increased risk for cardiovascular disease is already 
observed the first decade after the pregnancy3 (figure 1.2). 
Previous studies show a decreased cardiovascular health in formerly 
preeclamptic women17-27. They have higher blood pressure25 28-31, higher 
Figure 1.1. Risk factors for cardiometabolic disease are identifiable during excursions into 
the cardiometabolic syndrome of pregnancy (adapted from Sattar and Greer, 20021)  
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cholesterol level21 31, higher BMI31 32 and tend to be more insulin resistant25 33 
compared to women after an uncomplicated pregnancy. However, due to their 
relative young age traditional risk prediction models34-40 cannot identify these 
women as high-risk the first years after their pregnancy41. Extrapolated to an 
older age however, these women are clearly high-risk for cardiovascular 
events41. 
Risk factors for cardiovascular disease also increase the risk of 
preeclampsia18 42, suggesting a ‘common soil’ for preeclampsia, fetal growth 
restriction and cardiovascular disease (figure 1.3). Since studies focus on women 
after their pregnancy, it remains unclear whether the preeclampsia itself 
(irreversibly) affects cardiovascular health and whether different aspects of 
preeclampsia (severity, duration of the disease) have different effects on 
cardiovascular health. 
Figure 1.2. Risk of cardiovascular disease associated with a maternal placental syndrome 
(MPS, composite of preeclampsia, gestational hypertension, placental abruption or 
placental infarction) or an affected fetus or both3 
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Metabolic complications of pregnancy 
Gestational diabetes mellitus complicates 8-10% of all pregnancies. 
Women with a pregnancy complicated by gestational diabetes mellitus, are at 
increased risk for future type 2 diabetes mellitus. The 5 to 15-years risk for 
diabetes is 33%-60%43-48, compared to 2-3% after uncomplicated pregnancy. The 
more severe gestational diabetes mellitus (early onset <24 weeks of gestation, 
need for insulin), the higher the risk of future diabetes mellitus43. Also, BMI in 
case of gestational diabetes mellitus is independently positively associated with 
the risk of future diabetes mellitus43 44 46 47.  
Women with a history of gestational diabetes mellitus have a worse 
metabolic health compared to women with an uncomplicated pregnancy49. 
Fasting glucose levels are higher, as is BMI, lipid levels and blood pressure. 
Figure 1.3. ‘Common soil’ theory of the origin of preeclampsia, fetal growth restriction and 
cardiovascular disease 
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Studies show no increased risk for cardiovascular disease13 15. However, since 
diabetes mellitus is a risk factor for cardiovascular disease, the follow-up of the 
cohort studies might have been too short to identify this increased risk. 
Currently the pre-pregnancy metabolic health of women with a 
subsequent first episode of gestational diabetes mellitus has not been studied. 
Whether gestational diabetes mellitus itself adds to the risk of future diabetes 
mellitus is unclear. 
Metabolic syndrome 
Women with a history of preeclampsia, fetal growth restriction or 
gestational diabetes mellitus show increased risk factors for future 
cardiometabolic health: higher blood pressure, higher BMI, higher fasting 
Figure 1.4. The metabolic syndrome 
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glucose levels and higher cholesterol-levels. These symptoms are likely to co-
occur as the metabolic syndrome (figure 1.4). The metabolic syndrome is defined 
as the presence of three or more of the following traits50 51: 
 Abdominal obesity (waist circumference in men ≥ 102 cm, in women ≥ 88 
cm) 
 Elevated serum triglycerides (≥1.7 mmol/l) or drug treatment 
 Low high-density lipoprotein (HDL) cholesterol (in men <1.0 mmol/l, in 
women <1.3 mmol/l) or drug treatment 
 Blood pressure ≥ 130/85 or drug treatment 
 Elevated fasting plasma glucose (≥ 5.6 mmol/l) or drug treatment  
The metabolic syndrome is not the only explanatory link between a 
complicated pregnancy and future cardiometabolic risk. Other risk factors like 
genetic predisposition and maybe the complicated pregnancy itself contribute 
to the increased future risk (figure 3). 
Opportunities to reduce risk of future disease 
Whether complicated pregnancy is a marker or a risk factor for future 
cardiometabolic disease does not alter the fact that the complicated pregnancy 
uniquely identifies these women at a young age as high risk for future disease. 
Since in the major part of these women classic risk factors like hypertension or 
hypercholesterolemia are not manifested jet, primary lifestyle intervention can 
help to postpone or even prevent future cardiometabolic disease. As shown by 
the INTERHEART study, lifestyle factors have a cumulative population attributive 
risk for cardiovascular disease in women of 65%52 indicating the possible gain of 
lifestyle intervention.  
Smoking cessation reduces the risk for cardiovascular disease with 47% 
within 10 years, with the greatest effect in the first year after cessation53. 
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Consuming less unsaturated fat can lower cardiovascular risk with 40-50%54. 
Physical activity lowers cardiovascular risk with 52% if the time spent walking is 
more than 2 hours per week, compared to a sedentary lifestyle55. Physical 
activity also decreases weight and blood pressure. Lowering of BMI reduces the 
risk of myocardial infarction with 7% per 1 Kg/m256. Small changes in blood 
pressure can have tremendous effects on cardiometabolic risk. If diastolic blood 
pressure is 2 mmHg lower, the risk for future myocardial infarction is decreased 
by 6%. If lowered 5-6 mmHg, the decrease can be 25%. For cerebrovascular 
accidents, the decrease is 15% and 40% respectively57. Weight reduction and 
reduced fat intake, increased fiber intake and physical activity can reduce the 
risk of diabetes mellitus with 50%58 59. 
In applying primary lifestyle intervention, it is difficult to reach and 
motivate the eligible people to change their lifestyle. Participation and 
compliancy are generally low, while dropout rates are as high as 31%, even with 
short-term benefits of lifestyle intervention60. 
In contrast to other people that are eligible for primary lifestyle 
intervention, women after complicated pregnancy have been confronted with a 
-sometime life threatening- disease during pregnancy. Next to the fact that 
pregnancy itself is a motivator for lifestyle changes61 62, experiencing disease 
during pregnancy might be an additional strong motivator to comply with 
primary lifestyle intervention, opening a window of opportunity to guide these 
women to a healthier future63-70. The use of web-based interventions can 
increase compliance and effectiveness of primary lifestyle intervention 
programs65 71-78. However, whether lifestyle intervention after complicated 
pregnancy is feasible and effective still needs to be addressed. 
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Aims and outline of the thesis 
The general aim of this thesis is to develop and evaluate a postpartum 
program appraising cardiovascular health and offering lifestyle intervention 
after complicated pregnancy to reduce future cardiovascular risk. 
Part 2 describes research in developing postpartum appraisal of 
cardiovascular health. To identify when to appraise postpartum cardiovascular 
health, a historic prospective cohort was used to study recovery after a 
complicated pregnancy. The results are presented in chapter 4.1. Chapter 4.2 
presents a case series, showing associations between thrombophilia -being an 
unchangeable risk factor for future cardiovascular disease- and different 
phenotypes of preeclampsia. 
Part 3 discusses the development and evaluation of the lifestyle 
intervention program of the Postpartum Rotterdam Appraisal of Cardiovascular 
Health and Tailored Intervention (Pro-Active) study. First, chapters 5.1 and 5.2 
present literature-based studies on what is already known about post-partum 
lifestyle intervention and what estimated effect it might have on 
cardiometabolic risk. Second, chapters 5.3 and 5.4 show the results of focus 
group studies on the preferences, motivators and barriers in women with a 
formerly complicated pregnancy with regard to a postpartum lifestyle 
intervention program. Finally, chapter 5.5 displays the results of the Pro-Active-
study. In this chapter the feasibility and effect of a postpartum lifestyle 
intervention program after complicated pregnancy are described. 
Chapter 6 presents a general discussion and focusses on future clinical and 
scientific implications. 
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Part TwoPostpartum appraisal of cardiovascular health

Chapter 2.1RESOLUTION OF HYPERTENSION AND PROTEINURIAAFTER PREECLAMPSIA: A 2-YEAR FOLLOW-UP STUDY
Obstetrics & Gynecology
2009 Dec;114(6):1307-14
D. Berks
E.A.P. Steegers 
M. Molas
W. Visser
24 | Part 2 Cardiovascular Health 
ABSTRACT 
Objective (1) To estimate the time required for hypertension and proteinuria to 
resolve after preeclampsia. (2) How this time to resolution correlate with the 
levels of blood pressure and proteinuria during preeclampsia and the 
prolongation of pregnancy after the development of preeclampsia. 
Methods This is a historical prospective cohort study of 205 preeclamptic 
women, who were admitted between 1990 and 1992 at the Erasmus 
University Medical Center in Rotterdam, the Netherlands. Data were collected 
at 1.5, three, six, 12, 18 and 24 months after delivery. Hypertension was 
defined as a blood pressure ≥ 140/90 mmHg or use of antihypertensive drugs. 
Proteinuria was defined as ≥ 0.3 gram/day. Resolution of hypertension and 
proteinuria were analyzed with Turnbull’s extension to the Kaplan-Meier 
procedure. Correlations were calculated with an accelerated failure time 
model. 
Results At three months postpartum 39% still had hypertension, falling to 18% 
at two years postpartum. Resolution time increased with higher systolic 
(p<0.001) and diastolic blood pressure during preeclampsia (p=0.044), as well 
as a longer time interval between diagnosis and delivery (p=0.001). At three 
months postpartum 14% still had proteinuria, falling to 2% at two years 
postpartum. Resolution time increased with higher levels of proteinuria 
during preeclampsia (p<0.001). Gestational age at onset of preeclampsia was 
not correlated with resolution time of hypertension and proteinuria. 
Conclusion Following a preeclampsia, it can take up to two years for 
hypertension and proteinuria to resolve. Therefore, we suggest that further 
invasive diagnostic tests for underlying renal disease may be postponed until 
two years postpartum. 
2.1 Resolution of hypertension and proteinuria| 25 
INTRODUCTION 
Preeclampsia complicates about 5% of all pregnancies79. The associated 
hypertension and proteinuria usually resolve after delivery. But recent studies 
show that preeclampsia is associated with an increased risk for remote 
cardiovascular disease80 and end stage renal disease81. More knowledge on 
postpartum resolution of hypertension and proteinuria will help to properly 
identify chronic hypertension and proteinuria. This can help justify further 
invasive diagnostic tests for underlying disease. 
The time required for resolution however is not clear. International 
guidelines state that hypertension should resolve within three months after a 
preeclamptic pregnancy82 83. Otherwise, chronic hypertension is present. 
Previous publications indeed show rapid postpartum fall of the blood pressure84-
87. However, they were not designed to estimate resolution after three months 
postpartum, having a follow-up period of seven days or excluding patients with 
persistent hypertension at three months postpartum. If data of resolution of 
hypertension beyond three months postpartum was available, women with 
chronic hypertension could be better identified. For proteinuria, no statement 
exists when postpartum persistence should be considered chronic. Previous 
publications suggest a high risk of renal injury if proteinuria is persistent after six 
or 12 weeks postpartum. However, publications are case reports88 or consist of 
retrospectively collected data on renal biopsies89 90. If prospectively collected 
data of postpartum resolution of proteinuria was available, women with 
persistent proteinuria could also be better identified. In our own experience, 
hypertension and proteinuria could resolve beyond three months after a 
preeclamptic pregnancy. 
In this historical prospective cohort study, we address the following 
26 | Part 2 Cardiovascular Health 
questions. (1) How long can it take for hypertension and proteinuria to resolve 
after a preeclamptic pregnancy and (2) how do prolongation of pregnancy after 
the development of preeclampsia and the levels of blood pressure and 
proteinuria during preeclampsia correlate with postpartum time to resolution 
and to what extent? 
METHODS 
This historical prospective cohort study was carried out on preeclamptic 
women who were admitted to the Department of Obstetrics and Gynecology of 
the Erasmus University Medical Center and delivered between January 1, 1990 
and December 31, 1992. Preeclampsia was defined as the occurrence after 20 
weeks’ gestation of a blood pressure of 140/90 mmHg or more and proteinuria 
of 0.3 g/day or more. The HELLP syndrome was defined as the simultaneous 
occurrence of a platelet count of < 100 x 109/l, serum aspartate 
aminotransferase (ASAT) and serum alanine aminotransferase (ALAT) 
concentrations > 30 U/l (2 S.D. above the mean in our hospital). Women with a 
record of chronic hypertension or kidney disease prior to pregnancy or before 
20th week of gestation were excluded. Severity of the disease was retrospectively 
defined according to ACOG-criteria83. 
During the study period, a consultant of internal and obstetric medicine 
used a protocol for the follow-up. All women who were admitted with 
preeclampsia were offered visits at 1.5, three, six, 12, 18 and 24 months after 
delivery. If a woman did not present for the check-up, she was sent a reminder 
once. However, not every woman attended every visit. The hospital files were 
searched to collect data on blood pressure, use of anti-hypertensive drugs, 
urinary protein excretion and serum-creatinine levels at every attended visit. 
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Hypertension was defined as the use of anti-hypertensive drugs or a blood 
pressure ≥ 140/90 mmHg. Proteinuria was defined as ≥ 0.3 grams/day urinary 
protein loss. For both conditions separately the first visit of measured resolution 
was identified. Because resolution obviously occurred somewhere between 
visits, actual time of resolution was analyzed as interval censored. If no visit of 
resolution could be identified and follow-up data was incomplete, women were 
considered lost-to-follow-up. Turnbull’s extension of the Kaplan-Meier 
procedure to interval-censored data91 was then used to calculate resolution-
curves with 95% confidence bands (SAS 9.1.3, SAS Institute Inc., Cary, NC, USA). 
The women that were lost-to-follow-up were right-censored in the analysis 
under the assumption of independent censoring from the time of resolution. 
This means that after the last known visit, the proportion of right-censored 
women who showed resolution was equal to the proportion of women with 
complete follow-up who showed resolution at a specific time. 
Hospital files were searched to collect clinical features of preeclampsia. 
They included maximal systolic and diastolic blood pressure during admission, 
maximal level of proteinuria during admission, gestational age at onset of 
preeclampsia and the time interval between diagnosis and delivery. To analyze 
the correlation between these covariates and the rate of resolution, we used an 
accelerated failure time (AFT) model with flexible error distribution allowing for 
interval censoring as described elsewhere92 (smoothSurv 0.3-12 R 2.7.1, 
Komarek). This model is not restricted to assume a specific distribution for the 
error like Gaussian or extreme value distribution, but allows a smooth error 
distribution resulting from the penalized normal mixture. 
This study was approved by the Institutional Research Board of the 
Erasmus University Medical Center (trail number MEC-2009-169). 
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RESULTS 
A total of 242 women were admitted with preeclampsia during the study 
period. Of these women 37 were excluded: 30 women had been diagnosed with 
hypertension before pregnancy, two had been diagnosed with proteinuria 
before pregnancy and five women had been diagnosed with both. A total of 205 
women were included for analysis. Whilst for 116 women complete blood 
pressure data was available, complete proteinuria data was available for 121 
women. General characteristics are summarized in Table 2.1.1.  
Hypertension 
For 116 women, complete blood pressure data was available: for 112 
women resolution of hypertension was identified, four women still had (known) 
hypertension two years postpartum. The remaining 89 women were lost to 
follow-up before normalization of blood pressure. Table 2.1.2 shows the 
comparison between these two groups, showing the latter group having had 
worse clinical features of preeclampsia.  
Figure 2.1.1 shows the resolution curve for hypertension with 95% confidence 
Table 2.1.1. General characteristics of study population (n=205) 
Age (years) 28 (16-45) 
Gestational age at diagnosis (weeks) 31 (21-42) 
Gestational age at delivery (weeks) 34 (22-42) 
Prolongation of preeclampsia (days) 8 (0-62) 
Maximal systolic blood pressure during preeclampsia (mmHg) 170 (140-280) 
Maximal diastolic blood pressure during preeclampsia (mmHg) 110 (90-170) 
Maximal level of proteinuria during preeclampsia (g/24h) 4.2 (0.3-31.4) 
Maximal level of creatinine during preeclampsia (mmol/l) 82 (45-626) 
Nulliparous 69.8% (143) 
Severe preeclampsia  89.3% (183) 
HELLP 32.2% (66) 
Eclampsia 5.4% (11) 
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interval. At discharge after delivery 78% still had hypertension. At six weeks 
postpartum in 54%, and at three months postpartum in 39% of the women 
hypertension was still present. Finally, at two years postpartum 18% had 
persistent hypertension. No difference was observed in normalization between 
primiparous and multiparous women. In the AFT-model, both a higher maximal 
systolic blood pressure and higher maximal diastolic blood pressure during 
preeclampsia increased resolution time (resp. p<0.001 and p=0.044). Also, 
longer time interval between diagnosis and delivery increased resolution time 
(p=0.001). Figures 2.1.2, 2.1.3 and 2.1.4 show the effect of these variables on the 
resolution curve. The baseline in each figure is defined as maximal systolic blood 
pressure of 140 mmHg, maximal diastolic blood pressure of 90 mmHg and time 
interval between diagnosis and delivery of 0 days. The curves show the effect on 
the rate of resolution of hypertension when the specific variable changes, leaving 
the other variables at baseline. The coefficients for the corresponding AFT-model 
are presented in table 2.1.3. Resolution time of hypertension was not 
significantly correlated with the maximum level of proteinuria and gestational 
age at onset of preeclampsia.   
Table 2.1.2. Characteristics of women with full follow-up data and lost-to-follow-up with 
regard to blood pressure measurements 
 Complete Data 
n=116 
Lost-to-follow-up 
n=89 
p-value 
Gestational age at diagnosis (weeks) 32 (21-42) 31 (25-41) 0.02 
Prolongation of preeclampsia (days) 6 (0-60) 14 (0-62) 0.01 
Maximal systolic blood pressure  
during preeclampsia (mmHg) 
170 (130-226) 180 (130-280) 0.001 
Maximal diastolic blood pressure  
during preeclampsia (mmHg) 
110 (90-145) 115 (90-170) 0.02 
Maximal level of proteinuria  
during preeclampsia (gr/24h) 
4.0 (0.3-25.3) 5.4 (0.3-31.4) 0.09 
Maximal level of creatinine  
during preeclampsia (mmol/l) 
82 (45-626) 84 (52-394) 0.19 
Values are presented as median(range) and compared using Mann-Whitney tests. 
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Figure 2.1.2. Accelerated failure time model of resolution of hypertension for different 
levels of maximal systolic blood pressure during pregnancy 
 
 
Figure 2.1.1. Resolution of hypertension after preeclampsia (0 weeks = delivery) 
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Figure 2.1.3. Accelerated failure time model of resolution of hypertension for different 
levels of maximal diastolic blood pressure during pregnancy 
 
  
Figure 2.1.4. Accelerated failure time model of resolution of hypertension for different 
time intervals between diagnosis and delivery 
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Proteinuria  
For 121 women complete proteinuria data was available: for all those 
women resolution of proteinuria was identified. The remaining 84 women were 
lost to follow-up before resolution of proteinuria. Table 2.1.4 shows the 
comparison between these two groups, showing the latter group having had 
higher levels of maximal proteinuria during preeclampsia. 
Figure 2.1.5 shows the resolution curve for proteinuria with 95% 
confidence interval. At discharge after delivery 65% of women still had 
proteinuria. At six weeks postpartum in 21%, and at three months postpartum 
in 14% of women proteinuria was present. Finally, at two years postpartum 2% 
had persistent proteinuria. No difference was observed in normalization 
between primiparous and multiparous women. In the AFT-model, higher 
maximum level of proteinuria during preeclampsia increased resolution time 
(p<0.001). Figure 2.1.6 shows the effect on the rate of resolution of proteinuria 
when this variable changes. The coefficients for the corresponding AFT-model 
are presented in table 2.1.3. Resolution time of proteinuria was not significantly 
correlated with the maximal systolic and diastolic blood pressure during 
preeclampsia, gestational age at onset of preeclampsia and time interval 
between diagnosis and delivery. 
Table 2.1.3. Coefficients of the AFT-model 
 Coefficient (95%-CI) p-value 
Resolution of hypertension    
          Constant -10.76 (-14.21- -7.16)  
          Maximum systolic blood pressure (mmHg) 0.05 (0.03-0.07) <0.001 
          Maximum diastolic blood pressure (mmHg) 0.03 (0.00-0.07) 0.044 
          Prolongation of preeclampsia (days) 0.04 (0.01-0.06) 0.001 
    
Resolution of proteinuria    
          Constant -0.53 (-0.95-0.10)  
          Maximum level of proteinuria (gr/24h) 0.15 (0.11-0.19) <0.001 
Values are presented as median(range) and compared using Mann-Whitney tests. 
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 DISCUSSION 
Our results show that hypertension and proteinuria can resolve during the 
first two years following a preeclamptic pregnancy. Of all women that had 
hypertension at 3 months postpartum, 50% resolved within two years 
postpartum. So these women could not have had true chronic hypertension and 
would have been misclassified by current definition. Furthermore, a surprisingly 
14% still had proteinuria at three months postpartum. Of these women, 85%  
resolved within two years postpartum. Clinical features that were associated 
with a longer time to resolution were higher maximal blood pressure and higher 
maximal level of proteinuria during pregnancy and a longer time interval 
between diagnosis and delivery.   
Previous longitudinal studies of resolution of hypertension are limited in 
follow-up time and mainly focus on the differences of resolution between the 
types of hypertensive disorder in pregnancy84-87. The longest previous 
longitudinal study on resolution of hypertension had a follow-up time of 50 days 
Table 2.1.4. Characteristics of women with full follow-up data and lost-to-follow-up with 
regard to proteinuria measurements 
 Complete Data 
n=121 
Lost-to-follow-up 
n=84 
p-value 
Gestational age at diagnosis (weeks) 31 (21-42) 31 (25-41) 0.46 
Prolongation of preeclampsia (days) 5 (0-62) 11 (0-50) 0.11 
Maximal systolic blood pressure during  
preeclampsia (mmHg) 
170 (130-250) 170 (130-280) 0.73 
Maximal diastolic blood pressure during  
preeclampsia (mmHg) 
110 (90-170) 110 (90-160) 0.80 
Maximal level of proteinuria during  
preeclampsia (gr/24h) 
3.1 (0.3-27.2) 6.9 (0.3-31.4) 0.001 
Maximal level of creatinine during  
preeclampsia (mmol/l) 
82 (45-394) 83 (45-626) 0.72 
Values are presented as median(range) and compared using Mann-Whitney tests. 
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Figure 2.1.5. Resolution of proteinuria after preeclampsia (0 weeks = delivery) 
 
  
 
Figure 2.1.6. Accelerated failure time model of resolution of proteinuria for different 
maximal levels of proteinuria during pregnancy 
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after delivery84. However, women with persistent hypertension at 50 days 
postpartum were excluded for analysis, thereby precluding any estimate of later 
resolution. Suzuki et al87 describe a postpartum observational study of 52 
women with gestational hypertension. Of the 52 women, 9 (17%) still had 
hypertension two years postpartum. However, the rate of resolution between 
delivery and two years postpartum was not analyzed. 
We found an incidence of proteinuria of 14% at three months postpartum. 
This is higher than in previous studies. In 1992 Chua and Redman describe a 
longitudinal study on the resolution of proteinuria after preeclampsia93. They 
showed persistent proteinuria in 2% at three months postpartum. However, 
proteinuria was defined as ≥ 0.5 gram protein a day. That might explain the 
difference with our findings.  
Other studies have looked at renal lesions after preeclampsia89 90. Two 
types of renal lesions, characteristic for preeclampsia, can be discriminated: 
Those that disappear within days after delivery (glomerular deposits of various 
hemostatic factors) and those that resolve gradually until as long as 18 months 
after delivery (endothelial swelling and subendothelial enlargement). The latter 
supports our conclusion that proteinuria at three months postpartum does not 
imply chronic disease, but might still be a transient effect of endothelial damage 
during preeclampsia. Moreover, this finding suggests that a renal biopsy for 
prolonged proteinuria within two years postpartum may be postponed, since the 
majority of lesions will disappear. 
Sometimes, resolution of proteinuria might be explained by a fall in 
glomerular filtration rate, or a decrease in blood pressure. Unfortunately, serum-
creatinine levels were not routinely measured during follow-up, since all but five 
women had normal serum-creatinine levels within three months postpartum. 
So, we think it to be very unlikely that a fall in glomerular filtration rate would 
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have contributed to resolution of proteinuria. At every postpartum visit, blood 
pressure levels were comparable between women with and without proteinuria. 
So it is unlikely that the level of blood pressure has interfered with the resolution 
of blood pressure. 
This study of resolution of hypertension and proteinuria could well reflect 
endothelial recovery after preeclampsia, as previously suggested84. Endothelial 
dysfunction plays a central role in the pathogenesis of preeclampsia and might 
account for most of the pathological changes94 95. Our findings suggest that the 
level of endothelial cell injury during preeclampsia, reflected by highest blood 
pressure and level of proteinuria, is correlated with the time to postpartum 
recovery. Whether prolonged resolution is reassuring, remains unclear. It might 
very well reflect worse subclinical cardiovascular health. This should be aim for 
further research. If true, it can help to identify women at risk for future 
cardiovascular disease. 
Moreover, our findings also suggest that the duration of exposure to 
endothelial cell injury, as reflected by diagnose-to-delivery interval, is correlated 
with the time to postpartum resolution of hypertension. We are the first to 
describe this association. It suggests that preeclampsia itself affects remote 
cardiovascular health. This implies that temporizing treatment may increase 
remote cardiovascular risk. Whether this is true should be part of further study. 
The main limitation of this study is the number of women lost-to-follow 
up. With regard to the Turnbull’s analysis, they are considered right-censored. 
This means that after the last known visit, they were expected to behave like the 
women with complete follow-up. Since the women lost-to-follow-up had more 
severe clinical features of preeclampsia, our method probably resulted in a best-
case scenario. However, within the AFT-model the clinical features of 
preeclampsia have been adjusted for. These clinical features could be related to 
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the probability of censoring. Therefore, given the clinical features the censoring 
mechanism could have been independent from the time of resolution. In this 
case, as the resolution curves obtained from the AFT models are conditional on 
the clinical features, they would provide valid estimate of survival probability for 
the group with a given value of clinical features92. 
The second limitation of this study is that the follow-up period is two 
years. Hereby we preclude any estimate of later resolution. However, we believe 
it is unlikely that resolution would occur beyond two years postpartum. Because 
we found an incidence of hypertension of 18% at two years postpartum. This is 
comparable with other studies that showed similar proportions of women with 
hypertension until seven years after preeclampsia18 24 87 96.  
 The third limitation of this study is that, due to the fact that our hospital 
is a referral center, a large proportion of women have had severe preeclampsia 
(89%). This may limit the ability to generalize our findings to women with mild 
preeclampsia. 
The period of recruitment of this study was 1990 to 1992 for two reasons. 
First, the data of this cohort had already been processed to minimize missing 
data. However, proper analysis had never been conducted. Recent development 
of the accelerated failure time model92 made it possible to analyze the dataset 
as presented and quantify the effect of blood pressure, proteinuria and 
temporizing treatment of preeclampsia on postpartum resolution. Second, 
temporizing treatment was more common during the study-period, compared 
to current practice. This allowed a better analysis of effect of temporizing 
treatment on postpartum recovery, than if we had used more recent data. 
Since women with a preeclamptic pregnancy are at risk for cardiovascular 
disease and end stage renal disease, proper follow-up after delivery is necessary. 
However, this is not always the case: In 2004 Samwiil et al reported that of 257 
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former preeclamptic women, at six weeks postpartum 6% had not had their 
blood pressure measured and 68% had not had their urine tested for 
proteinuria97. Hypertension, if present, must be treated. Persistent proteinuria 
at three months postpartum must make the physician aware of a possible 
underlying renal disease and necessitates evaluation by a nephrologist. 
However, if the level of proteinuria stays below 3 gram/day, further invasive 
diagnostic tests for underlying renal disease may be postponed until 
hypertension and/or proteinuria persist after two years postpartum. Further 
studies must focus on the correlation between time to resolution of 
hypertension and proteinuria, and remote cardiovascular risk. 
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ABSTRACT 
Background Preeclampsia (PE) complicates 2-8% of all pregnancies. Studies on 
the association of PE with thrombophilia (TP) are conflicting. Clinical 
heterogeneity of the disease may be one of the explanations. The present 
study addresses the question whether different phenotypes of PE are 
associated with TP factors. 
Materials and Methods We planned a retrospective cohort study. From 1985 
until 2010 women with PE were offered postpartum screening for the 
following TP factors: anti-phospholipid antibodies (APA), APC-resistance (APC-
r), protein C deficiency (PCD) and protein S deficiency (PSD), 
hyperhomocysteineamia (HHC), factor V Leiden (FVL) and Prothrombin gene 
mutation (F2M). Hospital records were used to obtain information on 
phenotypes of the PE and placental histology. 
Results We identified 844 women with singleton pregnancies who were 
screened for TP factors. HELLP complicated 49% of pregnancies; IUGR 
complicated 61% of pregnancies. Early delivery (<34th week) occurred in 71% 
of pregnancies. Any TP factor was present in 29% of the women. Severe PE 
was associated with PSD (p=0.01). IUGR was associated with APA (p<0.01). 
Early onset PE was associated with APA (P=0.01). Extensive placental 
infarction (>10%) was associated with APA (p<0.01). Low placental weight 
(<5th percentile) was associated with HHC (p=0.03). 
Discussion Severe and early onset PE, especially if complicated by IUGR, are 
associated with APA. Other phenotypes of PE, especially HELLP syndrome, 
were not associated with TP. We advise only to test for APA after severe, early 
onset PE, especially if complicated by IUGR. We suggest enough evidence is 
presented to justify no further studies are needed. 
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INTRODUCTION 
Preeclampsia complicates 2-8% of all pregnancies4. The cause of 
preeclampsia has not yet been elucidated and is most probably heterogenic4. 
One possible cause is a maternal pro-thrombogenic state, leading to mal-
adaptation of the spiral arteries in early pregnancy and placental thrombosis and 
infarction in mid- and late pregnancy4. A pro-thrombogenic state can be caused 
by inherited or acquired thrombophilia98-100. Maternal thrombophilia seems to 
be associated with preeclampsia in cohort studies. However, these results 
cannot be reproduced in larger prospective studies4. 
An explanation of these conflicting results might be that preeclampsia is a 
heterogenic disease with different phenotypes. Not only can preeclampsia be 
classified as mild or severe, it may also be complicated by hemolysis, elevated 
liver enzymes or low platelets (HELLP-syndrome) and/or intrauterine growth 
restriction (IUGR) and/or early onset preeclampsia. Histological examination of 
placentas of pregnancies complicated by preeclampsia may show extensive 
infarction, but also no abnormal findings at all99. Some authors suggest that early 
preeclampsia has another pathophysiological basis than late preeclampsia101. It 
might be that these different phenotypes of preeclampsia are differently 
associated with thrombophilia. If this is true, future research should be focused 
on the pathophysiology, prediction and ultimately prevention of preeclampsia in 
combination with these thrombophilia factors. 
This retrospective cohort study addresses the question which phenotypes 
of preeclampsia are associated with thrombophilia. 
44 | Part 2 Cardiovascular Health 
MATERIAL AND METHODS 
From 1985 until 2010 all patients with a singleton pregnancy who were 
admitted for mild or severe preeclampsia to the department of obstetrics of the 
Erasmus University Medical Center, University Medical Centre Rotterdam, were 
offered to be postpartum screened for thrombophilia factors. Preeclampsia was 
diagnosed according to the definition of the International Society for the Study 
of Hypertension (ISSHP). Severe preeclampsia was diagnosed if one or more of 
the following criteria were present: a blood pressure of 160 mmHg systolic or 
higher or 110 mmHg diastolic or higher proteinuria of 5 gram or more in a 24-
hour urine specimen or dipstick urinalysis of 3+ or greater in two random urine 
samples collected at least 4 hours apart; cerebral or visual disturbances; elevated 
liver enzymes; thrombocytopenia; fetal growth restriction. HELLP was defined as 
a combination of platelet count <100x109/L, serum aspartate aminotransferase 
(ASAT) ≥30 U/L and serum alanine aminotransferase (ALAT) ≥30 U/L (2 SD above 
the mean in our hospital). Intrauterine growth restriction (IUGR) was defined as 
a birth weight below the 10th centile. 
At least six weeks postpartum, patients were tested for: anti-cardiolipin 
antibodies, lupus anticoagulans, APC-ratio, levels of protein C and S, 
homocysteine and heterozygosity for factor V Leiden and Prothrombin gene 
mutation. None of the patients were using vitamin supplements during the 
period of testing.  
The reference values for the coagulation assays were ascertained in a 
population of at least 40 normal male volunteers. Anti-cardiolipin antibodies 
were determined by enzyme-linked immunoassay (ELISA) according to the 
directives of Harris (normal values IgG and IgM <31 units GPL and <12 units MPL 
respectively). The presence of lupus anticoagulant was determined with the 
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diluted Prothrombin time (Recombiplastin, Instrumentation Laboratories, Italy, 
normal ratio < 1.20) and the activated partial thromboplastin time assay 
(Platelin, Organon Teknika, USA, normal value < 40 seconds). Effect of factor 
deficiency was eliminated by mixing 1:1 patient and normal pool plasma. Protein 
S (normal range 0.70-1.40 U/ml) was determined as protein S activity by a 
clotting assay (Diagnostica Stago, France) and as free protein S by an ELISA 
(Biopool, USA). Protein S deficiency is defined as an outcome of <0.70 (IU/ ml) 
for two assays at least 6 weeks apart without use of oral contraceptives. Protein 
C (normal range 0.70-1.40 U/ml) deficiency was determined by measuring 
protein C activity (IL Testkit ProclotTM Proclot, Instrumentation Laboratory, 
Italy) and protein C antigen by a house-made ELISA with the use of rabbit 
antihuman anti-protein C (Dako Cytomation, Denmark). Protein C deficiency is 
defined as an outcome of <0.70 (IU/ ml) for two assays at least 6 weeks apart.  
Serum homocysteine concentrations were measured both after (an 
overnight) fasting and 6 hours after an oral loading dose of L- methionine (0.1 
g/kg body weight). During the test the patients were given a standardized 
methionine-poor breakfast and lunch. EDTA-blood samples were kept on ice and 
plasma was separated within one hour for determination of homocysteine. 
Plasma total homocysteine was determined using HPLC with fluorescence 
detection. The patients were considered to have hyperhomocysteineamia if the 
fasting homocysteine concentration exceeded 15 µmol/L and/or the post-load 
value exceeded 45 µmol/L. 
Factor V Leiden and Prothrombin gene mutation were determined by 
polymerase chain reaction. 
Patients with an abnormal test result, except for factor V Leiden, 
Prothrombin gene mutation, and serum homocysteine concentrations were 
retested at least six weeks after the initial test. Only if the same abnormality was 
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confirmed a patient was considered positive for this coagulation abnormality. If 
a patient with an initial abnormal test result was not retested, the presence or 
absence of this coagulation abnormality was reported as missing. 
The percentage of placental infarction was estimated by combining 
macroscopy and microscopy of the placenta. Placental weight was measured 
without umbilical cord and membranes. The percentile was calculated according 
to a previous study102. 
The thrombophilia factors were tested for associations. If more than one 
thrombophilia measurements were missing, the category ‘one or more 
thrombophilia’ was also marked as missing. The phenotypes of preeclampsia 
tested for associations were: HELLP syndrome, IUGR, early (<34 weeks) or late 
onset (≥ 34 weeks), minimal (<10%) versus extensive (≥10%) placental infarction 
and normal (>5th centile) versus low (≤5th centile) placental weight.  
Furthermore, we did a factor analysis with a fixed 2-axis model. For this 
we defined 4 different subgroups with the 2 most important phenotypes of 
  
Table 2.2.1. General characteristics (N=844); values are presented as % of the study 
population (n) or as median (range). 
Maternal age at conception (years) 29 (17-43) 
Nulliparous 74% (627) 
Gestational age at delivery (weeks) 31 (27-40) 
Gestational age at onset of preeclampsia (weeks) 29 (15-40) 
Severe preeclampsia 91% (768) 
HELLP syndrome 49% (413) 
Intra uterine growth restriction 61% (512) 
Eclampsia 3% (28) 
Placental abruption 4% (30) 
Birth weight (grams) 1090 (275-3720) 
Birth weight percentile 3.1 (0-100) 
Fetal death 14% (116) 
Information on placental histology 65% (545) 
Placental weight (grams) 235 (45-700) 
Placental weight percentile 6.5 (0-100) 
Placental infarction (%) 5 (0-90) 
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preeclampsia: IUGR and HELLP. The 4 subgroups were defined as IUGR-HELLP-, 
IUGR+, HELLP-, IUGR-, HELLP+ and IUGR+HELLP+. For the above mentioned 11 
thrombophilia factors we used the continuous data for the analysis. If more than 
one sample was available, we used the result that was least abnormal. 
Associations of thrombophilia factors with the different phenotypes of 
preeclampsia and the factor analysis were done with the statistical software 
package IBM SPSS Statistics Version 20 (IBM Corporation, 2011) using X2-tests 
with continuity correction. Missing values were excluded for the analysis. A two-
sided p-value of less than 0.05 was considered statistical significant.  
RESULTS 
A total of 844 women were tested for thrombophilia. The general 
characteristics of these patients are summarized in table 2.2.1. Placental 
histology was available for 545 women. 
Table 2.2.2 shows the preeclampsia phenotypes and the prevalence of the 
thrombophilia. Overall 29% of the women had one or more abnormal 
thrombophilia results. Severe preeclampsia was significantly associated with a 
higher presence of one or more thrombophilia result (p=0.01) and with more 
prevalent Protein-S deficiency (p=0.01) compared to mild preeclampsia. 
IUGR was significantly associated with a higher presence of one or more 
thrombophilia factors (p<0.01) and more prevalent anti-phospholipid antibodies 
(p<0.01) compared to normal grown fetuses. Early onset preeclampsia 
(gestational age <34weeks at delivery) was significantly associated with a higher 
presence of one or more thrombophilia factors (p<0.01) and more prevalent 
anti-phospholipid antibodies (p=0.01) compared to late preeclampsia 
(gestational age ≥ 34weeks at delivery). Increased placental infarction (≥ 10% of 
48 | Part 2 Cardiovascular Health 
 
Table 2.2.2. Prevalence of thrombophilia factors (figures presented as % (total tested in subgroup), 
bold and greyed numbers represent p < 0.05) 
Factor Overall Preeclampsia severity HELLP syndrome 
   Mild Severe Absent Present 
≥1 thrombophilia factor 239/740 (32.3%) 12/68 (17.6%) 227/672 (33.8%) 108/369 (29.3%) 131/371 (35.3%) 
Anti-phospholipid 
antibodies 59/759 (7.8%) 3/72 (4.2%) 56/687 (8.2%) 27/391 (6.9%) 32/368 (8.7%) 
Protein-C deficiency 6/778 (0.8%) 0/72 (0.0%) 6/706 (0.8%) 2/395 (0.5%) 4/383 (1.0%) 
Protein-S deficiency 99/720 (13.8%) 2/66 (3.0%) 97/654 (14.8%) 43/354 (12.1%) 56/366 (15.3%) 
APC Resistance (FVL 
excluded) 45/640 (7.0%) 6/56 (10.7%) 39/584 (6.7%) 20/321 (6.2%) 25/319 (7.8%) 
Hyperhomocysteineamia 125/424 (29.5%) 6/30 (20.0%) 119/394 (30.2%) 51/193 (26.4%) 74/231 (32.0%) 
Factor V Leiden 
(heterozygous) 38/807 (4.7%) 1/75 (1.3%) 37/732 (5.1%) 20/410 (4.9%) 18/397 (4.5%) 
Prothrombin gene 
mutation (heterozygous) 25/806 (3.1%) 2/75 (2.7%) 23/731 (3.1%) 9/409 (2.2%) 16/397 (4.0%) 
           
  IUGR Gestational age 
   Absent Absent ≥34 weeks <34 weeks 
≥1 thrombophilia factor   74/295 (25.1%) 163/443 (36.8%) 49/208 (23.6%) 190/532 (35.7%) 
Anti-phospholipid 
antibodies   15/294 (5.1%) 44/463 (9.5%) 8/220 (3.6%) 51/539 (9.5%) 
Protein-C deficiency   3/311 (1.0%) 3/464 (0.6%) 2/229 (0.9%) 4/549 (0.7%) 
Protein-S deficiency   32/292 (11.0%) 67/425 (15.8%) 20/204 (9.8%) 79/516 (15.3%) 
APC Resistance (FVL 
excluded)   15/246 (6.1%) 28/392 (7.1%) 12/182 (6.6%) 33/458 (7.2%) 
Hyperhomocysteineamia   37/141 (26.2%) 88/283 (31.1%) 24/101 (23.8%) 101/323 (31.3%) 
Factor V Leiden 
(heterozygous)   11/322 (3.4%) 27/482 (5.6%) 6/237 (2.5%) 32/570 (5.6%) 
Prothrombin gene 
mutation (heterozygous)   9/321 (2.8%) 16/482 (3.3%) 4/237 (1.7%) 21/569 (3.7%) 
           
  Placental infarction Placental weight percentile 
   ≥10% <10% ≥10% <10% 
≥1 thrombophilia factor   120/351 (34.2%) 48/116 (41.4%) 82/217 (37.8%) 61/180 (33.9%) 
Anti-phospholipid 
antibodies   22/353 (6.2%) 16/121 (13.2%) 16/221 (7.2%) 10/185 (5.4%) 
Protein-C deficiency   3/368 (0.8%) 1/118 (0.8%) 1/230 (0.4%) 1/188 (0.5%) 
Protein-S deficiency   55/336 (16.4%) 19/113 (16.8%) 42/209 (20.1%) 24/176 (13.6%) 
APC Resistance (FVL 
excluded)   22/301 (7.3%) 6/103 (5.8%) 14/185 (7.6%) 9/159 (5.7%) 
Hyperhomocysteineamia   66/200 (33.0%) 20/78 (25.6%) 28/111 (25.2%) 46/117 (39.3%) 
Factor V Leiden 
(heterozygous)   21/380 (5.5%) 10/122 (8.2%) 12/237 (5.1%) 13/194 (6.7%) 
Prothrombin gene 
mutation (heterozygous)   13/380 (3.4%) 6/121 (5.0%) 9/237 (3.8%) 8/193 (4.1%) 
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Table 2.2.3. Odds-ratios for phenotypes of preeclampsia, grey cells flag p < 0.05 
Factor Model 1 Model 2 Model 3 
 IUGR without HELLP (cases = 241, controls = 190) 
One or more thrombophilia factor 2,02 (1,26-3,22) 1,87 (1,16-3,01) 1,79 (1,05-3,05) 
Anti-phospholipid antibodies 1,6 (0,7-3,67) 1,43 (0,61-3,32) 0,99 (0,39-2,53) 
Protein-C deficiency 0,85 (0,05-13,61) 0,98 (0,06-16,26) 2,93 (0,15-58) 
Protein-S deficiency 2,21 (1,11-4,39) 2,01 (1-4,04) 1,87 (0,86-4,03) 
APC Resistance (FVL excluded) 1,9 (0,71-5,07) 2,02 (0,74-5,53) 2,37 (0,8-7,01) 
Hyperhomocysteineamia 1,38 (0,71-2,68) 1,46 (0,74-2,86) 1,62 (0,75-3,49) 
Factor V Leiden (heterozygous) 1,58 (0,62-4,03) 1,45 (0,56-3,77) 1,16 (0,41-3,31) 
Prothrombin gene mutation (heterozygous) 0,65 (0,17-2,47) 0,53 (0,13-2,13) 0,42 (0,09-1,92) 
 HELLP without IUGR (cases = 138, controls = 190) 
One or more thrombophilia factor 1,54 (0,91-2,61) 1,41 (0,82-2,41) 1,39 (0,8-2,41) 
Anti-phospholipid antibodies 0,92 (0,32-2,66) 0,98 (0,33-2,88) 0,82 (0,27-2,44) 
Protein-C deficiency 2,81 (0,25-31,35) 2,43 (0,22-27,35) 2,22 (0,18-27,15) 
Protein-S deficiency 2,06 (0,97-4,34) 1,81 (0,85-3,87) 1,97 (0,89-4,33) 
APC Resistance (FVL excluded) 2,11 (0,73-6,12) 1,89 (0,64-5,55) 1,81 (0,61-5,41) 
Hyperhomocysteineamia 1,5 (0,7-3,18) 1,58 (0,73-3,4) 1,68 (0,77-3,67) 
Factor V Leiden (heterozygous) 0,77 (0,22-2,7) 0,68 (0,19-2,41) 0,51 (0,14-1,85) 
Prothrombin gene mutation (heterozygous) 1,09 (0,29-4,14) 1,01 (0,26-3,89) 0,98 (0,25-3,87) 
 HELLP and IUGR (cases = 271, controls = 190) 
One or more thrombophilia factor 2,21 (1,41-3,47) 2,05 (1,29-3,26) 2 (1,15-3,45) 
Anti-phospholipid antibodies 2,16 (0,98-4,73) 2,1 (0,95-4,67) 1,15 (0,46-2,88) 
Protein-C deficiency 1,45 (0,13-16,13) 1,4 (0,12-15,99) 3,11 (0,11-91,97) 
Protein-S deficiency 2,17 (1,12-4,23) 1,67 (0,84-3,34) 1,92 (0,85-4,35) 
APC Resistance (FVL excluded) 1,59 (0,6-4,24) 1,76 (0,64-4,83) 2,81 (0,89-8,89) 
Hyperhomocysteineamia 1,63 (0,88-3,03) 1,79 (0,95-3,36) 1,9 (0,91-3,97) 
Factor V Leiden (heterozygous) 1,47 (0,58-3,71) 1,41 (0,55-3,65) 0,84 (0,28-2,5) 
Prothrombin gene mutation (heterozygous) 1,76 (0,61-5,07) 1,63 (0,55-4,79) 1,51 (0,43-5,25) 
Controls: no IUGR and no HELLP 
Model 1: crude estimates 
Model 2: adjusted for maternal age at conception and nulliparous 
Model 3: model 2 + adjusted for gestational age at onset of preeclampsia 
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total volume) was significantly associated with more prevalent anti-phospholipid 
antibodies (p<0.01) compared to normal placental infarction (< 10% of total 
volume). A low placental weight (≤ 5th percentile) was significantly associated 
with more prevalent hyperhomocysteineamia (p=0.03) compared to normal 
placental weight (> 5th percentile). HELLP was not associated with any 
thrombophilia. The following thrombophilia factors were not associated with 
any phenotype of preeclampsia: Protein-C deficiency, APC-resistance, factor V 
Leiden mutation and Prothrombin gene mutation. 
Table 2.2.3 shows adjusted odds-ratios for thrombophilia factors if only 
HELLP or only IUGR is present. After adjusting for gestational age at onset of 
preeclampsia, correlations with IUGR disappear for Protein-S deficiency. 
The factor analysis with fixed 2-axis model performed poorly, only 
explaining 34% of the variance in the results of thrombophilia factors.  
DISCUSSION 
Thrombophilia was more present if the preeclampsia was severe, 
combined with IUGR, a delivery before the 34th week of gestation, placental 
infarction was more than 10% or placental weight was lower than the 5th centile. 
To our knowledge this is the largest cohort-study so far, testing for the 
association between different phenotypes of preeclampsia and thrombophilia. 
Previous studies show wide ranges in the prevalence of thrombophilia 
factors as shown in table 2.2.4. This is probably caused by differences in known 
confounders103 like laboratory methods, chosen cut-off points to define 
abnormal results, definition of the presence of thrombophilia factors (one or two 
positive tests), timing of the testing and heterogeneity of the cases race, 
gestational age at delivery and preeclampsia severity.  
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If preeclampsia was severe, we found a higher prevalence of Protein-S 
deficiency. Associations disappeared when testing for the other of preeclampsia. 
Two previous studies also found a significant association between severe 
preeclampsia compared to normal controls104 105. 
If preeclampsia was accompanied with IUGR, we found a higher 
prevalence of anti-phospholipid antibodies. Yasuda et al106 found similar results 
in 22 women with IUGR without preeclampsia, while another study did not find 
this association in 25 women107. Other studies did not perform a comparative 
analysis108 or were unable to do so because of a 94% incidence of IUGR in their 
cohort109. 
In early preeclampsia, we found a higher prevalence of anti-phospholipid 
antibodies. Another study did not show a difference in anti-phospholipid 
antibodies in women with preeclampsia that delivered before and after the 28th 
gestational week110. 
In case of increased placental infarction >10% we found a higher 
prevalence of anti-phospholipid antibodies. No previous study tested this 
association. 
In case of a low placental weight ≤ 5th percentile we found a higher 
prevalence of hyperhomocysteineamia. Only one previous study found an 
association between elevated homocysteine levels and placental 
vasculopathy138. One study showed an increased placental weight when folic 
acid supplementation was started preconceptionally139. Since folic acid lowers 
homocysteine levels, these and our results suggest that elevated homocysteine 
levels could impair placental growth capability. 
We found no association between HELLP and any kind of thrombophilia, 
unlike other studies99 105 116. The factor analysis did not show any association in 
the continuous results also. 
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Table 2.2.4. Overview of studies on preeclampsia and thrombophilia (C= cohort study, C-C= Case-control 
study, PC= prospective cohort study, SR= systematic review, SPE= severe preeclampsia, MPE= mild 
preeclampsia, PlacPath= placental pathology, ACA= anti-cardiolipin antibodies, LAC= lupus anti-coagulans,  
 Study-
Type 
  
n (PE) 
 AFS  
Study Comparisons All ACA LAC PCD 
Current C * 890 32.9% 9.0% 1.9% 0.7% 
        
1995, Dekker et al104 C ±SPE 101  28.4% 0.0% 1.2% 
2001, Many et al111 C ±SPE, ±IUGR, 
±PlacPath 
25 48.0%    
2002, Sikkema et al99 C-C ±PlacPath 47 68%  4% 7% 
2005, Mello et al105 C-C ±SPE, ±MPE 402 16.7% 3.2%   
2006, Van Rijn et al112 C PE±HELLP, 
PE±IUGR, ±28w 
120 24%  0.8% 2.5% 
2008, Muetze et al113 C ±HELLP 68     
2009, Facchinetti et al114 C 
 
±SPE 60 46.7% 35% 20%  
2009, Kahn et al115 C-C ±PE 113     
2010, Sep et al116 C PE±HELLP 75  8% 3% 0% 
2010, Sep et al116 C PE±HELLP 40  9% 0% 3% 
Robertson 2006117 SR ±PE, ±IUGR 481 8.9% 9.1% 2.9% 
1995, Yasuda et al106 PC PE±S, ±IUGR 22  31.2%  
1998, Nagy et al118 C-C ±SPE 69    
1999, Kupferminc et al119 C-C ±SPE, ±IUGR 34    
1999, Mello et al120 C-C ±PE 46  2.2% 2.2% 
1999, O’Shaughnessy et al121 C ±PE 283    
1999, Van Pampus et al110 C-C ±SPE, ±28w 345    
2000a, Kupferminc et al122 C-C ±SPE, ±MPE, 
±IUGR 
80    
2000b, Kupferminc et al123 C-C ±SPE 63 66.7% 3.2%  
2001, Alfirevic et al107 C-C ±SPE, ±IUGR 63  14.3% 9.5% 
2001, Dreyfus et al124 C-C ±PE 180  3.9% 0.6% 
2002, Agorastos et al125 C-C ±PE, ±IUGR 16    
2002, Benedetto et al126 C-C ±PE, PE±HELLP, 
PE±IUGR 
111    
2002, Currie et al127 C-C ±SPE 48    
2002, D’Elia et al128 C-C ±PE 58    
Rodger 2010129 SR ±PE, ±IUGR 1060    
2000, Murphy et al130 PC ±PE, ±IUGR 12    
2004, Salomon et al131 PC ±PE, ±IUGR 29 34.5%   
2005, Dizon-Thownson et al132 PC ±PE, ±IUGR 134    
2006, Lindqvist et al133 PC ±PE, ±IUGR, 
±33w 
34    
2008, Karakantza et al134 PC ±PE, ±IUGR 8    
2008, Dudding et al135 PC ±PE, ±IUGR 243    
2008, Clark et al136 PC ±PE, ±IUGR 66    
2010, Silver et al137 PC ±PE, ±IUGR 129 
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PCD= Protein-C deficiency, PSD= Protein-S deficiency, rAPC= APC-resistance, HHC= hyperhomocysteineamia, 
MLT= methionine loading test, FVL= factor V Leiden, PGM= Prothrombine gene mutation) 
 
   FVL PGM   
PSD rAPC HHC +/-, +/+ +/-, +/+ Country (Ethnicity) Special remarks 
13.5% 7.1% 28.9% 5.0% 2.9% Netherlands 91% severe PE, 2*positive = positive 
       
24.7% 16% 17.7%   Netherlands 100% severe, FVL not yet known 
 
 
    Israel Placental parameters 
13% 9% 57% 21%  Netherlands SPE and/or IUGR <34w, 1*pos = pos 
   3.2% 4.0% Italy, 100% Caucasian 100% mild PE 
1.7% 3% 17% 11%  Netherlands 100% early onset PE, 1*pos = pos; Only 
total thrombophilia factors compared 
   16.9% 4.2% Germany 100% HELLP 
  11.7% 28.3% 20% Italy, 100% Caucasian 60% severe PE, 2*pos = pos; Only total 
thrombophilia factors compared 
  5.4% 14.3% 2.7% Montreal, Canada ?% severe PE 
4%   2.0% 3% Netherlands 100% HELLP 
3%   13.0% 17% Netherlands 100% PE without HELLP 
5.0% 32.1% 11.3% 7.2%% 3.5% -  
     Japan 36% severe PE 
   18.8%  Hungary, 100% Cauc 100% severe PE 
   26.5% 5.9% Israel, 44% Ashkenazi 100% severe PE 
4.3% 26.1%  26.1%%  Italy, 100% Caucasian  
   5.3%  UK  
 11.3% 12.1% 6.0%  Netherlands 100% severe, 1*pos = pos 
    8.8% 
 
Israel, 96% Ashkenazi Severe PE (n=55); PGM 9.1% 
Mild PE (n=25): PGM = 8.0% 
7.9%   23.8% 7.9% Israel, 25% Ashkenazi 100% Severe PE 
 28.6%  1.6%  UK, 88% Caucasian 100% Severe PE 
     France 35% Severe PE 
   18.8% 0.0% Greece  
   7.2% 
 
7.2% Italy PE+HELLP (n=32): FVL 15.6%, PGM 6.4% 
PE+IUGR (n=31): FVL 9.6%, PGM 3.2% 
   8.3%  Australia 100% Severe PE 
   5.2% 1.7% Italy  
  5.1% 4.0%   
  0.0%  Ireland  
    Israel (only LAC, FVL, PGM) 
  3.7%  US, 69% Cauc, 10% 
African Amer, 19% Hisp 
 
 5.9%   Sweden  
  0.0% 0.0% Greece  
  7.0% 2.1% Australia  
  4.7%  Scotland  
   4.7% US, 31% Cauc, 34% 
African Amer, 33% Hisp 
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Our study found no association between any of the preeclampsia phenotypes 
and factor V Leiden. Previous cohort and case-control studies showed conflicting 
results on the association between the occurrence of preeclampsia and factor V 
Leiden105 107 113 115 116 118-120 123 125-128. However, reported prevalence range widely 
from 2% to 28%. Ethnicity may explain some of this variance, next to small study 
groups and bias due to study design. In larger studies110 121 as well as in 
prospective cohort studies (systematically review by Rodger et al129) prevalence 
ranged from 3-7%, showing no association with preeclampsia and are in line with 
our findings. This leaves factor V Leiden only a possible associated factor in 
Ashkenazi-Jews, but not in Caucasians. 
We found no associations with Prothrombin gene mutations. Previous 
cohort and case-control studies showed conflicting results105 113 115 116 119 122 123 125 
126 128. However, a systematic reviews of only prospective cohort studies129, 
showed no associations. 
We found no associations with Protein-C deficiency and (non-factor V 
Leiden) APC-resistance. Although the incidence in our population was very low, 
it confirms the findings in other studies107 116 120 123 124 133. 
This study has several limitations. Firstly, bias in patient inclusion before 
2006 could not be excluded. Until 2006 mainly severe cases of preeclampsia 
were being screened for thrombophilia. Since 2006 screening for thrombophilia 
is offered to all women with preeclampsia. Secondly, placental infarction was 
not scored using a standardized protocol, lowering the power of the findings 
with regard to placental infarction. Thirdly, the tests of association we 
performed were numerous, causing multiple-testing. Forth, abnormality of some 
factors of thrombophilia had a low prevalence in this population (Protein-C), 
leading to a probable power-problem. On the other hand, the low prevalence 
indicates a low clinical value, sustaining our conclusion. 
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The most important strength of this study is the high number of cases, 
which enabled comparisons between preeclampsia phenotypes. 
Overall, severe preeclampsia is associated with anti-phospholipid 
antibodies. This is mainly explained by the association with placental 
insufficiency (placental infarction and IUGR), but not with HELLP syndrome. We 
hypothesize that this is due to the fact that this thrombophilic factor does not 
act through systemic coagulation pathways, but at the placental side. Ernst et al 
report on the pathophysiologic mechanisms of anti-phospholipid syndrome140. 
The primary hypothesis is that anti phospholipid antibodies cause placental 
thrombosis, leading to placental infarction. The associations we found between 
anti phospholipid antibodies and placental infarctions, impaired fetal growth and 
deliveries before the 34th gestational week confirm this hypothesis, since the one 
phenotype is very likely to result from the other. 
One acting mechanism might be through Beta-2GP1 molecule, present on 
the surface of trophoblastic cell membranes. It appears to inhibit thrombosis by 
reducing the conversion of Prothrombin to thrombin on platelets and inhibiting 
the activation of the intrinsic coagulation cascade140. Beta-2GP1 antibodies block 
the Beta-2GP1 molecule, so it can no longer inhibit thrombosis. Another acting 
mechanism might be the disruption of annexin V, that normally binds to the 
phospholipid molecules on the surface of the trophoblastic membrane, 
preventing thrombosis by forming a protective protein coat. 
In 2012 the FRUIT-study, a randomized controlled trial studying the effect 
of low-molecular weight heparin on recurrence risk of preeclampsia in women 
with thrombophilia, suggests that if inheritable thrombophilia like Protein-S 
deficiency are present, administration of aspirin and low molecular weight 
heparin during a next pregnancy may decrease the recurrence risk141. Studies 
measuring the effect of low-molecular weight heparin on the recurrence risk of 
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preeclampsia in thrombophilic women with acquired thrombophilia like anti-
phospholipid syndrome are currently being conducted. 
In conclusion, phenotyping of preeclampsia can help to determine if 
screening for thrombophilia is warranted. We advise to screen for anti-
phospholipid antibodies after early onset preeclampsia, especially if complicated 
by IUGR. We do not recommend routine screening for thrombophilia and 
screening after other phenotypes of preeclampsia. We suggest that enough 
evidence is presented to conclude that associations between preeclampsia and 
thrombophilia are not clinically important and further studies should not be 
conducted. 
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ABSTRACT 
Postpartum lifestyle interventions are recommended for women after 
pregnancies complicated by preeclampsia, intrauterine growth restriction, 
and/or gestational diabetes, since they are at increased cardiovascular risk. To 
identify potential intervention strategies to reduce this risk, a systematic review 
of the literature is presented on the effectiveness of postpartum lifestyle 
interventions aimed at weight loss, smoking cessation, and smoking relapse 
prevention. The main characteristics of these postpartum lifestyle interventions 
are briefly described. The PubMed, Embase, Web of Science, PsychInfo, and 
Cinahl databases were searched for studies on the effects of postpartum lifestyle 
interventions on weight loss, and smoking cessation or prevention of smoking 
relapse, initiated for up to 1 year postpartum. No studies on the effectiveness of 
postpartum lifestyle interventions after the aforementioned specific pregnancy 
complications were found. However, 21 studies are included that describe 
existing postpartum lifestyle interventions, which were applied to unselected 
(on the basis of pregnancy complications) postpartum women. Six of 8 weight 
loss interventions, 4 of 5 smoking cessation interventions, and 4 of 8 smoking 
relapse prevention interventions were effective. Individually tailored counseling, 
group counseling sessions, and use of diaries or other correspondence materials 
were shown to be effective. Currently, postpartum lifestyle interventions 
tailored specifically for women who experienced the pregnancy complications 
are lacking. While awaiting their development, it seems reasonable to utilize 
existing lifestyle interventions shown to be effective in unselected postpartum 
women. 
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INTRODUCTION 
Women who have experienced preeclampsia, intrauterine growth 
restriction, and/or gestational diabetes are at increased risk to develop 
cardiovascular disease later in life compared with women who did not 
experience these complications1-3 10. Women with such complications more 
often exhibit cardiovascular risk factors, including higher circulating 
concentrations of fasting insulin, increased blood pressure, increased lipids, 
increased body mass index, and increased insulin resistance21 24 26 31 142-144. It has 
been suggested that women who have experienced these complications during 
pregnancy should be screened for postpartum cardiovascular risk factors, and 
should be offered a postpartum lifestyle intervention to reduce future 
cardiovascular morbidity and mortality24 142. Moreover, after a pregnancy 
complicated by preeclampsia, intrauterine growth restriction, and/or gestational 
diabetes, the immediate postpartum period is considered to be a window of 
opportunity for preventive interventions1. Lifestyle interventions have been 
effective in ameliorating risk factors for cardiovascular disease, by promoting 
smoking cessation and weight loss145 146, with substantial effects on 
cardiovascular risk reduction147. 
To date, however, few data are available to inform the choice of specific 
lifestyle interventions for promoting a healthy postpartum lifestyle after 
complicated pregnancy. Considering the specific challenges that women who 
have experienced complications face, such lifestyle interventions would ideally 
be tailored to the specific needs, characteristics, and preferences of these high-
risk women in order to promote participation and adherence to the intervention. 
For example, compared with women with an uncomplicated pregnancy, women 
who experienced pregnancy complications more frequently experience 
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emergency caesarean section, preterm birth, and admission to an intensive care 
unit. Furthermore, in the postpartum period, women who have experienced 
pregnancy complications more frequently report physical symptoms (e.g., 
headache and fatigue)148, cognitive difficulties (e.g., problems with 
concentration and memory)149, and emotional duress150 151. These postpartum 
problems can be important barriers to the adoption of a healthy lifestyle.  
In order to select an effective intervention strategy, an overview of the 
effects of existing postpartum lifestyle interventions is needed. Therefore, we 
present a systematic review of the literature on the effects of postpartum 
lifestyle interventions targeted at weight loss, smoking cessation, and smoking 
relapse prevention. The characteristics of these postpartum lifestyle 
interventions are also briefly described. After completion of this educational 
activity, physicians should be better able to counsel patients on how to apply 
existing postpartum intervention strategies aimed at weight loss, smoking 
cessation, and smoking relapse prevention to lower cardiovascular risk.  
METHODS 
Literature Search 
A systematic review of the literature up to May 2010 was conducted using 
the following computerized databases: PubMed, Embase, Web of Science, 
PsychInfo, and Cinahl. First, these databases were searched for literature on the 
effects of postpartum lifestyle interventions on weight loss, smoking cessation, 
and the prevention of smoking relapse, with specific regard to women who 
experienced preeclampsia, intrauterine growth restriction, and/or gestational 
diabetes.  
Since no articles on the effects of lifestyle interventions after these 
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pregnancy complications were found, a broader search, focusing on the effects 
of postpartum lifestyle interventions on weight loss, smoking cessation, and 
smoking relapse in unselected women was conducted using the following terms: 
puerperium or postpartum period or postpartum or postpartum and lifestyle or 
life style or risk reduction behavior or risk reduction behavior or health 
promotion or smoking cessation or weight loss or weight reduction or smoking 
relapse prevention. Articles retrieved from this search were copied to a 
reference library (EndNote) and duplicates, if any, were deleted.  
Selection Procedure 
First, the titles and abstracts of the retrieved articles were screened and 
labeled in EndNote. Articles were excluded when they were not written in the 
English language, when non-human research was described, when the study was 
not an original research article (e.g., a review article), when the study did not 
deal with the postpartum period, and when the study did not describe the effect 
of a lifestyle intervention.  
Second, the full texts of the remaining articles were examined. 
Additionally, a manual search of the reference lists of these articles was 
conducted. We included original research articles describing effects of 
postpartum lifestyle interventions that were initiated up to 1 year after delivery. 
Only articles that described the effects of postpartum lifestyle interventions for 
weight loss, smoking cessation, and smoking relapse prevention were included, 
since they address the established cardiovascular risk factors of 
overweight/obesity and smoking. Articles on the effects of lifestyle interventions 
on other outcome measures (e.g., fruit and vegetable intake or physical activity) 
were excluded, since our focus was on the effect of lifestyle interventions for 
established modifiable cardiovascular risk factors only. Furthermore, studies 
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without a control group, studies that did not describe the effect of a behavioral 
lifestyle intervention (e.g., that described the effect of reduced nicotine 
cigarettes), and studies on the effect of lifestyle interventions initiated during 
pregnancy were also excluded.  
Data Extraction 
For the articles included in the present review, the following 
characteristics were recorded: first author and year of publication, country, 
study design, interventions, participant demographics, sample sizes, 
measurements, and the effects of the interventions in terms of weight loss, 
smoking cessation, and smoking relapse prevention. With regard to weight loss, 
reported outcome measures were mean weight loss or weight retention in 
kilograms (kg) at follow-up, mean weight loss per time unit, and percentage of 
women who returned to their pre-pregnancy weight at follow-up. With regard 
to smoking cessation, reported outcome measures were number of cigarettes 
smoked (self-reported or biochemically validated), salivary cotinine levels, self-
reported and biochemically validated 7-day abstinence, 4-week point prevalence 
abstinence rates, quit rates, daily smoking rates, and percentages of women who 
reported sustained or continuous cessation. With regard to smoking relapse 
prevention, the following outcome measures were reported: relapse rates, 
percentage of nonsmokers, and percentage of women who reported sustained 
or continuous cessation.  
All reported outcome measures in the intervention group were compared 
to a control group. An intervention was considered to be effective when a 
significant difference (P < 0.050 was found between the intervention and control 
group for the outcome measure at follow-up. Study results were also interpreted 
in the context of the study design. A randomized controlled trial (RCT) was 
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considered to be the preferred study design with regard to interpretation of the 
effectiveness of the study. 
Additionally, when available, the following intervention characteristics 
were described: type of intervention, duration of the intervention, participant 
contact during the intervention (such as the number/type of contacts, e.g., face-
to-face or telephone contact), by whom the intervention was delivered, type of 
counseling, the materials and methods used during counseling, and (when 
applicable) the theoretical background of the counseling.  
Figure 3.1.1. Diagram showing the reasons for exclusion from the review and the number of 
excluded articles 
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RESULTS 
Study Selection 
After removal of duplicates, the searches in PubMed, Embase, Web of 
Science, PsychInfo, and Cinahl resulted in a total of 2590 articles. Of these, 33 
full texts were examined. The manual search provided an additional 2 full texts. 
From the 35 full texts screened, 21 articles were suitable for inclusion in this 
review (Figure 3.1.1). 
Data Extraction 
Table 3.1.1 gives an overview of the effectiveness of the included 
intervention studies. Details on the effects and characteristics of interventions 
aimed at weight loss are given in Table 3.1.2, and those aimed at smoking 
cessation or smoking relapse prevention in Table 3.1.3. 
Postpartum Lifestyle Interventions 
Weight Loss 
Tables 3.1.1 and 3.1.2 give an overview of 10 articles describing the effect 
of 8 lifestyle interventions on postpartum weight loss152-161. Of these 
interventions, 6 were diet and exercise interventions153-155 157-159 161, of which 5 
described statistically significant effects on weight loss153-155 157 159 161. In these 
latter studies, mean weight loss ranged from 1.9 kg157 to 7.8 kg154. One study 
reported no significant effect on weight loss158; however, a positive relation was 
found between the number of visits attended and weight loss (P = 0.01). 
Of the 2 other studies, 1 described the effect of an exercise intervention 
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Table 3.1.1. Summary of the Effectiveness of the Included Intervention Studies 
        First Author, year Country P 
 
Weight loss 
  
    Diet Intervention 
        De Castro, 2009160 
 
Brazil 
 
* 
    Exercise intervention 
        Lovelady, 1995156 and Dewey, 1994152 
 
USA 
 
NS 
    Combined diet and exercise intervention 
        Kinnunen, 2007153 
        Leermakers, 1998154 
        Lovelady, 2000155 and Lovelady, 2006161 
        McCrory, 1999157 
        Ostbye, 2009158 
        O’Toole, 2003159 
 
 
USA 
USA 
USA 
USA 
USA 
Finland 
 
# 
# 
* 
* 
NS 
# 
Smoking   
    Smoking cessation 
        Fossum, 2004162 
 
Sweden 
 
#@ 
    Smoking relapse prevention 
        French, 2007163 
        Van ’t Hof, 2000167 
        Johnson, 2000164 and Ratner, 2000165 
        Suplee, 2005166 
 
USA 
USA 
Canada 
USA 
 
# 
NS 
#$ 
NS 
    Combined smoking cessation and relapse prevention 
        Hannover, 2009170 
            Smoking cessation 
            Smoking relapse prevention 
        Roske, 2008171 
            Smoking cessation 
            Smoking relapse prevention 
        Severson,1997168 and Wall, 1995169 
            Smoking cessation 
            Smoking relapse prevention 
        Winickoff, 2010172 
            Smoking cessation 
            Smoking relapse prevention 
 
Germany 
 
 
Germany 
 
 
USA 
 
 
USA 
 
 
# 
NS 
 
# 
# 
#$ 
&$ 
 
NS 
NS 
Significance of the intervention effect *P<0.001, &P<0.01, #P<0.05, NS=Not Significant 
@This study reported conflicting results: while salivary cotinine levels indicated an effect 
on the smoking cessation intervention, the self-reported cessation rate indicated no 
intervention effect. 
$These interventions showed a significant intervention effect at 6 months postpartum. 
However, this effect was no longer significant at 12 months postpartum164 165 168 169 
 
70 | Part 3 Lifestyle intervention 
only, which had no significant effect on weight loss152 156, and 1 study described 
the effect of a diet intervention only, which did have a significant effect on 
weight loss160. 
Smoking Cessation and Smoking Relapse Prevention 
Tables 3.1.1 and 3.1.3 give an overview of 11 articles describing the effect 
of 9 interventions on smoking cessation and smoking relapse prevention162-172. 
One article described the effect of a postpartum smoking cessation intervention 
only162. Results of this study were contradictory. Although salivary cotinine levels 
indicated an effect of the smoking cessation intervention, the self-reported 
cessation rate indicated an opposite effect162. 
Five articles described the effect of 4 postpartum smoking relapse 
prevention interventions163-167. Of the 4 smoking relapse prevention 
interventions, 2 showed no significant effect on smoking relapse prevention166 
167. One smoking relapse prevention intervention was shown to be effective in 
preventing smoking relapse at 3 and 6 months postpartum163. Smoking 
abstinence at both 3 and 6 months postpartum was 18.2% in the intervention 
group compared with 5.2% in the control group. In this study, a prospective 2-
group design (not an RCT) was used to evaluate intervention efficacy163. The 
other smoking relapse prevention intervention was shown to have a significant 
intervention effect at 6 months postpartum. Daily smoking was reported in 34% 
of the intervention group, compared with 48% in the control group164 165. 
However, this intervention effect was not sustained at 12 months postpartum164 
165. 
Five other articles described 4 interventions aimed at both smoking 
cessation and smoking relapse prevention168-172. An intervention aimed at both 
smoking cessation and the prevention of smoking relapse evaluated in 2 studies 
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was shown to be effective in promoting smoking cessation and preventing 
smoking relapse at 6 months postpartum (P < 0.01)169. A 7-day abstinence rate 
was reported by 5.9% in the intervention group, compared with 2.7% in the 
control group; 45% of the intervention group reported smoking relapse 
compared with 55% of the control group. At 12 months postpartum, this effect 
was not sustained168. While 1 intervention demonstrated a significant effect on 
both smoking cessation and smoking relapse prevention at 6 months 
postpartum171, another failed to show significant effects at 3 months postpartum 
on either outcome measures172. The fourth intervention reported a small effect 
on smoking cessation (sustained abstinence rate of 3% in the intervention group 
compared with 0% in the control group) and no effect on smoking relapse170. 
Characteristics of the Interventions 
Of the 21 included articles, 14 were conducted in the United States152 154-
159 161 163 166-169 172 and the remaining 7 were conducted in Finland153, Sweden162, 
Canada164 165, Brazil160 and Germany170 171. Apart from 1 study that used a 
prospective 2-group design163 and one that used a prospective cohort design160, 
the studies were RCTs. The number of participants per study ranged from 33152 
156 to 1875168. 
Weight Loss 
Of the 6 effective weight loss interventions, 5 were individually tailored153-
155 157 159 161. The duration of these 6 effective interventions ranged from 11 
days157 to 9 months159. Only 1 study reported the use of a lifestyle intervention 
that was based on a theoretical background153. This latter study used the 
theoretical models of Laitakari and Asikainen173, PRECEDE-PROCEED174, and 
Stages of Change175. 
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Table 3.1.2. Description of postpartum lifestyle interventions and their effect on weight loss 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
Diet     
    De Castro, 2009, Brazil160 Prospective 
cohort 
High-protein (HP) 
diet n=261 
Low-protein (LP) 
diet n=160 
Pp women, recruited 
1-3d after delivery 
Mean age (SD): 
HP: 25.5 (6.0) 
LP: 26.7 (5.9) 
 
 
 
 
 
 
At 2, 6 and 9 mo 
pp 
Exercise     
    Lovelady, 1995, USA156 and 
    Dewey, 1994, USA152 
RCT I: Regular 
supervised 
exercise, n=18 
C: Exercise 
restricted to once a 
week, n=15 
Exclusively 
breastfeeding 
women, recruited 6-
8weeks pp 
Mean age: 
I: 31.1 
C: 29.7 
 
 
 
At 12-14 wk pp 
and at 18-20 wk 
pp 
Diet and Exercise     
    Kinnunen, 2007, Finland153 RCT I: Diet and physical 
activity, n=53 
C: Usual care, n=39 
Primiparas, recruited 
through public child 
health clinics at 3 mo 
pp 
Mean age (SD): 
I: 29.5 (3.9) 
C: 28.3 (4.4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 mo pp 
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Intervention Description Mean baseline 
Weight in kg 
(SD) 
Weight Loss 
   
High-protein (HP) diet: protein intake above or equal to 
1.2 g per kg per day of body weight. 
Low-protein (LP) diet: protein intake below 1.2 g per kg 
per day of body weight. 
HP: 59.4 (10.4) 
LP: 67.9 (11.6) 
At 6 mo pp, women with and HP diet 
lost more body weight than women 
with an LP diet 1.69 (3.7) vs 0.77 
(4.3) kg (p=0.08). 
Mean difference in body weight loss 
form baseline to 9 mo pp between 
the HP and LP groups was 0.84 kg 
(p=0.17). 
Women with an HP diet lost more 
(324 [0.06] g) per mo than women 
with a LP diet (P<0.00001). 
   
Regular supervised aerobic exercise (at a level of 60%-
70% of the heart rate reserve) for 45 min/d, 5d/wk for 
12 wk. Individually tailored exercise sessions. The 
program began with 20-min sessions, with 5-min 
increments every 3 d until the woman could complete 
45 min of continuous exercise at the target heart rate. 
I: 67.3 
C: 67.0 
At 12-14wk pp, women in the 
intervention group lost 0.60 kg, 
while women in the control group 
lost 1.00 kg. 
At 18-20 wk pp both women in the 
intervention group and in the 
control group had lost 1.60 kg 
Differences between the 
intervention group and the control 
group at both time points were NS. 
   
Individual counseling on diet and physical activity 
delivered by a public health nurse. Five visits at 2, 3, 5, 
6, and 10 mo pp. Counseling was based on the 
theoretical models of Laitakari and Asikainen173, 
PRECEDE-PROCEED174 and Stages of Change175. 
Individual physical activity counseling consisted of one 
primary counseling session (20-30 min) at the 2 mo pp 
and 4 booster sessions (10-15 min) at 3, 5, 6 and 10 mo 
pp. An individual weekly physical activity plan was 
composed, adherence to this plan was assessed and 
the plan was revised if needed. Also: option to attend 
supervised group exercise sessions, developed 
specifically for pp women, held once a week for 45-60 
min. 
The dietary counseling consisted of one primary 
counseling session (20-30 min) at 3 mo pp and 3 
booster sessions (10 min) at 5, 6 and 10 mo pp. After 
comparing the personal habits to the 
recommendations, the public health nurse and the 
participant discussed the need for dietary changes, as  
I: 67.1 (11.1) 
C: (64.7 (7.8) 
Weight 
retention (kg): 
I: 4.3 (4.0) 
C: 4.2 (3.9) 
Of the women in the I group, 50% 
(n=23) returned to their pre-
pregnancy weight at follow-up 
(weight retention ≤ 0 kg), while 30% 
(n=11) of the women in the C group 
did (p=0.06). OR 3.89 (95% CI: 1.16-
13.04, p=0.03). 
Mean weight retention in the I 
group (1.8 [4.3] kg) was not 
significantly different from weight 
retention in the C group (1.0 [4.4] 
kg) 
   
Continues on next page 
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Table 3.1.2. Continued 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
 
 
 
 
 
 
    
    Leermakers, 1998, USA154 RCT I: Behavioral 
weight loss 
intervention, n=47 
C: no treatment, 
n=43 
3-12mo pp non-
lactating women, 
exceeded pre-
pregnancy weight by 
at least 6.8 kg; BMI ≥ 
22 
Mean age (SD): 
I: 32.4 (4.5) 
C: 30.3 (5.6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directly after 
end at 6 mo 
    Lovelady, 2000, USA155 RCT I: diet and exercise, 
n=21 
C: no intervention, 
n=19 
Breastfeeding 
women, overweight 
(BMI 25-30) recruited 
at 4 wk pp 
Mean age (SD): 
I: 31 (4) 
C: 33 (4) 
 
 
 
 
14 wk pp 
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Intervention Description Mean baseline 
Weight in kg 
(SD) 
Weight Loss 
 
well as opportunities for and barriers to making the 
changes. Also received two take home leaflets on 
healthy diet. Weekly record of compliance with the 
individual objectives was kept. 
 
  
Diet: consisting of 1000-1500 kcal/d, with fat restricted 
to 20% of caloric intake. Physical activity: Aerobic 
exercise program: gradually increasing the frequency 
and duration of walking, until 2 miles/d on at least 
5d/wk was reached. Consistent with guidelines of all 
adults, American College of Sports Medicine (ACSM)187. 
Included 3 components: (1) Two group sessions (at 
beginning and at 2 mo). Discussion of eating and 
exercise progress and problem solving. (2) 
Correspondence materials. Consisted of 16 written 
lessons about nutrition, exercise and behavior change 
strategies. These lessons were sent weekly for the first 
12 wk, biweekly for the next 4 wk and monthly for the 
last 8 wk. Women were asked to monitor their calorie 
and fat intake and their exercise on a daily basis 
throughout the 6-mo program and return their record 
by mail. Behavioral lessons, which focused on strategies 
to modify diet and exercise behaviors, were tailored to 
the special needs of the new mothers. Each lesson 
included a 1 to 2-page homework assignment, which 
was to be completed and returned with the self-
monitoring diaries. (3) Brief telephone contacts, 5-15 
min, weekly or biweekly, depending on the 
participants’ desires and needs. The discussions 
focused on eating and exercise progress, goal setting 
and problem solving. 
 
I: 78.7 (11.2) 
C: 82.9 (15.2) 
Weight loss among women in the I 
group (7.8 kg) differed significantly 
form weight loss in the C group (4.9 
kg) at follow-up (p=0.03). 
Significantly more women in the I 
group (33%) returned to their pre-
pregnancy weight at follow-up than 
women in the control group (11.5%) 
(p<0.05). 
Diet: 500 kcal fewer than daily energy requirements. 
Diet prescription: 25% of energy from fat, 20% from 
protein, 55% from carbohydrate, with no less than 
1800 kcal (7531 kJ) total per day. Trained graduate 
research assistants used the Food Guide Pyramid188 to 
meet dietary recommendations. Food models were 
used to demonstrate portion size. Cognitive and 
behavioral strategies were discussed at individual 
weekly sessions. Six low-fat, low-calorie frozen dinners 
were provided each week. Exercise: brisk walking, 
jogging, or aerobic dancing at 65-80% of maximum  
I: 75.9 (9.3) 
C:76.8 (7.8) 
Women in the intervention group 
lost significantly more weight (4.8 
[1.7] kg) than women in the control 
group (0.8 [2.3] kg), (p<0.001) 
   
Continues on next page 
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Table 3.1.2. Continued 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
   
 
 
 
 
  
    Lovelady, 2006, USA161 RCT I: diet and exercise, 
n=19 
C: no intervention, 
n=16 
Breastfeeding 
women, overweight 
(BMI 25-30) recruited 
at 4 wk pp 
 
14 wk pp 
    McCrory, 1999, USA157 RCT Diet (D): n=22 
Diet and exercise 
(D+E): n=22 
C: n=23 
Exclusively 
breastfeeding 
women, recruited at 
12 (4) wk pp 
Mean age (SD): 32 (5) 
 
 
 
 
 
 
 
 
 
 
At 12 (4) wk pp 
+ 11 d 
    Ostbye, 2009, USA158 RCT I: n=225 
C: n=225 
Overweight or obese 
women BMI ≥25, 
recruited at 6 wk pp. 
Mean age (SD): 
I: 30.6 (5.8) 
C: 31.2 (5.3) 
1 mo after end 
at 12 mo pp 
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Intervention Description Mean baseline 
Weight in kg 
(SD) 
Weight Loss 
heart rate 4 times per week during 10 wk. Initial 
exercise session 15 min. The following sessions 
increased by 2 min/d until women were exercising with 
their target heart rate for 45 min. 
 
  
Same as Lovelady, 2000155 I: 75.9 (9.8) 
C: 77.2 (8.3) 
Women in the intervention group 
lost significantly more weight (4.8 
[1.6] kg) than women in the control 
group (0.8 [1.8] kg), (p<0.001) 
 
D: Aimed at 35% energy deficit. Diets were individually 
tailored and food was provided in preweighted 
amounts. 
D+E: Aimed at 35% net energy deficit, 60% by dietary 
restriction and 40% by additional exercise. Exercise was 
prescribed in terms of a target heart rate range (50%-
70% of maximal heart rate) and total time. Exercise 
sessions were self-supervised. Energy expended in 
exercise (based on heart rate monitoring) was checked 
every 1-3d during the intervention period, and the 
prescription was adjusted as necessary. 
C: Asked to maintain their weight during the 
intervention by maintaining their usual diet and activity 
patterns. 
 
D: 68.3 (10.2) 
D+E: 69.0 
(12.8) 
C: 68.5 (8.5) 
Women in the D group had lost 1.9 
kg, and women in the D+E group lost 
1.9 kg at follow-up, while the 
women in the C group had lost 0.2 
kg (p < 0.00001) 
Diet: Eight healthy-eating classes to reduce total caloric 
intake, increase in fruit and vegetable consumption. In 
the classes, women were taught practical skills shown 
to facilitate weight loss, including making choices that 
decrease consumption of high-fat, high-sugar foods and 
beverages; learning appropriate portion sizes; cooking 
easy, low-fat meals; making appropriate choices at fast-
food restaurants; and avoiding over-eating in stressful 
situations. Participants were provided with a study 
notebook with exercises and recipes. 
Ten physical activity classes: increasing physical activity 
to the recommended 30 min a day, 5 times a wk. 
Counseling sessions by a trained counselor: every 6 wk, 
lasting 20 min each, delivered primary over the phone, 
but occasionally in person. Consistent with motivational 
interviewing, the counselor utilized reflective listening 
techniques, self-motivational statements, and change 
talk to elicit participants’ personal behavioral goals and 
troubleshoot barriers to achieving them. Participants  
I: 88.7 (18.8) 
C: 88.4 (18.5) 
Mean weight at follow-up in I group 
was 87.8(20.7) kg, and in the C-
group 88.1 (20.2) kg. Mean weight 
loss was 0.9 (5.1) kg in the I group 
and 0.4 (4.9) kg in the C group; this 
difference was NS. There was a 
positive association between classes 
attended and weight loss (p=0.01). 
There were no significant 
differences between the 2 groups in 
other measures of weight change, 
including return to pre-pregnancy 
weight and percent weight loss. 
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Table 3.1.2. Continued 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
     
    O’Toole, 2003, USA159 RCT I: Structured diet 
and physical 
activity 
C: Self-directed 
diet and physical 
activity, n=40 
6 wk-6 mo pp 
overweight women 
Mean time since 
delivery (SD): 
I: 12 (5) wk 
C: 14 (4) wk 
Mean age (SD): 
I: 30.8 (4.2) 
C: 32.2 (4.9) 
 
 
 
 
 
 
 
 
 
 
 
 
At 1 yr pp 
     
Pp = postpartum; BMI = Body mass index; kg = Kilo grams; I = Intervention group; C = Control group; SD = 
Standard deviation; NS = Not significant; RCT = Randomized controlled trial; min = Minute(s); d = Day(s); wk = 
Week(s); mo = Month(s); yr = Year(s) 
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Intervention Description Mean baseline 
Weight in kg 
(SD) 
 
Weight Loss 
received a pedometer and a sport stroller. Control: 
biweekly newsletter with general tips for pp mothers. 
 
  
Diet: individualized from baseline measurement by a 
dietician to a deficit of at least 350 kcal/d. Exercise: 
individualized physical activity prescriptions from 
baseline measurement by an exercise physiologist to 
increase energy expenditure by at least 150 kcal/day. 
Kept daily food and activity diaries and met for group 
educational sessions dealing with nutrition and physical 
activity strategies. Group sessions: weekly for the first 
12 wk, biweekly for the following 2 mo, monthly 
thereafter until 1 yr pp. 
Self-directed intervention: met individually with a 
dietician and exercise physiologist for a single 1-h 
educational session about diet and physical activity. 
Received copies of the American Dietetic Association 
Brochure Nutrition and Health for women189, and the 
Food Guide Pyramid188. Also received copies of the 
ACOG brochure Exercise and Fitness: A Guide for 
Women190. 
 
I: 78.6 (1.6) 
C: 85.4 (3.5) 
After 12 wk of intervention, women 
on the I group had lost 5.6 kg, and 
women on the C group had lost 0.6 
kg (p<0.05). 
After 1 yr pp, women in the I group 
had lost 7.3 kg, while women in the 
C group had lost 1.3 kg (p<0.05). 
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Table 3.1.3. Description of postpartum lifestyle interventions and their effect on smoking cessation and 
smoking relapse 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
Smoking cessation     
    Fossum, 2004, Sweden162 RCT I: “smoke-free 
children” 
counseling, n=26 
C: Usual care, n=15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Smoking mothers, 
recruited 0-4 wk pp at 
child health center 
At 3 mo pp 
Smoking relapse prevention     
    French, 2007, USA163 Prospective 
2-group 
design 
I: brief 
intervention, 
n=122 
C: Usual care, n=97 
Women who had quit 
smoking during their 
pregnancy, and at 
least 7 d before 
deliver. 
Recruited during pp 
hospitalization. 
 
 
 
 
 
 
 
 
 
 
 
    Van ‘t Hof, 2000, USA167 RCT I: relapse 
prevention, n=141 
C: Usual care, 
n=146 
Smoking during the 
30 d before 
pregnancy and quit 
during pregnancy 
At 6 mo pp 
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Intervention Description Baseline 
values 
Weight Loss 
  
 
 
Counseling method “Smoke-free children” developed 
by Swedish child centers191. Based upon a client-
centered approach. Based on the principles developed 
by Greenberg et al192. Delivered by a child health nurse. 
Contacts at child health centers. 
Aimed at increasing self-efficacy. Five key elements: (1) 
asking what the mothers themselves know about the 
effects of smoking on children. (2) suggesting to the 
mothers that they register how much tobacco smoke 
there is in the child’s proximity. (3) discussing the 
results of the mothers’ survey and asking what they 
think about present smoking habits and whether they 
heave suggestions about possible changes. (4) 
supporting any attempt they might carry out to change 
smoking habits and discussing problems that may 
emerge. (5) supporting women who have stopped 
smoking during pregnancy to continue to refrain from 
smoking. 
Self-reported 
number of 
cigarettes: 
I: 13.1 (6.5) 
C: 10.8 (5.7) 
Biochemically 
validated 
number of 
cigarettes: 
I: 12.7 (6.6), 
n=22 
C: 8.4 (3.9), 
n=8 
Mean cotinine 
level: 
I: 185 ng/mL 
C: 245 ng/mL 
In the I group, the number of self-
reported cigarettes smoked was 
reduced with 0.3 at follow-up, 
compared to 2.6 in the C group 
(p<0.05). Mothers reported more 
smoking in the I group than in the C 
group. 
When biochemically validated, the 
number of cigarettes smoked in the I 
group increased with 0.2, while the 
number of smoked cigarettes in the 
C group decreased with 1.3 
however, salivary cotinine levels 
indicated a decrease of 20 ng/mL 
cotinine in the I group compared to 
a n increase of 101 ng/mL in the C 
group (p=0.03). 
Weak correlations between self-
reported smoking and cotinine-
levels were found. 
   
Home visiting program during hospitalization (5 min), 
home visit at 1 wk pp (15 min) and 2 follow-up 
telephone calls or home visits (15 min). Delivered by a 
nurse. Based on the principles of motivational 
interviewing193 194, Use of the US public health service 
clinical practice guideline: 5A’s177 178. Use of the 5 A’s of 
asking if the women smoked, advising her to quit, 
assessing her willingness to quit, assisting her in 
quitting and arranging a follow-up. Topics included: 
relapse prevention, stress management, skills building, 
trigger avoidance, relapse rehearsal, pp depression. 4-
part intervention: pp hospitalization: brief intervention 
(congratulations and encouragement) home visit at 1 
wk pp (smokers: 5A’s, non-smokers: encouragement 
and further problem solving) and 2 follow-up telephone 
calls or home visits (same status-dependent content). 
 
All women had 
quit smoking 
during 
pregnancy: 
100% 
abstinence 
Smoking abstinence at 3 mo pp was 
26.4% in the I group, compared to 
12.4% in the C group (OR 2.4, 95% CI 
1.16-4.98). 
Smoking abstinence at 6 mo pp was 
21.5% in the I group compared to 
10.2% in the C group (OR 2.5, 95% CI 
1.13-5.71). 
Smoking abstinence at both 3 and 6 
mo pp was 18.2% in the I group 
compared to 5.2% in the C group 
(OR 2.4, 95% CI 1.16-4.93). 
Biochemically verified (salivary 
cotinine level < 14 ng/mL). 
Counseling delivered by nurse and the pediatric 
provider: during the hospital stay (15-30 min), 2wk pp 
and at 2 “well baby” visits (2 and 4 mo pp). The nurse 
delivered counseling during the first visit, the pediatric  
287 quitters 41% of the women in the I group 
relapsed to smoking (any smoking 
during the last 7 d), compared to 
37% of the women in the C group  
   
Continues on next page 
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Table 3.1.3. Continued 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
 
 
 
 
 
  
 
 
 
 
 
  
    Johnson, 2000, Canada164 RCT I: brief in-hospital 
intervention 
C: Usual care, 
n=254 
Recruited while 
admitted to hospital 
for delivery. 
Stopped smoking at 
least 6 wk before 
delivery. 
Age 15-40 yr 
 
 
 
 
 
 
 
 
 
At 3 and 6 mo 
pp 
    Ratner, 2000, Canada165 RCT n=251  At 12 mo pp 
   
 
 
 
 
 
 
 
 
  
    Suplee, 2005, USA166 RCT I: counseling 
C: no intervention, 
n=62 
Enrollment during 
pregnancy, smoking 
cessation during 
pregnancy. 
Mean age: 
22.6, range 14-45 yr 
 
 
 
 
 
At 4-8 wk pp 
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Intervention Description Baseline 
values 
 
Weight Loss 
provider delivered counseling during the other 3 visits. 
Counseling about reason for maintaining cessation and 
help in developing a plan for doing so. 
Reinforcement if they quit and if not, given 
encouragement and a plan to try to quit again. 
 
 (NS). Biochemically validated with 
cotinine. 
Face-to-face in-hospital counseling sessions at birth, 
followed by 8 telephone follow-up sessions, home 
visits, or face-to-face visits outside the home during the 
first 3 mo pp. Delivered by a nurse. Sessions were 
weekly during the first mo pp and biweekly during the 
second and third mo pp. Counseling based on principles 
derived from Marlatt’s relapse model176 180. Aim 
counseling: teaching women to identify high-risk 
situations for smoking relapse and determining 
strategies to manage those situations, thereby 
strengthening their smoking cessation self-efficacy. The 
nurse supported efforts to maintain smoking 
abstinence, reviewing high-risk situations encountered 
and reviewed the lessons learned from any relapses. 
Supplemented with written materials. 
 
All women had 
stopped 
smoking 
during 
pregnancy. 
100% 
abstinence. 
Continuous abstinence rate at 3 and 
6 mo pp was 38% in the I group, 
compared to 27% in the C group. OR 
1.63, 95% CI 0.96-2.78. 
At 6 mo pp, daily smoking was 
reported in 34% of the I group, 
compared to 48% of the C group, OR 
1.80, 95% CI 108-2.99. Validated 
with CO in expired air. 
  At 12 mo, daily smoking was 41.2% 
in the I group and 50.4% in the C 
group, OR 1.45, 95% CI 0.87-2.43. 
Continuous abstinence rate at 6 and 
12 mo pp was 12% in the I group and 
18.5% in the C group, OR 1.17, 95% 
CI 0.62-2.22. 
Significant intervention effect at 6 
mo was not sustained at 12 mo pp. 
 
One brief (10-20 min) counseling session provided 
during the immediate pp hospitalization in the 
participants’ hospital room, delivered by a researcher. 
Using empowerment techniques, motivational 
interviewing193 194, identification of stressors and 
individual coping strategies, and educational material. 
Personal Rulers Worksheet61, Marlatt and Gordon’s 
relapse prevention model176 180. The participant 
received 4 different educational brochures developed 
by the American Lung Association and Agency for 
Health Care Policy and Research. 
 
All non-
smoking 
 
Relapse rate in the I group was 63%, 
compared to 75% in the C group 
(NS). 
Quit rate in the I group was 37%, 
compared to 25% in the C group 
(NS). 
   
Continues on next page 
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Table 3.1.3. Continued 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
Smoking cessation and smoking relapse prevention   
   Hannover,2009,Germany170 RCT I: smoking 
cessation and 
relapse prevention, 
n=299 
C: Usual care, 
n=345 
Pp women who 
smoked prior to or in 
pregnancy and who 
had quit no longer 
than 4 wk prior to 
pregnancy. 
Recruited directly 
after birth in 
maternity wards. 
Mean age (SD): 
I: 26.2 (5.7) 
C: 26.0 (5.4) 
 
At 6, 12, 18 and 
24 mo pp 
    Roske, 2008, Germany171 RCT I: smoking 
cessation and 
relapse prevention, 
n=239 
C: n=272 
Pp women who had 
smoked before 
pregnancy. 
Recruited at the time 
of giving birth. 
Mean age (SD): 
I: 26.7 (2.7) 
C: 26.0 (5.4) 
 
 
At 4 wk, 6 mo 
and 12 mo pp 
    Severson, 1997, USA168 RCT 
(MOMS-
study) 
Smokers: 
I: n=1073 
C: n=802 
Quitters: 
I: n=609 
C: n=417 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enrollment at 10-14 d 
pp 
Smoking 1 mo prior to 
becoming pregnant 
At 12 mo pp 
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Intervention Description Baseline 
values 
 
 
Weight Loss 
I: face-to-face counseling 40 d pp plus telephone 
counseling calls 4 and 12 wk later. Motivational 
interviewing193 194 and relapse prevention176 served as 
principles for the intervention. Counseling 
incorporated: information on the health effects of 
smoking and environmental tobacco smoke, balancing 
of the pros and cons of smoking, self-efficacy for 
behavioral change, reflecting previous, observed or 
imagined behavioral changes, exploring high-risk 
situations and relapse prevention strategies and the 
abstinence violation effect. 
C: usual care plus self-help material for each parent. 
 
Median = 35 d 
pp 
Smokers: 
I: n=151 (51%) 
C: n=187 (54%) 
Mean number 
of cigarettes 
per day (SD): 
I: 11.6 (6.9) 
C: 11.8 (7.5) 
With regard to smoking cessation, 4 
wk point prevalence abstinence 
rates were higher in the I group 
compared to the C group at 6, 12 
and 18 mo (7% vs 1%, 7% vs 2% and 
9% vs 1% respectively), p<0.05. 
Sustained abstinence was higher in 
the I group at 6 mo follow-up (3% vs 
0%), p<0.05. 
Small effect with regard to smoking 
cessation. No effect with regard to 
relapse prevention. 
I: home counseling sessions 4-6wk pp and 2 telephone 
counseling sessions 4 and 12 wk later. The counseling 
was conducted by 4 trained study co-workers. It was 
based on the principles of motivational interviewing193 
194 and tailored to the motivation stage of change. 
Both the I and C group received: a self-help manual 
addressing maternal smoking, smoking cessation and 
relapse prevention; and a manual addressing the 
partner of the participating women. 
Non-smokers: 
I: n=134 
(56.1%) 
C: n=145 
(53.3%) 
Women in the I group were 
significantly more likely to be non-
smokers 6 mo after the intervention 
(p<0.05). 
Membership in the I group 
significantly predicted non-smoking 
at 6 mo, but no 1 yr pp, after 
controlling for demographic, 
smoking and pp risk variables. 
 
Same intervention as Wall169 Smokers: 
n=1875 
Quitters: 
n=1026 
Smokers: at 12 mo pp 5.5% of the 
women in the I group reported to 
have quit smoking, vs. 4.7% of the 
women in the C group (NS). 
Continuous quit at both 6 and 12 mo 
pp was 2.3% in the I group and 1.2% 
in the C group (p<0.05). However, no 
effect was found on sustained 
quitting (OR 1.78, 95% CI 0.84-3.74). 
Quitters: at 12 mo pp 42.9% in the I 
group reported to still have quit, vs. 
39.1% in the C group. (NS). 
Continuous quit at both 6 and 12 mo 
pp was 32.8% in the I group and 
26.1% in the C group (p<0.05). No 
intervention effect was found on 
sustained quitting (OR 1.25, 95% CI 
0.93-1.68). The effect of the 
intervention at 6 mo pp was reduced 
at 12 mo pp. 
   
Continues on next page 
 
 
86 | Part 3 Lifestyle intervention 
  
Table 3.1.3. Continued 
    First Author, Year, Country Study 
Design 
Groups and 
Sample Sizes (n) 
 
Participants Follow-Up 
    Wall, 1995, USA169 RCT 
(MOMS-
study) 
I: extended 
intervention, 
smokers n=842; 
quitters n=514 
C: minimal 
intervention, 
smokers n=636; 
quitters n=344 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enrollment at 10-14 d 
pp 
Smoking 1 mo prior to 
becoming pregnant 
At end at 6 mo 
pp 
   Winickoff, 2010, USA172 RCT I: n=42 (32 women) 
C: Usual care, n=53 
(35 women) 
Parents (both fathers 
and mothers) who 
were current smokers 
(1 cigarette, even a 
puff, in past 30 d) or 
recent quitters 
(smoked since 1 mo 
before conception) 
Recruited directly pp 
Median age: 
I: 28 
C: 30 
 
 
 
 
At 3 mo pp 
     
Pp = postpartum; BMI = Body mass index; kg = Kilo grams; I = Intervention group; C = Control group; SD = 
Standard deviation; NS = Not significant; PC = Prospective cohort; RCT = Randomized controlled trial; min = 
Minute(s); d = Day(s); wk = Week(s); mo = Month(s); yr = Year(s) 
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Intervention Description Baseline 
values 
 
Weight Loss 
Pediatric office-based smoking intervention, delivered 
by a pediatrician. Implemented during ‘well baby’ office 
visits at 2 wk, 2, 4 and 6 mo pp. Duration of counseling 
1-2 min. 
Hospital packet containing written information about 
passive smoking and a letter advising them to quit + 
oral and written advice. 
Content of advice: adverse health effects of passive 
smoking, hints for quit strategies, role modeling and a 
letter to the fathers. Videotape: potential health effects 
of passive smoking, benefits of quitting. Brief discussion 
about amount smoked, barriers to quitting and results 
of past quit attempts. Smokers were asked whether 
they were willing to set a quit date. If mothers 
expressed a willingness to set a quit date, they were 
given the Freedom From Smoking materials developed 
by the American Lung Association and a list of local 
resources for assistance in quitting. They were 
encouraged to follow through and a project quit kit was 
distributed. Quitters were encouraged to stay quit. 
 
Smokers: 
n=1478 
Quitters: 
n=858 
Smokers: at 6 mo pp, 5,9% of the 
women in the I group reported a 7-d 
abstinence compared to 2.7% of the 
women in the C group (p<0.01). OR 
1.82, 95% CI 1.02-3.25. 
Quitters: At 6 mo pp, 45% of the I 
group reported smoking relapse, 
compared to 55% in the C group, OR 
1.56, 95% CI 1.16-2.10. 
I: one 15-min in-person counseling session delivered by 
trained study staff working from adapted materials and 
messages specifically tailored for parental smokers 
(available at: www.ceasetabacco.org); offer of 
enrollment in a proactive state-of-the-art telephone 
counseling session (QuitWorks, the Massachusetts 
statewide quitline) and letters faxed to the newborn’s 
pediatrician, parents’ primary care provider and 
mothers’ obstetrician indicating the parents’ tobacco 
use status and their readiness to quit and 
recommending useful strategies to facilitate parental 
cessation, the need for ongoing support and 
medication prescription when appropriate. The overall 
strategy was based on the 5A model177 178 and tailored 
to the circumstances of the parental smoker in the 
hospital setting when their child is hospitalized. 
 
Smokers: 
I: 69% (63% 
female) 
C: 62% (54% 
female) 
Median 
number of 
cigarettes per 
d: 
I: 4.4 
C: 5.0 
At 3 mo postpartum self-reported 7-
d point abstinence decreased from 
31% to 25% among I parents vs 38% 
to 23% among C subjects (effect size 
9.4%, NS). Among current smokers 
at baseline who were reached at 
follow-up (n=36), self-reported 
cotinine-confirmed 7-d abstinence 
rates at follow-up were 9% in the I 
group and 3% in the C group (NS). 
Among mothers who were smokers 
at baseline, 10% in the I group and 
5% in the C group self-reported 7-d 
abstinence at the 3 mo follow-up 
(NS). 
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Participants were recruited as early as 1 day after delivery160 and up to 12 
months postpartum154. Of the 6 effective intervention studies, 5 had specific 
participant inclusion criteria: 1 intervention included exclusively breast-feeding 
women157, 2 interventions recruited breast-feeding, overweight women155 161, 1 
intervention included non-breast-feeding, overweight women154, and another 
intervention included overweight women irrespective of breast-feeding159. 
Effective diet interventions consisted of a high-protein diet160, group 
sessions154 159, correspondence materials (e.g., homework assignments)154, 
telephone contact154, food diaries154 159, and individual counseling sessions153 161. 
In some interventions, food was provided in preweighed amounts155 157 161. Diet 
interventions were delivered by a dietician159, a public health nurse153, or a 
trained graduate research assistant161. 
Effective physical activity interventions consisted of self-supervised 
exercise sessions157, an aerobic exercise program154, an individualized activity 
plan159, correspondence materials154, telephone contact154, physical activity 
diaries154 159, individual counseling sessions153 and individualized exercise 
sessions161. Physical activity interventions were delivered by an exercise 
physiologist159, a public health nurse153, or a research assistant161. 
Smoking Cessation and Smoking Relapse Prevention 
A smoking cessation and smoking relapse prevention intervention that 
was found effective was office-based, delivered by a pediatrician, and 
implemented during 4 routine "well baby" office visits (from 2 weeks to 6 months 
postpartum)168 169. This intervention consisted of a hospital packet (containing 
written information about passive smoking and a letter advising women to quit), 
a videotape, and a brief discussion. Another effective intervention consisted of 
a home counseling session and 2 telephone counseling sessions, and was based 
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on the principles of motivational interviewing and motivational stages of 
change171. A third smoking cessation and smoking relapse prevention 
intervention that was shown to be effective in smoking cessation, but not in 
preventing smoking relapse, consisted of face-to-face and telephone counseling 
sessions based on the principles of motivational interviewing and relapse 
prevention170. 
One effective smoking relapse prevention intervention consisted of 9 
contacts during 3 months: one face-to face counseling session at birth followed 
by 8 telephone counseling sessions or home visits delivered by a nurse164 165. This 
intervention was based on Marlatt's relapse model176. Another effective smoking 
relapse prevention intervention was also delivered by a nurse, and consisted of 
4 home visits or telephone contacts over 2 months163. This intervention was 
based on the principles of motivational interviewing, and the "5As"177 178. 
Motivational interviewing is a directive patient-centered counseling technique 
that aims to promote intrinsic motivation for behavior change179. The "5As" refer 
to asking if the women smoked, advising her to quit, assessing her willingness to 
quit, assisting her in quitting, and arranging a follow-up. 
The smoking cessation intervention that reported conflicting results was 
based on a client-centered approach and aimed at increasing self-efficacy162. It 
was delivered by a child health nurse. 
DISCUSSION 
This extensive literature search identified existing postpartum lifestyle 
interventions that were shown to be effective in lowering cardiovascular risk 
factors in general populations of postpartum women. Although the immediate 
postpartum period after a pregnancy complicated with pre-eclampsia, 
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intrauterine growth restriction, and/or gestational diabetes is considered to be 
a window of opportunity for preventive interventions, no studies were identified 
which have specifically examined the effects of postpartum lifestyle 
interventions among women with such complications. Whether the 
interventions aimed at general populations of postpartum women identified in 
our present study will also be effective in women who have experienced 
complicated pregnancies should be the subject of further research. Awaiting the 
results of such future studies, utilization of lifestyle interventions that have been 
shown to be effective in postpartum women in general should be considered for 
use in women who have experienced complicated pregnancies. 
Specifically, the current review suggests that individually tailored 
postpartum weight loss interventions with both a diet and an exercise 
component might be used, since 5 out of the 6 interventions included in this 
review were effective. Group sessions, correspondence materials, telephone 
contact, food diaries, or individual counseling sessions may be effective in 
improving postpartum diet. Self-supervised exercise sessions, an aerobic 
exercise program, an individualized activity plan, correspondence materials, 
telephone contact, activity diaries, and counseling sessions could be used to 
promote postpartum physical activity. Home visits, face-to-face counseling, and 
telephone counseling, might be used to promote postpartum smoking cessation 
and prevent smoking relapse. 
Furthermore, the results of this literature study suggest that a theoretical 
background can be used to develop postpartum lifestyle interventions. For 
example, the theoretical models of Laitakari and Asikainen173, Precede-
Proceed174, and Stages of Change175 might be used in the development of weight 
loss interventions. Smoking cessation and smoking relapse prevention 
interventions could be based on the principles of motivational interviewing (49), 
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the "5As"177 178, and Marlatt's relapse model176 180. However, a theoretical 
framework that takes into account the context of the lives of women after 
pregnancies complicated by preeclampsia, intrauterine growth restriction, 
and/or gestational diabetes may more specifically contribute to the 
development of effective interventions to reduce cardiovascular risk in these 
women (56). To our knowledge, such a theoretical framework has not yet been 
described. 
Besides the interventions identified in his study, the results of other 
research, such as research on lifestyle and related factors among women with a 
recent pregnancy complicated by gestational diabetes, could also provide useful 
information to be taken into account when developing effective interventions 
for women who experience a complicated pregnancy181-185. For example, lack of 
time and childcare duties have been identified as barriers to physical activity, 
suggesting that interventions should preferably be delivered at variable hours 
and should entail minimal travel time. Also, involvement of family (e.g., to 
provide child care) is suggested to enhance participation. 
To our knowledge, only 1 study has explored the needs, ideas, and 
opinions of women who have experienced preeclampsia, intrauterine growth 
restriction, and/or gestational diabetes as they relate to postpartum lifestyle 
counseling186. This study showed that these women do perceive a need for 
postpartum lifestyle counseling and prefer to receive a combination of face-to-
face personal counseling, supported by computer-tailored lifestyle advice 
offered on the internet186. 
Methodological Considerations/Limitations 
Although the most relevant articles on the effectiveness of postpartum 
lifestyle interventions are probably in the English language, relevant non-English 
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literature might have been missed for inclusion in the present review. 
Additionally, although studies reporting nonsignificant results were retrieved in 
the literature search, due to publication bias ineffective interventions might 
have been underreported. Another limitation is that we did not assess the 
quality of the included studies. However, all included studies incorporated a 
control group in their design, and most of them were RCTs. Since the participants 
of the included studies were diverse (e.g., they differed with regard to breast-
feeding and baseline weight) and the interventions used were mostly unique 
across the included studies, we could not estimate overall mean effects in a 
meta-analysis. 
CONCLUSION 
In conclusion, existing postpartum lifestyle interventions might be used to 
achieve weight loss, smoking cessation, or to prevent smoking relapse in women 
who have experienced preeclampsia, intrauterine growth restriction, and/or 
gestational diabetes. Ideally, lifestyle interventions tailored for these high-risk 
women will be developed and tested. The interventions identified in this study 
could provide a solid starting point for the development of such tailored 
interventions. Future research should also focus on the long-term effectiveness 
of such interventions.
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ABSTRACT 
Objective This study addresses the following questions. Do cardiovascular risk 
factors fully explain the odds-ratio of cardiovascular risk after preeclampsia? 
What is the effect of lifestyle interventions (exercise, diet and smoking 
cessation) after preeclampsia on the risk of cardiovascular disease? 
Design Literature based study. 
Methods Data for the calculations were provided by studies, identified by 
Pubmed searches. First, the differences in cardiovascular risk factors after 
preeclampsia compared to an uncomplicated pregnancy were estimated. 
Second, the effects of lifestyle interventions on cardiovascular risk were 
estimated. Validated risk prediction models were used to translate these 
results into cardiovascular risk.  
Results After correction for known cardiovascular risk factors, the odds-ratio of 
preeclampsia for ischaemic heart disease is 1.89(1.76-1.98), and for stroke it 
is 1.55(1.40-1.71). Lifestyle interventions after preeclampsia on exercise, 
dietary habits and smoking cessation decreases cardiovascular risk with an 
odds-ratio of 0.91 (0.87-0.96). 
Conclusion Cardiovascular risk factors do not fully explain the risk of 
cardiovascular disease after preeclampsia. The gap between estimated and 
observed odds-ratios may be explained by an additive risk of cardiovascular 
disease by preeclampsia. Furthermore, lifestyle interventions after 
preeclampsia seem effective in decreasing cardiovascular risk. Future 
research is needed to overcome the numerous assumptions we had to make 
in our calculations. 
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INTRODUCTION 
Preeclampsia occurs as a complication in 2-8% of pregnancies4. After 
preeclampsia, women have an increased risk of cardiovascular disease, including 
ischaemic heart disease and stroke2. Moreover, since preeclampsia and 
cardiovascular disease share most risk factors like hypertension, obesity, 
diabetes, and hypercholesterolemia195 196, preeclampsia functions as a marker 
for cardiovascular risk1. However, it is not yet known whether preeclampsia itself 
independently adds to cardiovascular risk197 198. If this is true, then preeclampsia 
would be an independent risk factor, and not just a marker for cardiovascular 
disease. 
Furthermore, the burden of cardiovascular disease in women is high. In 
2004 cardiovascular disease accounted for 57.0% of global female mortality199. 
This emphasises the need for preventive lifestyle (or medical) interventions. 
Early detection of high-risk individuals maximises the effect of such 
interventions. After preeclampsia, women are thought to be good subjects for 
such interventions, since they are young and probably well motivated. Other 
authors have indeed suggested postpartum lifestyle interventions after 
preeclampsia to lower cardiovascular risk4 197. However, although previous 
research has shown that lifestyle interventions are effective if cardiovascular risk 
factors are already present200, the effect remains uncertain in the absence of 
cardiovascular risk factors201. Thus, since the majority of women after 
preeclampsia have no cardiovascular risk factors202 and studies of post-
preeclamptic lifestyle interventions are lacking, possible effects remain 
unknown. However, effects of lifestyle interventions after preeclampsia could be 
estimated. 
This study addressed the following questions. Do cardiovascular risk 
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factors fully explain the increased odds-ratios of cardiovascular risk after 
preeclampsia? What is the effect of lifestyle interventions after preeclampsia on 
the risk of cardiovascular disease? 
MATERIAL AND METHODS 
Estimating both the contribution of cardiovascular risk factors, as well as 
preeclampsia itself, on cardiovascular risk and the effect of lifestyle interventions 
on cardiovascular risk involves a number of steps. The estimation process is 
visualised in figure 3.2.1. 
Cardiovascular risk after preeclampsia (steps 1a-1f) 
In step 1a we searched for studies that reported on differences in 
cardiovascular risk factors between women with a history of preeclampsia 
compared to women with a history of an uncomplicated pregnancy. We focused 
on cardiovascular risk factors used in the prediction models in step 1c: systolic 
and diastolic blood pressure, cholesterol levels, weight, smoking, diabetes, 
familial cardiovascular disease and the level of C-reactive protein. A Pubmed 
search with the term “preeclampsia AND risk factors AND cardiovascular 
disease” was used to identify original case/control studies that reported on these 
cardiovascular risk factors after preeclampsia, see Figure 2. Preeclampsia was 
according to the International Society for the Study of Hypertension in Pregnancy 
(ISSHP) criteria, defined as a blood pressure of 140/90 mmHg or higher and 
proteinuria of at least 300 mg/day at a gestational age of at least 20 weeks. 
Studies with women with chronic hypertension were allowed, but we excluded 
studies that included women with pre-existing renal or cardiovascular disease. 
As for this and all other searches (steps 1c and 2a), publications until January 
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2010 were included, and Non-English and non-human studies were excluded.  
In step 1b we calculated the difference in cardiovascular risk factors 
between women with a history of preeclampsia and women with a history of a 
healthy pregnancy by subtraction. For each cardiovascular risk factor, the 
median value and interquartile range of the reported differences was calculated. 
This resulted in a collection of median differences of the cardiovascular risk 
factors as shown in the first column of table 3.2.1. 
In step 1c we searched for cardiovascular risk prediction models. A recent 
review by Cui et al203 was used to identify validated cardiovascular risk prediction 
models. An additional hand search provided the Framingham 30-years 
prediction model39. We used the original articles that reported on the 
Figure 3.2.1. Steps in estimating the contribution of cardiovascular risk factors, additive 
cardiovascular risk of preeclampsia and the effect of lifestyle interventions on future 
cardiovascular disease (numbers correspond with numbered steps in text).  
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coefficients that were used in the prediction models. The following models were 
used: MONICA37, PROCAM34, SCORE35, Eurostroke38, CUORE36, Framingham 30-
years prediction model39 and Reynolds Risk Score40.  
In step 1d we calculated the odds-ratios of cardiovascular risk between 
women with a history of preeclampsia and women with a history of a healthy 
pregnancy, based on the differences in cardiovascular risk factors as provided in 
step 1b. Here for we used the cardiovascular risk prediction models as supplied 
by step 1c. The interquartile range in step 1b was used to calculate a confidence 
interval of the odds-ratios. 
In step 1e the meta-analysis of Bellamy et al2 was used to provide the 
observed risk of cardiovascular disease after preeclampsia. This study reported 
separately on ischaemic heart disease and stroke. 
In step 1f we calculated the additive effect of preeclampsia on of 
cardiovascular risk, corrected for the cardiovascular risk factors as mentioned in 
step 1a. To obtain this effect the observed odds-ratios (step 1e) were divided by 
the calculated odds-ratios (step 1d), both for ischaemic heart disease and stroke. 
 
Estimated effect of lifestyle interventions on cardiovascular risk after 
preeclampsia (steps 2a-2d) 
In step 2a we searched PubMed for studies that reported on the effect of 
lifestyle interventions on cardiovascular risk factors. The recent review by our 
research group provided us with studies reporting on weight reduction and 
smoking cessation after pregnancy204. For improving the lipid profile and 
lowering blood pressure, we used the identical Pubmed search strategy as in the 
review: “(puerperium OR postpartum period OR postpartum OR post-partum) 
AND (lifestyle OR life style OR risk reduction behaviour OR risk reduction 
behaviour OR health promotion OR <specific search term>)”. As specific search 
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Figure 3.2.2. Pubmed searches (all searches included studies until January 2010). 
Search: preeclampsia AND risk factors AND cardiovascular disease 
      
  Pubmed hits Title and 
abstract 
Full text 
articles 
Included 
  878 723 21 13 
      
Exclusions (overlapping 
categories) 
    
 Non-human 11    
 Non-English 146    
 No report on outcome  699 7  
 Double dataset   1  
 
Search: (puerperium OR postpartum period OR postpartum OR post-partum) AND 
(lifestyle OR life style OR risk reduction behavior OR risk reduction behavior OR 
health promotion OR lowering blood pressure OR hypertension) 
      
  Pubmed hits Title and 
abstract 
Full text 
articles 
Included 
  2576 182 29 0 
      
Exclusions (overlapping 
categories) 
    
 Non-human 266    
 Non-English 342    
 No trial 2384    
 No lifestyle interventions  153   
 No report on outcome   29  
 
Search: (puerperium OR postpartum period OR postpartum OR post-partum) AND 
(lifestyle OR life style OR risk reduction behavior OR risk reduction behavior OR 
health promotion OR lowering lipids OR dyslipidaemia OR 
hypercholesterolemia) 
      
  Pubmed hits Title and 
abstract 
Full text 
articles 
Included 
  1134 105 28 0 
      
Exclusions (overlapping 
categories) 
    
 Non-human 123    
 Non-English 87    
 No trial 1026    
 No lifestyle interventions  77   
 No report on outcome   28  
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 term we used “lowering lipids OR dyslipidaemia OR hypercholesterolemia” and 
“lowering blood pressure OR hypertension”, respectively. Non-human studies 
and non-English articles were excluded. However, neither search provided any 
usable studies (figure 3.2.2). Therefore, we used the Cochrane Library to select 
studies reporting on the effects on lipid profile and blood pressure after primary 
interventions205. We selected studies reporting on effects in women aged 30-60 
years. Studies were categorised according to cardiovascular risk factor (table 
3.2.4). Next, for each cardiovascular risk factor the median value of the reported 
effects was calculated. This resulted in a collection of median effects of lifestyle 
intervention on the cardiovascular risk factors as shown in the second column of 
table 3.2.1. For each risk factor, a 1st and 3rd quartile value was calculated. 
In step 2b we calculated the difference in cardiovascular risk factors 
between women with a history of preeclampsia with or without lifestyle 
interventions. The same studies as found in step 1a were used. The reported 
values of women with a history of preeclampsia were considered to be without 
the effect of lifestyle interventions. To compile a new fictive dataset with values 
of women with a history of preeclampsia that would have had lifestyle 
interventions, the collection of median effects of lifestyle interventions (step 2a) 
was used to recalculate the values of the cardiovascular risk factors into new 
values, as if these women would have had lifestyle interventions after 
preeclampsia. 
In step 2c we calculated the difference in cardiovascular risk factors 
between women with a history of preeclampsia with or without lifestyle 
interventions. For each cardiovascular risk factor the median value and 
interquartile range of the difference between the original and the fictive, 
recalculated values as provided in step 2b was calculated by subtraction. This 
resulted in a collection of median differences of the cardiovascular risk factors 
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(values not shown). 
In step 2d we used the risk prediction models found in step 1c to calculate 
the odds-ratios of cardiovascular risk between women with a history of 
preeclampsia with or without lifestyle interventions, based on the differences of 
cardiovascular risk factors as provided in step 2c. The interquartile range in step 
2c was used to calculate a confidence interval of the odds-ratios.  
RESULTS 
Cardiovascular risk after preeclampsia 
The search in Step 1a resulted in 878 articles. As shown in figure 3.2.2, 13 
Table 3.2.1. Differences in cardiovascular risk factors in women 1 to 30 years after 
preeclampsia compared to controls without preeclampsia and estimated effects of lifestyle 
interventions programs. 
 
Differences of risk factors 
after preeclampsia 
compared to controls* 
Effect of lifestyle 
interventions ** 
Risk factor Median (IQR) Median (IQR) 
      
Potentially modifiable risk factors     
    Systolic blood pressure (mmHg) 7.5 (6.3-10.5) -2.4 (-5.7– -1.3) 
    Diastolic blood pressure (mmHg) 7.0 (5.0-9.0) -1.8 (-4.5 – -0.9) 
    Total cholesterol (mg/dl) 11.5 (5.0-18.0) -2 (-16 – -2) 
    HDL-Cholesterol (mg/dl) 0.0 (-1.5-0.0) 0 (-3 – -1) 
    Body mass index (kg/m2) 2.8 (1.8-3.0) -1.0% (-3.6% – 0.0%) 
    Smoking (%) -10.9% (-18.0%-5.0%) -2.2% (-7% – -0.7%) 
    Diabetes mellitus (%) 1.7% (0.0%-3.0%) No Data 
    Treatment for hypertension (%) 15.4% (12.3%-22.6%) No Data 
     
Non-modifiable risk factors     
    Familial CVD (<60y) (%) 22.2% (21.8%-26.3%)   
    (hs-)CRP (mg/l) 0.5 (0.42-0.59)   
IQR = Interquartile Range, CVD = cardiovascular disease, CRP = C-reactive protein 
*Based on reported studies listed in table 3.2.3. 
**Paired analysis before vs. after interventions, based on reported studies listed in table 
3.2.4. 
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articles were included. Screening the references of these articles resulted in an 
additional 3 studies. Table 3.2.3 lists all 16 studies included in the analysis 
categorised by cardiovascular risk factor. Of each cardiovascular risk factor the 
median and interquartile range of the difference between former preeclamptic 
women and women without a former preeclamptic pregnancy is shown in table 
3.2.1.  
The calculated odds-ratios based on these values are shown in table 3.2.2. For 
ischaemic heart disease a median odds-ratio of 1.14 was calculated based on the 
differences of cardiovascular risk factors after a history of preeclampsia 
compared to a healthy pregnancy. Dividing the observed odds-ratio of 2.16 with 
this calculated odd-ratio of 1.14, an odds-ratio of 1.89 (1.76-1.98) remained as 
the additive effect of preeclampsia to risk of ischaemic heart disease, corrected 
for cardiovascular risk factors. For stroke, an odds-ratio of 1.17 was calculated 
based on the difference of cardiovascular risk factors after a history of 
preeclampsia compared to a healthy pregnancy. Dividing the observed odds-
Table 3.2.2. Calculated odds-ratios (OR) for cardiovascular disease (CVD). 
 
OR for CVD after 
preeclampsia 
(preeclampsia vs. control) 
OR for CVD of hypothetical 
lifestyle interventions after 
preeclampsia 
(before vs. after) 
Risk prediction model OR (Q1-Q3*) OR (Q1-Q3*) 
Ischemic Heart Disease     
 MONICA37 1.23 (1.19-1.36) 0.92 (0.84-0.96) 
 PROCAM34 1.09 (0.98-1.23) 0.94 (0.88-0.97) 
 SCORE35 1.14 (1.02-1.30) 0.87 (0.81-0.96) 
Stroke     
 EuroStroke38 1.17 (1.06-1.29) 0.96 (0.91-0.98) 
Ischemic Heart Disease and 
stroke 
 
   
 CUORE36 1.31 (1.16-1.57) 0.88 (0.85-0.99) 
 Reynolds Risk Score40 1.42 (1.25-1.71) 0.87 (0.80-0.98) 
 Framingham 30y-BMI39 1.27 (1.10-1.46) 0.95 (0.87-0.98) 
 Framingham 30y-Lipids39 1.25 (1.10-1.49) 0.87 (0.83-0.98) 
 
3.2 Effect of Lifestyle Interventions after Preeclampsia| 105 
ratio of 1.81 with this calculated odds-ratio of 1.17, an odds-ratio of 1.55 (1.40-
1.71) remained as the additive effect of preeclampsia to risk of stroke, corrected 
for cardiovascular risk factors. 
Estimated effect of lifestyle interventions on cardiovascular risk after 
preeclampsia 
The included studies are listed in table 3.2.4 categorised by cardiovascular 
risk factor. Table 3.2.1 shows the median and interquartile range of the effects 
for each cardiovascular risk factor. 
Based on these values we estimated the odds-ratios for cardiovascular 
disease after lifestyle interventions in former preeclamptic women to be 
between 0.87-0.96 (table 3.2.2). 
DISCUSSION 
Main findings 
Our estimates showed that cardiovascular risk factors used in the 
prediction models did not fully explain the risk of cardiovascular disease after 
preeclampsia. A major part of the observed odds-ratios of cardiovascular disease 
after preeclampsia remained after adjustment for these cardiovascular risk 
factors. 
According to our estimates, lifestyle interventions after preeclampsia will 
decrease the cardiovascular risk by 4-13%. This might be an underestimation, 
since we had to use studies that did not account for possible motivational effects 
of having had preeclampsia186 205 206. On the other hand, the duration of follow-
up of the studies was well below the time-span of the prediction models. Thus, 
a possible rebound effect after cessation of the interventions would lower the 
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effect on cardiovascular risk. This might have led to an over-estimation of the 
possible effect. 
Interpretation 
We hypothesise that preeclampsia itself is a true risk factor, rather than a 
marker, for cardiovascular disease. Since transient endothelial dysfunction can 
last up to 2 years after preeclampsia202, it is likely that preeclampsia has a 
permanent effect on cardiovascular health. This may partly be reflected by 
permanent effects on cardiovascular risk factors. Indeed, Romundstad et al 
showed that the difference in cardiovascular risk factors of women after 
preeclampsia compared to women with a healthy pregnancy is 28-60% higher 
than the pre-pregnant difference207. However, preeclampsia may also directly 
increase cardiovascular risk through other yet unknown pathways. 
Another explanation of the found independent additive effect of 
preeclampsia on cardiovascular risk might be a higher prevalence of 
thrombophilic factors in formerly preeclamptic women. Indeed, thrombophilic 
factors like Protein-C and -S deficiencies increase the risk of early-life 
cardiovascular disease208 209. However, whether these thrombophilic factors are 
more prevalent in formerly preeclamptic women is still unclear, but is modest at 
best4. 
The studies we included to calculate the differences in cardiovascular risk 
factors between women with a history of preeclampsia and women with a 
healthy pregnancy (Table 3.2.3), were very heterogeneous. Preeclampsia has 
different phenotypes. For instance, preeclampsia can be early or late, severe or 
mild, with or without HELLP or IUGR. The observed odds-ratios we used were 
also based on very heterogeneous studies2. It is to be expected that each 
phenotype is differently associated with cardiovascular disease. 
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Limitations and strengths 
To calculate our results, we had to make several assumptions. The first 
assumption we made was that cardiovascular risk factors have the same effect 
on cardiovascular risk in women as they do in men, since the cardiovascular risk 
prediction models used were mainly based on male cohorts. However, it is 
suggested that cardiovascular disease in women might have a different 
pathogenesis than cardiovascular disease in men210. The second assumption we 
made was that the effects of lifestyle interventions after preeclampsia are the 
same as the effects of lifestyle interventions in general or after any pregnancy, 
because specific literature was lacking. The third assumption we made was that 
the effects of lifestyle interventions will last for the time-span of the 
cardiovascular risk prediction models (10-30 years) since the studies we could 
use lasted for at most 6 years. 
Our study has several limitations. First, the above-mentioned assumptions 
we had to make weaken the results of our study. Second, we only included 
studies that were published in Pubmed registered journals and that were written 
in English. This could have resulted in an overestimation in our calculations of 
the contribution of cardiovascular risk factors and effects of lifestyle 
interventions, due to publication-bias. Third, we were limited to use only 
cardiovascular risk factors that were used in the prediction models. Other 
cardiovascular risk factors, like ethnicity, apolipoproteins and others, we could 
not use in our model. This could have led to an over-estimation of the 
independent effect of preeclampsia on cardiovascular risk. Forth, due to 
heterogeneity of the included studies in table 3.2.3 and table 3.2.4, we could not 
perform meta-analyses for each risk factor. We therefor used less accurate 
medians and interquartile ranges in our calculations.  
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CONCLUSION 
Cardiovascular risk factors do not fully explain the risk of cardiovascular 
disease after preeclampsia. The gap between estimated and observed odds-
ratios may be explained by an additive risk of cardiovascular disease by 
preeclampsia. Furthermore, lifestyle interventions after preeclampsia seem 
effective in decreasing cardiovascular risk. 
Further studies should focus on the effects of post-preeclamptic lifestyle 
interventions on cardiovascular risk and cardiovascular risk factors. Preferably, 
follow-up would last for 10 to 30 years. This would eliminate the necessity to 
make the above-mentioned assumptions in our model. 
Since we found an additive effect of preeclampsia on future cardiovascular 
disease, possible prevention of preeclampsia by preconception or early-
pregnancy lifestyle modification is of even greater importance. 
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Table 3.2.3. Cardiovascular risk factors in women after preeclamptic pregnancies compared to normal 
pregnancies. 
  
 
PE Control ΔPE-Control ln(PE) ln(Contr) 
Systolic blood pressure (mmHg)      
          He 199921 120 108 12 4,79 4,68 
          Sattar 200325 124 116 8 4,82 4,75 
          Wolf 200427 111 105 6 4,71 4,65 
          Kaaja 200522 134 128 6 4,90 4,85 
          Girouard 200720 115 108 7 4,75 4,68 
          Manten 200724 127 116 11 4,84 4,75 
          Berends 200818 126 121 5 4,84 4,80 
          Gaugler-Senden 200819 130 115 15 4,87 4,75 
          Magnussen 200923 132 125 7 4,88 4,83 
          Smith 200926 120 111 9 4,79 4,71 
      
Diastolic blood pressure (mmHg)      
          He 199921 74 65 9 4,30 4,17 
          Sattar 200325 83 76 7 4,42 4,33 
          Wolf 200427 73 68 5 4,29 4,22 
          Kaaja 200522 79 76 3 4,37 4,33 
          Girouard 200720 75 70 5 4,32 4,25 
          Manten 200724 84 75 9 4,43 4,32 
          Berends 200818 81 75 6 4,39 4,32 
          Gaugler-Senden 200819 83 75 8 4,42 4,32 
          Smith 200926 81,5 72 9,5 4,40 4,28 
      
Use of anti-hypertensive drugs (%)      
          Sattar 200325 17,5 5,0 12,5   
          Wilson 20037 26,7 14,5 12,2   
          Berends 200818 19,1 0,9 18,2   
          Gaugler-Senden 200819 35,0 0,0 35,0   
          Magnussen 200923 9,6 2,2 -7,4   
      
Smoking (%)      
          He 199921 20,0 38,0 -18,0   
          Sattar 200325 22,5 15,0 7,5   
          Wolf 200427 7,0 3,0 4,0   
          Kaaja 200522 21,5 22,5 -1,0   
          Manten 200724 31,0 38,0 -7,0   
          Berends 200818 22,0 49,1 -27,1   
          Gaugler-Senden 200819 10,0 15,0 -5,0   
          Edlow 2009211 8,8 20,0 -11,2   
          Magnussen 200923 26,4 37,3 -10,9   
      
Total cholesterol (mg/dl)      
          Sattar 200325 201 182 19 5,30 5,20 
          Girouard 200720 184 176 8 5,22 5,17 
          Manten 200724 201 182 19 5,30 5,20 
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Δln(PE)-ln(Control) 
Mean or median time 
after PE (y) 
Mean age at 
follow-up (y) Special remarks 
    
0,11 4,5 37,5 56% severe preeclampsia 
0,07 19,0 42,0 Mainly late-onset preeclampsia 
0,06 1,5 35,2  
0,05 17,5 47,9  
0,06 8,1 35,8  
0,09 0,8 40,8 Early-onset preeclampsia 
0,04 7,0 36,2 Mainly late-onset preeclampsia 
0,12 5,5 37,7 Severe, early-onset preeclampsia 
0,05 16,6 39,9  
0,08 1,0 31,5 51% severe preeclampsia 
    
    
0,13 4,5 37,5 56% severe preeclampsia 
0,09 19,0 42,0 Mainly late-onset preeclampsia 
0,07 1,5 35,2  
0,04 17,5 47,9  
0,07 8,1 35,8  
0,11 0,8 40,8 Early-onset preeclampsia 
0,08 7,0 36,2 Mainly late-onset preeclampsia 
0,10 5,5 37,7 Severe, early-onset preeclampsia 
0,12 1,0 31,5 51% severe preeclampsia 
    
    
 19,0 42,0 Mainly late-onset preeclampsia 
 32,0 56,2  
 7,0 36,2 Mainly late-onset preeclampsia 
 5,5 37,7 Severe, early-onset preeclampsia 
 16,6 39,9  
    
    
 4,5 37,5 56% severe preeclampsia 
 19,0 42,0 Mainly late-onset preeclampsia 
 1,5 35,2  
 17,5 47,9  
 0,8 40,8 Early-onset preeclampsia 
 7,0 36,2 Mainly late-onset preeclampsia 
 5,5 37,7 Severe, early-onset preeclampsia 
 0,6 26,6  
 16,6 39,9  
    
    
0,10 19,0 42,0 Mainly late-onset preeclampsia 
0,04 8,1 35,8  
0,10 0,8 40,8 Early-onset preeclampsia 
Continues on next page 
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Table 3.2.3. Continued 
  
 
PE Control ΔPE-Control ln(PE) ln(Contr) 
      
          Berends 200818 186 209 -23 5,23 5,34 
          Gaugler-Senden 200819 193 189 4 5,26 5,24 
          Smith 200926 181 166 15 5,20 5,11 
      
HDL-cholesterol (mg/dl)      
          Sattar 200325 60 56 4 4,09 4,03 
          Girouard 200720 51 55 -4 3,93 4,01 
          Manten 200724 53 53 0 3,97 3,97 
          Berends 200818 50 50 0 3,91 3,91 
          Gaugler-Senden 200819 62 62 0 4,13 4,13 
          Magnussen 200923 56 58 -2 4,03 4,06 
          Smith 200926 57 58 -1 4,04 4,06 
      
BMI (kg/m2)      
          Marin 2000212 29,8 26,5 3,3 3,40 3,28 
          Sattar 200325 27,0 26,0 1,0 3,30 3,26 
          Wolf 200427 29,2 24,0 5,2 3,37 3,18 
          Kaaja 200522 27,7 26,2 1,5 3,32 3,27 
          Girouard 200720 26,9 24,7 2,2 3,29 3,21 
          Manten 200724 26,0 23,0 3,0 3,26 3,14 
          Berends 200818 27,2 24,4 2,8 3,30 3,20 
          Gaugler-Senden 200819 25,7 22,7 3,0 3,25 3,12 
          Edlow 2009211 29,3 29,3 0,0 3,38 3,38 
          Magnussen 200923 27,4 25,3 2,1 3,31 3,23 
          Smith 200926 29,0 26,0 3,0 3,37 3,26 
      
Diabetes (%)      
          Marin 2000212 1,9 2,3 -0,4   
          Kaaja 200522 3,4 1,7 1,7   
          Berends 200818 4,3 0,0 4,3   
          Gaugler-Senden 200819 0,0 0,0 0,0   
          Edlow 2009211 8,0 5,0 3,0   
      
Familial cardiovascular disease (<60y) (%)      
          Roes 2005213 53,9 31,7 22,2   
          Rigo 2006214 43,2 16,5 26,7   
          Valdés 2009215 42,2 20,5 21,7   
      
(hs-)CRP (mg/l)      
          Girouard 200720 1,8 1,2 0,6 0,59 0,18 
          Gaugler-Senden 200819 2,0 1,5 0,5 0,69 0,41 
          Smith 200926 2,9 2,5 0,4 1,08 0,93 
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Δln(PE)-ln(Control) 
Mean or median time 
after PE (y) 
Mean age at 
follow-up (y) Special remarks 
    
-0,12 7,0 36,2 Mainly late-onset preeclampsia 
0,02 5,5 37,7 Severe, early-onset preeclampsia 
0,09 1,0 31,5 51% severe preeclampsia 
    
    
0,07 19,0 42,0 Mainly late-onset preeclampsia 
-0,08 8,1 35,8  
0,00 0,8 40,8 Early-onset preeclampsia 
0,00 7,0 36,2 Mainly late-onset preeclampsia 
0,00 5,5 37,7 Severe, early-onset preeclampsia 
-0,04 16,6 39,9  
-0,02 1,0 31,5 51% severe preeclampsia 
    
    
0,12 14,2 43,3  
0,04 19,0 42,0 Mainly late-onset preeclampsia 
0,20 1,5 35,2  
0,06 17,5 47,9  
0,09 8,1 35,8  
0,12 0,8 40,8 Early-onset preeclampsia 
0,11 7,0 36,2 Mainly late-onset preeclampsia 
0,12 5,5 37,7 Severe, early-onset preeclampsia 
0,00    
0,08 16,6 39,9  
0,11 1,0 31,5 51% severe preeclampsia 
    
    
 14,2 43,3  
 17,5 47,9  
 7,0 36,2 Mainly late-onset preeclampsia 
 5,5 37,7 Severe, early-onset preeclampsia 
 0,6 26,6  
    
    
 N/A 34,0 Severe preeclampsia 
 N/A 28,7 Severe preeclampsia 
 N/A 60,9  
    
    
0,41 8,1 35,8  
0,29 5,5 37,7 Severe, early-onset preeclampsia 
0,15 1,0 31,5 51% severe preeclampsia 
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Table 3.2.4. Effects of lifestyle intervention programs 
 
Type of 
study Intervention n % women 
     
Systolic blood pressure (mmHg)     
          Gillet 1987216 RCT Tailored intensive aerobic exercise (I) 
vs commercial aerobic exercise (C) 
20 100% 
          HPTR group 1990217 RCT Dietary counselling (I) vs no dietary 
counselling (C) 
841 35% 
          Eriksson 1991218 RCT Dietary treatment and increased 
activity with annual check-ups (I) vs no 
intervention (C) 
181 - 
          Sjostrom 1999219 PC Diet & exercise (I) vs no intervention 
(C) 
380 100% 
          Stevens 2001220 RCT Group meetings and individual 
counselling for 3 years (I) vs usual care 
(C) 
595 34% 
     
Diastolic blood pressure (mmHg)     
          Gillet 1987216 RCT Tailored intensive aerobic exercise (I) 
vs commercial aerobic exercise (C) 
20 100% 
          HPTR group 1990217 RCT Dietary counselling (I) vs no dietary 
counselling (C) 
841 35% 
          Eriksson 1991218 RCT Dietary treatment and increased 
activity with annual check-ups (I) vs no 
intervention (C) 
181 - 
          Sjostrom 1999219 PC Diet & exercise (I) vs no intervention 
(C) 
380 100% 
          Stevens 2001220 RCT Group meetings and individual 
counselling for 3 years (I) vs usual care 
(C) 
595 34% 
     
Smoking cessation (% of women)     
          Wall 1995169 RCT Oral and written information and 
advice at 4 visits (I) vs written 
information once (C) 
1478 100% 
          Severson 1997168 RCT Oral and written information and 
advice at 4 visits (I) vs oral information 
and advice once (C) 
1875 100% 
          Glasgow 2000221 RCT Video, counselling and follow-up 
telephone calls (I) vs advice only (C) 
 
1154 100% 
          Solomon 2005222 RCT Free nicotine patches & 
proactive tel support (I) vs patches 
only (C) 
171 100% 
          Solomon 2005223 RCT Free nicotine patches & 
proactive tel support (I) vs patches 
only (C) 
171 100% 
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Age Group (y) 
Duration of 
Follow-up 
Lost to 
follow-up Effect Special remarks 
     
     
43,8 (5,7) 
 
16 weeks 6,0% 0,0  
25-40 
 
3 years 12,0% -2,4  
- 
 
 
6 years - -8,8 Men and women with IGT 
- 
 
5 years - -5,7  
30-54 
 
 
4 years 11,0% -1,3  
     
     
43,8 (5,7) 
 
16 weeks 6,0% 0,0  
25-40 
 
3 years 12,0% -1,8  
- 
 
 
6 years - -5,0 Men and women with IGT 
- 
 
5 years - -4,5  
30-54 
 
 
4 years 11,0% -0,9  
     
     
- 
 
 
6 months - -2,2% 2 weeks postpartum women 
- 
 
 
12 months - -0,7% 2 weeks postpartum women 
15-35 6 months 10,0% 0,0% Women attending planned parenthood 
clinics 
Biochemically validated 
33,7(8,9) 
 
 
3 months 6,0% -17,0% Low-income women 
Self-reported abstinence 
33,7(8,9) 6 months 13,0% -7,0% Low-income women; Self-reported 
abstinence; Measurements 3 months 
after stop program 
Continues on next page 
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Table 3.2.4. Continued 
 
Type of 
study Intervention n % women 
     
Total cholesterol (mg/dl)     
          Gillet 1987216 RCT Tailored intensive aerobic exercise (I) 
vs commercial aerobic exercise (C) 
20 100% 
          Baron 1990224 RCT Nutritional advice (I) vs no advice (C) 179 100% 
          Manning 1991225 RCT Strength training 3 sessions (I) vs no 
training (C) 
16 100% 
          Simkin 1995226 RCT Dietary & behavior intervention (I) vs 
no intervention (C) 
253 100% 
          Janssen 2002227 RCT Dietary treatment & aerobic exercise 
(I) vs dietary treatment only (C) 
11 100% 
          Janssen 2002227 RCT Dietary treatment & resistance 
exercise (I) vs dietary treatment only 
(C) 
14 100% 
          Cheng 2004228 RCT Monthly dietary counselling (I) vs no 
counselling (C) 
175 69% 
          Wister 2007229 RCT Health report card and counselling by 
telephone (I) vs usual care (C) 
315 45% 
     
HDL-cholesterol (mg/dl)     
          Baron 1990224 RCT Nutritional advice (I) vs no advice (C) 179 100% 
          Manning 1991225 RCT Strength training 3 sessions (I) vs no 
training (C) 
16 100% 
          Simkin 1995226 RCT Dietary & behavior intervention (I) vs 
no intervention (C) 
253 100% 
          Janssen 2002227 RCT Dietary treatment & aerobic exercise 
(I) vs dietary treatment only (C) 
11 100% 
          Janssen 2002227 RCT Dietary treatment & resistance 
exercise (I) vs dietary treatment only 
(C) 
14 100% 
     
Weight loss (% of baseline weight)     
          Lovelady 1995156 RCT Aerobic exercise 45min/d for 5d/w (I) 
vs no exercise 
33 100% 
          Leermakers 1998154 RCT Behavioral intervention 90 100% 
          McCrory 1999157 RCT 35% reduction in dietary energy intake 
(I) vs no reduction (C) 
45 100% 
          McCrory 1999157 RCT Combined 35% reduction in dietary 
energy intake and increased exercise 
(I) vs no reduction (C) 
45 100% 
          Lovelady 2000155 RCT Dietary restriction of 500 kCal/d & 
exercise 45 mins/d for 4d/w (I) vs no 
restriction or exercise (C) 
40 100% 
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Age Group (y) 
Duration of 
Follow-up 
Lost to 
follow-up Effect Special remarks 
     
     
35-57 
 
16 weeks 6,0% 0 Sedentary, overweight women 
25-60 1 year 9,0% -2  
22-57 
 
12,5 weeks 8,3% 0 Sedentary, obese women 
44-50 
 
6 months 2,8% -13  
24,8 (5,8) 
 
16 weeks 0,0% -16 Overweight, obese women 
24,8 (5,8) 
 
 
16 weeks 0,0% -23 Overweight, obese women 
52,80 
 
4 months 16,0% -15 Hypercholesterolemic, non-medicated 
patients 
55,80 
 
1 year 11,7% -16 10y-framingham score >= 10% 
     
     
25-60 1 year 9,0% 0  
22-57 
 
12,5 weeks 8,3% -3 Sedentary, obese women 
44-50 
 
6 months 2,8% -2  
24,8 (5,8) 
 
16 weeks 0,0% -1 Overweight, obese women 
24,8 (5,8) 
 
 
16 weeks 0,0% -3 Overweight, obese women 
     
     
30,5 
 
12 weeks - 0,0% Breastfeeding women 
32,4 (4,5) 6 months 23,0% -4,0% Women at 3-12 months postpartum 
32 (5) 
 
11 days - -2,5% Breastfeeding women 
32 (5) 
 
 
11 days - -2,0% Breastfeeding women 
31 (4) 
 
 
10 weeks 16,7% -5,3% Breastfeeding, overweight women 
Continues on next page 
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Table 3.2.4. Continued 
 
Type of 
study Intervention n % women 
     
          O’Toole 2003159 RCT Weekly counselling of diet and physical 
activity (12 weeks total) and daily food 
and activity diaries (I) vs 1-hour 
educational session (C) 
40 100% 
          Lovelady 2006161 RCT Dietary restriction of 500 kCal/d & 
exercise 45 mins/d for 4d/w (I) vs no 
restriction or exercise (C) 
45 100% 
          Kinnunen 2007153 RCT 5 counselling sessions on diet and 
physical activity (I) vs usual care (C) 
92 100% 
          De Castro 2009160 PC High Protein-intake (I) vs low-protein 
intake (C) 
421 100% 
          Ostbye 2009158 RCT 18 health classes and 6 telephone 
counselling sessions (I) vs no 
intervention (C) 
450 100% 
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Age Group (y) 
Duration of 
Follow-up 
Lost to 
follow-up Effect Special remarks 
     
31,5 (4,6) 
 
 
 
1 year - -7,8% 1-6 months postpartum, overweight 
women 
- 
 
 
5 years - 0,0% Breastfeeding, overweight women 
29,0 (4,1) 
 
8 months - 0,0% 2 months postpartum women 
 
 
9 months - 0,0% 1-3 days postpartum women 
30,9 (5,6) 
 
 
10 months - 0,0% 2 months postpartum, overweight 
women 
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ABSTRACT 
Objective To describe women’s preferences for postpartum lifestyle counseling 
after a pregnancy complicated by preeclampsia, intrauterine growth 
restriction and/or gestational diabetes.  
Methods 
 Thirty-six women who had experienced these pregnancy complications 
participated in six focus group interviews. 
Results All women expressed a need for participation in postpartum lifestyle 
counseling. They preferred participation to be tailored to individual 
preferences. A combination of face-to-face counseling supported by 
computer-tailored lifestyle advice appealed to them. 
Conclusion Postpartum lifestyle counseling aimed at these women should be 
tailored to individual needs and preferences. 
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INTRODUCTION 
Epidemiological data indicate that an obstetric history of preeclampsia, 
intrauterine growth restriction and/ or gestational diabetes is associated with a 
significantly increased risk for remote cardiovascular diseases, such as 
hypertension, myocardial infarction, ischemic heart disease, and 
cerebrovascular accidents230. Women who have experienced these pregnancy 
complications share cardiovascular and metabolic risk factors, such as abdominal 
obesity, insulin resistance, atherogenic dyslipidemia, and elevated blood 
pressure51.  
 It is suggested that lifestyle-related risk factors should primarily be 
targeted to reduce cardiovascular and metabolic risk in women who have 
experienced these pregnancy complications51. Research in other high-risk groups 
has shown that lifestyle interventions have been effective in lowering risk factors 
for cardiovascular disease231-234 and diabetes mellitus type II58 59. Potentially 
modifiable lifestyle-related risk factors associated with cardiovascular disease 
are consumption of saturated fat, fruit, vegetables, and alcohol, physical activity, 
smoking, and psychosocial factors235.  
Currently, in the health care setting, tailored interventions (such as face-
to-face counseling) are widely applied. Such interventions are intended to reach 
one specific person, are based on characteristics that are unique to that person, 
are related to the outcome of interest, and have been derived from an individual 
assessment236 237.  
However, in the last decades, potentially important new channels for 
health communication have emerged, such as computers and the Internet238. 
Computer-tailored lifestyle counseling (e.g., computer-tailored nutrition 
education) can provide people with both individualized feedback and advice on 
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personal performance levels (e.g., nutritional intake) and awareness of their own 
performance, as well as personal motivation to change, goals, outcome 
expectations, subjective norms, self-efficacy, self-regulation processes and other 
possible behavioral determinants237 239. Now that computer-tailored health 
education is recognized as a promising health education strategy, computer-
tailored lifestyle interventions for various behaviors are currently offered on the 
World Wide Web65 240 241. 
Considering the individual differences in pregnancy complications and 
their consequences, physical and psychological recovery, and other personal 
factors (e.g., education and family composition), the use of tailored lifestyle 
interventions seems to be highly suitable. For example, face-to-face lifestyle 
counseling or computer-tailored lifestyle advice might be offered. Moreover, 
tailoring a lifestyle intervention to the specific characteristics and preferences of 
these high-risk women is expected to promote participation and adherence to 
the intervention. In the process of developing such a tailored intervention, 
opinions, needs, and ideas of women who have recently experienced such 
pregnancy complications should be taken into account. 
Although the postpartum period after a pregnancy complicated with 
preeclampsia, intrauterine growth restriction and/or gestational diabetes, is 
considered to be a window of opportunity for preventive interventions shortly 
after delivery1 230, little is known about what the lifestyle interventions aimed at 
these high-risk women should consist of. Up to now, little information is 
available about women’s preferences regarding postpartum lifestyle counseling. 
Therefore, we conducted focus group interviews among women after a 
pregnancy complicated with preeclampsia, intrauterine growth restriction 
and/or gestational diabetes in order to document their needs, opinions, and 
ideas regarding postpartum lifestyle counseling. Two different types of lifestyle 
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interventions were discussed: face-to-face counseling by a health care specialist 
and computer-tailored lifestyle counseling.  
METHODS 
Participants  
Patients with pregnancies complicated by preeclampsia, intrauterine 
growth restriction and/or gestational diabetes who had given birth in the 
Erasmus University Medical Center in Rotterdam between November 2004 and 
October 2006, were eligible for participation in the focus group interviews. By 
searching hospital records, 182 eligible patients were selected and invited by 
mail to participate in the focus groups.  
Preeclampsia was diagnosed according to ISSHP criteria. Intrauterine 
growth restriction due to placental insufficiency was defined when the ultrasonic 
fetal abdominal circumference was below the 5th percentile in combination with 
abnormal Doppler patterns of the umbilical artery (pulsatility index above the 
95th percentile and/or in case of absent or reversed end diastolic flow)242. 
Patients were diagnosed with gestational diabetes when 1-hour postprandial 
glucose level was above 7.0 mmol/l243.  
A complication was defined as severe when delivery occurred at a 
gestational age of 32 weeks or less, when the newborn was admitted to the 
neonatal intensive care unit, or in case of perinatal mortality83.  
Procedure 
The study was approved by the Medical Ethical Committee of the Erasmus 
University Medical Center. Focus group interviews were held at the Erasmus 
University Medical Center in December 2006 and February 2007, and lasted 
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about 60 minutes each. Prior to the interviews, participants provided informed 
consent and completed a questionnaire assessing ethnicity (Dutch, non-Dutch), 
level of education (primary school, secondary school, and higher education) 
smoking (yes, no), and self-reported weight and height. A moderator (M.H.), 
assisted by a facilitator (D.B/ W.B), led the focus group interviews. Interviews 
were audiotaped, and were held in line with focus group principles provided by 
Morgan et al244. A semi structured focus group discussion guide was used to 
structure discussion topics.  
Analysis 
Questionnaire 
Self-reported weight and height were used to calculate the body mass 
index (BMI). A BMI of 25 or higher was defined as overweight and 30 or higher 
as obesity. Birth weight and gestational age at delivery were retrieved from 
hospital records. A participant was designated to be of non-Dutch ethnic origin 
if one of her parents was born abroad245. Educational level was assessed by the 
highest completed education and reclassified into three categories: 1) primary 
school, 2) secondary school and 3) higher education246.  
Interviews 
Focus groups were audiotaped, transcribed verbatim, and checked for 
accuracy. After transcripts were made, a qualitative data analysis program (the 
software package QSR Nvivo, version 7) was used to analyze the transcripts in 
accordance with content analysis principles244. Discussion topics were identified, 
sorted, and labeled according to the technique of content analysis. A systematic 
summary of what each group said about a topic was made. Discussion topics 
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were examined across groups and for all groups combined. Discussion topics 
addressed in the interview guide were preferred characteristics of the 
postpartum lifestyle counseling, face-to-face lifestyle counseling, and computer-
tailored lifestyle counseling. To illustrate some findings, quotations are reported.    
  
Table 3.3.1. Demographic data and clinical characteristics of the study participants. 
 n (%) Mean (SD) Range 
Women     
   Age (years) 
    
36  32.7 (4.5) 
 
22 -41 
   Ethnicity 
      Dutch 
 
20 
 
(55.6%) 
 
 
 
 
   Educational level 
      Primary school 
      Secondary school 
      Higher education 
 
 
5 
15 
14 
 
 
(14.7%) 
(44.1%) 
(41.2%) 
 
 
 
 
     
   Smoking 
      Yes 
 
3 
 
(8.3%) 
 
 
 
     
   Body mass index  
       25-30 
        30 
 
12 
4 
 
(36.4%) 
(12.1%) 
24.8 (4.9) 
 
 
17.1-39.3 
     
   Pregnancy complication 
       Preeclampsia  
       Intrauterine growth restriction 
       Gestational diabetes   
       Preeclampsia and intrauterine growth 
                                                     restriction  
 
21 
4 
5 
6 
 
(16.7%) 
(58.3%) 
(11.1%) 
(13.9%) 
  
     
Offspring     
   Birth weight (g) 36  2352 (1155) (690-4360) 
   Gestational age at delivery (days) 36  246 (4.9) (184- 290) 
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RESULTS 
Participants 
Of the 36 women participating in the focus group interviews, 21 had 
experienced preeclampsia, 4 intrauterine growth restriction, 5 gestational 
diabetes, and 6 women had experienced both preeclampsia and intrauterine 
growth restriction. The number of participants per group ranged from 4 to 10 
(average 6). See table 3.3.1 for demographic data and clinical characteristics of 
the study participants. 
Postpartum Lifestyle Counseling 
All women expressed a need for postpartum lifestyle counseling. “Every 
piece of advice, guidance and information after delivery is very valuable.” 
Generally, women said that they would like to receive personal feedback on their 
current health status and their future risk. “It would help if someone would say: 
You are too heavy, these are the consequences of being too heavy, and this is 
what you can do to lose weight”. However, all stated that postpartum lifestyle 
counseling should preferably not be too time consuming and should not cost too 
much effort.  
 
All preferred to receive tailored postpartum lifestyle advice. In addition, 
women mentioned that participation in postpartum lifestyle counseling should 
preferably be tailored to personal preferences regarding the frequency, onset, 
duration, and the length of personal guidance. For example, some reported that 
they would like to be able to decrease the frequency of counseling visits after a 
certain time after delivery. Also, women who had experienced a prolonged 
period of recovery, preferred to postpone participation in a lifestyle counseling 
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program until completely recovered from their pregnancy. The idea that 
prolonged guidance might decrease a woman’s fear of recurrence of the 
condition and hence their threshold for a next pregnancy, was mentioned as a 
reason for the desire for lifestyle support until the next pregnancy.  
Particularly women who experienced a severe complication expressed a 
need for more and longer physical and psychological guidance after their 
complicated pregnancy as part of postpartum counseling: “Such counseling is a 
step in the right direction towards better follow-up care”.  
Face-to-Face Counseling 
All women indicated that they would like to receive postpartum lifestyle 
counseling from a health care specialist. Face-to-face counseling from a health 
care specialist was perceived as effective and motivating. Women said that they 
would feel motivated to show the counselor what progress they had made. They 
would like to receive support from the counselor and they would like to receive 
reminders of why it is important to improve their lifestyle. “Regularly being 
reminded of what you are doing it for would help”. Furthermore, they would like 
the idea of their lifestyle being monitored by a health care specialist; they would 
prefer regular moments of evaluation; and they would like to be able to observe 
progress from participating in lifestyle counseling.  
A preferred counsellor was reported to be someone who had sufficient 
and extensive knowledge about lifestyle, and about the pregnancy complications 
and their consequences. Women mentioned that the counsellor must be 
experienced, and should be familiar with experiences of other women who had 
the same complications during pregnancy. “It must be someone who knows how 
to put our experiences into perspective.” 
Several health care specialists were mentioned as potential counselors: 
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specialized nurses, general practitioners, gynecologists, and midwives. A 
gynecologist was perceived as sufficiently specialized, but overqualified to apply 
lifestyle counseling. The general practitioner was perceived as easily accessible, 
but not sufficiently specialized. Women generally stated that a nurse might be 
easier to talk to than a physician. Additionally, they would like the counselor to 
be able to provide information, and both medical and psychological support, 
when needed. When the counselor cannot provide this support, he or she should 
preferably be able to transfer the patient to other health care specialists (e.g., a 
psychologist or a dietician).  
Most women said that they would rather receive counseling from the 
same person so that they can build a relationship on mutual trust. Others 
indicated they would not mind if they would receive counseling from multiple 
counselors, because they might profit from the variance in both the level and the 
nature of knowledge between counselors. For most women, the gender of the 
counselor was irrelevant.  
Women generally preferred the location of the counseling to be close to 
home. “As a young mother, you’re not very flexible in making appointments.” 
Suggested locations for the counseling included: the general practitioner’s 
premises, the infant welfare center, and a nearby hospital. Additionally, women 
suggested that lifestyle counseling might also be administered at home, or that 
counseling might take place by telephone. Others suggested that counseling 
could take place at a location where they could meet fellow sufferers. 
Finally, they said that it would be practical to combine a counseling visit 
with one of the standard postpartum visits to a healthcare specialist (e.g., 
gynecologist or pediatrician) that they have already planned. This was 
particularly the case for women who had experienced a severe complication, 
since they generally had more postpartum hospital visits. However, some 
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women preferred a separate visit so that they could pay full attention to 
counseling (and could choose whether or not to bring their child). All women 
stated that they were willing to pay a separate visit (or extra visits) for lifestyle 
counseling.  
Computer-Tailored Counseling: Alternative or Supplement?  
The use of computer-tailored lifestyle counseling was perceived as 
appealing. Women reported that a computer-tailored lifestyle promotion 
program should be readable, comprehensible and accurate. It would be 
appreciated if the progress of their lifestyle behaviors could be registered on the 
computer-tailored lifestyle promotion program. It was suggested that lifestyle 
behavior could be monitored and displayed in a graph, so that progress could be 
made “visible”. Women said this would stimulate them to (re)gain control and 
responsibility over their own lifestyle behavior.  
The majority preferred a computer-tailored advice to be accessible on the 
Internet, so that they could complete the intervention wherever and whenever 
convenient. “Internet is widespread and universally accessible; when you’re not 
able to complete the intervention at home, there are lots of places where you 
can.” Moreover, it was suggested that a computer-tailored lifestyle program on 
the Internet could provide a forum. Such a forum was mentioned as an easy way 
to get in contact with other women who had experienced the same pregnancy 
complication. Others, however, perceived making contact with fellow suffers by 
means of a forum on the Internet as too impersonal. 
Although the Internet was generally thought to be a suitable medium to 
offer computer-tailored lifestyle advice, it was mentioned that caution should be 
paid to safety on the Internet. The Internet connection has to be secure, and 
privacy has to be guaranteed. “It has to be a personal, protected space on the 
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Internet, not everyone should be able to read what’s on it.” With regard to 
lifestyle questionnaires, a minority preferred the use of paper and pencil to the 
use of a computer, or keeping a “lifestyle” diary. They thought the Internet 
would be too impersonal and not motivating enough. “Internet could be too 
undisciplined.“ Moreover, women mentioned that lack of access to the Internet 
and lack of skills to adequately surf on the Internet could be barriers towards 
computer-tailored counseling on the Internet. They also mentioned that, 
although the Internet is widespread, not everyone has a computer at home or a 
fast connection on the Internet. 
Thus, although a computer was seen as an attractive medium to provide 
tailored lifestyle counselling, the use of a computer-tailored advice alone was 
considered to be too minimal, perhaps less effective and not suited for longer-
term purposes, because “the computer doesn’t answer back”. Computer-tailored 
advice was seen as a way to support face-to-face counselling. A combination of 
face-to-face personal counselling supported by computer-tailored lifestyle 
advice offered on the Internet appealed to women. This combination was 
perceived as desirable, effective, and motivating. 
DISCUSSION 
This first study exploring the needs, ideas and opinions on postpartum 
lifestyle counseling of women who had experienced preeclampsia, intrauterine 
growth restriction, and/or gestational diabetes shows that these women have a 
need for postpartum lifestyle counseling. They preferred to receive tailored 
lifestyle advice. According to these women, participation in postpartum lifestyle 
counseling should preferably be tailored to individual preferences regarding the 
location, onset, duration, length, and the frequency of personal guidance. A 
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combination of face-to-face personal counselling, supported by computer-
tailored lifestyle advice offered on the Internet, appealed to these women. 
Our results show that women, who are at increased cardiovascular and 
metabolic risk after they have experienced a pregnancy complication, are 
motivated to participate in postpartum lifestyle interventions. Women reported 
that they would like to be guided in adopting a healthy lifestyle, and that they 
would like their lifestyle to be monitored by a health care specialist. This is in line 
with the window of opportunity for preventive interventions in women after a 
pregnancy complicated with preeclampsia, intrauterine growth restriction 
and/or gestational diabetes, as demonstrated earlier1.  
To our knowledge, our study is the first to describe preferences for 
postpartum lifestyle support among women who have experienced 
preeclampsia, intrauterine growth restriction and/or gestational diabetes. 
However, we found one other study that investigated preferred types of lifestyle 
support among women with recent gestational diabetes in order to improve the 
development of diabetes prevention strategies. The results of this study by Zehle 
et al182 show that advice from a dietician and telephone support from a health 
educator were the most preferred forms of health assistance to improve dietary 
and physical activity habits. The results of our study confirm the conclusion of 
Zehle et al that dietary change programs, informed by the beliefs and 
circumstances of this high-risk population, need to be developed182. 
The finding that the Internet might be a suitable medium to offer lifestyle 
counseling supports previous research. It was earlier concluded that the Internet 
can be a valuable tool to support physicians and nurses in the field of adolescent 
preventive care247. The use of a combination of face-to-face counseling and 
computer-tailored counseling is also supported by previous research. In the field 
of child preventive health care, Internet-tailored fruit and vegetable education 
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was combined with brief counseling248; this integrated two-component 
intervention induced positive changes in knowledge and awareness of intake 
levels of fruit and vegetables among schoolchildren.  
In addition to individual counseling, our results seem to indicate that 
group counseling might be suitable for these women as well. However, this 
needs to be further examined. During the focus group meetings, women 
reported that they would like to share their experiences with fellow sufferers. 
Their preference for a location where they could meet fellow sufferers, and their 
preference for a forum to get in touch with fellow sufferers, reflects this desire. 
This is also demonstrated by the fact that, after the focus group interviews, 
participants exchanged their e-mail addresses. In their social environment, 
women generally seem to lack the company of women who have experienced 
the same pregnancy complication(s), probably because of lack of knowledge and 
lack of understanding about the complication and its consequences. Due to this 
lack of social support, during participation in lifestyle counseling they would like 
contact with other women who have experienced the same pregnancy 
complication(s).  
Some methodological considerations of the present study need to be 
addressed. Some selection bias may have occurred since only patients who gave 
birth in the Erasmus University Medical Center (a tertiary referral hospital) were 
invited to participate; despite efforts to prevent bias (e.g., by having random, 
consecutive participant selection), a volunteer bias might have occurred. In 
addition, an investigator bias may have arisen; although using more than one 
analyst might have improved the consistency or reliability of the analyses, the 
appropriateness of the interrater reliability concept in qualitative research is still 
debated249.  
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CONCLUSION 
The results of our study suggest that postpartum lifestyle counseling 
aimed at women who had experienced preeclampsia, intrauterine growth 
restriction, and/or gestational diabetes should be tailored to individual needs 
and preferences. However, further quantitative studies should be conducted to 
determine the relative importance of the reported preferences. 
Postpartum lifestyle counseling aimed at these women should preferably 
be developed in collaboration with a multidisciplinary team of health care 
specialists and in close collaboration with potential users, should address 
important behavioral determinants, and should be both theory and evidence 
based. Further research is needed to establish whether women who have 
experienced different pregnancy complications also differ in their preferences 
for postpartum lifestyle counseling. 
Based on our results, we conclude that postpartum lifestyle promotion 
among women who have experienced these pregnancy complications deserves 
more attention in clinical practice. Gynecologists should play a central role in 
informing women of their increased cardiovascular and metabolic risk. Before 
evidence-based interventions are developed specifically for this high-risk group, 
they could already emphasize the importance of adopting a healthy postpartum 
lifestyle.  
Practice Implications 
The efficacy of a developed lifestyle counseling strategy should eventually 
be tested in a randomized controlled trial. Meanwhile, the preferences reported 
in the present study provide a basis for desired health promotion support. These 
preferences can be implemented in the process of developing and implementing 
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a lifestyle promotion program for use in this high-risk group. Addressing these 
preferred lifestyle-counseling characteristics might promote participation in and 
adherence to postpartum lifestyle counseling aimed at women who have 
experienced these pregnancy complications.   
  
Table 3.3.2. Prompts to explore women’s preferences for postpartum lifestyle counseling 
after a pregnancy complicated with preeclampsia, intrauterine growth restriction and/or 
gestational diabetes.  
To what extent do you need postpartum lifestyle counseling? 
 
What would be your preferred characteristics of a lifestyle promotion program? 
    Face-to-face counseling 
 By whom would you prefer the lifestyle counseling to be offered? 
 Would you prefer your counselor to be a man or a woman?  
 What profession would you prefer the counselor to have? 
 Would you prefer seeing the same counselor across visits? Would you prefer 
multiple counselors? 
 Where would you prefer the lifestyle counseling to take place? 
 When would you prefer the lifestyle counseling to be offered? 
 Would you prefer a separate visit for counseling or would you prefer to combine 
visits?  
 What would you prefer with regard to the frequency of counseling visits?  
Computer-tailored counseling 
 What do you think about offering computer-tailored counseling on the Internet? 
 What do you think of combining lifestyle counseling with a computer-tailored 
lifestyle promotion program? 
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ABSTRACT  
Objective To describe motivators and barriers to the adoption of a healthy 
postpartum lifestyle after a pregnancy complicated by preeclampsia, 
intrauterine growth restriction, and/or gestational diabetes. 
Methods 36 women with complicated pregnancies participated in six focus 
group interviews that aimed to explore perceptions of modifiable 
determinants of postpartum lifestyle.  
Results Although women expressed that they intended to live a healthy 
postpartum lifestyle, it was generally not achieved. Motivators included 
improving their own current health condition as well as modeling a healthy 
lifestyle for their children. Important barriers were reported to be lack of 
knowledge, poor recovery and lack of professional support after delivery.  
Conclusions The reported motivators and barriers can be used to develop a 
postpartum lifestyle intervention. 
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INTRODUCTION  
Cardiovascular disease and diabetes mellitus type II continue to be major 
causes of mortality and morbidity. Women who have experienced pregnancy 
complications like preeclampsia, intrauterine growth restriction and/or 
gestational diabetes are not only at an increased risk for recurrence of these 
complications in a subsequent pregnancy250-252, but they share an increased risk 
to develop cardiovascular disease or diabetes mellitus type II later in life2 3 10 26. 
Furthermore, maternal placental syndromes, such as preeclampsia and 
intrauterine growth restriction more often occur in women with metabolic risk 
factors for cardiovascular disease, such as obesity, hypertension, and diabetes 
mellitus2 3. 
Risk factors for cardiovascular disease and diabetes mellitus type II, such 
as dyslipidemia, hypertension and obesity, are significantly related to lifestyle 
behaviors59 235 253. Lifestyle interventions have proven to be effective in reducing 
these risk factors for cardiovascular disease253 and diabetes mellitus type II58 254. 
For example, improving poor nutrition, smoking cessation, and increasing 
physical activity can delay or prevent the onset of diabetes mellitus type II3 255. 
Guidelines recommend lifestyle measures to reduce cardiovascular risk256. 
More specifically, current literature suggests adoption of a healthy postpartum 
lifestyle to ameliorate cardiovascular and metabolic risk in women who have 
experienced these pregnancy complications83. However, it remains unclear how 
postpartum lifestyle can best be promoted in this women. In order to understand 
how a healthy postpartum lifestyle can best be promoted, women’s perceptions 
of modifiable determinants of postpartum lifestyle need to be explored. 
Therefore, focus group interviews were held to describe motivators and barriers 
to the adoption of a healthy postpartum lifestyle. 
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METHODS 
Participants  
Patients with pregnancies complicated by preeclampsia, intrauterine 
growth restriction and/or gestational diabetes, who delivered in the Erasmus 
University Medical Center in Rotterdam between November 2004 and October 
2006, were invited to participate in the focus group interviews. After searching 
hospital records, 182 patients were selected and invited by mail.  
Preeclampsia was defined according to the criteria of the International 
Society for the Study of Hypertension in Pregnancy (ISSHP): development of 
systolic blood pressure  140 mmHg and/or diastolic blood pressure  90 mmHg 
after 20 weeks of gestation in a previous normotensive woman plus proteinuria. 
Proteinuria was defined as a 24-hour urine collection containing at least 300 mg 
of protein5.  
Intrauterine growth restriction due to placental insufficiency was defined 
as an ultrasonic fetal abdominal circumference below the fifth percentile in 
combination with a pulsatility index of the umbilical artery > p 95 or absent or 
reversed end diastolic flow242. Gestational diabetes was diagnosed in case of at 
least one abnormal result (fasting>= 7.0 mmol/l or two hours>= 7.8 mmol/l) of a 
two-hour 75-gram oral glucose tolerance test257 258. 
A pregnancy complication was defined as severe if the gestational age at 
delivery was less than 32 weeks, the newborn was admitted to the Neonatal 
Intensive Care Unit, or resulted in perinatal death. 
Procedure 
Six focus group interviews were held at the Erasmus University Medical 
Center, Rotterdam, the Netherlands, between December 2006 and February 
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2007. Four of the group interviews consisted of patients with either mild or 
severe preeclampsia or isolated intrauterine growth restriction. One group 
interview consisted of women diagnosed with severe preeclampsia. Another 
group interview consisted of women diagnosed with gestational diabetes. Prior 
to the interviews, participants provided informed consent and completed a 
questionnaire regarding ethnicity, level of education, smoking habits, and self-
reported weight and height. A moderator (M.H.), assisted by a facilitator 
(D.B./W.B.), led the focus group interviews. Interviews were held in line with the 
focus group principles provided by Morgan et al244. A semi-structured focus 
group discussion guide was used to structure discussion topics (see Table 3.4.2). 
Topics addressed in the semi-structured discussion guide were motivators and 
barriers to adoption of a healthy postpartum lifestyle. Additionally, components 
of the Theory of Planned Behavior were addressed: attitude, subjective norm, 
perceived behavioral control, and intention (see theoretical framework below). 
Interviews were audio taped and each lasted about 60 minutes. The study was 
approved by the Medical Ethical Committee of the Erasmus University Medical 
Center.  
Theoretical framework 
Interpretation of results was theoretically framed within the Theory of 
Planned Behavior. The topics in the semi-structured interview guide were 
derived from the components of the Theory of Planned Behavior, according to 
which attitude, subjective norm, and perceived behavioral control determine 
intention to behavior. Attitude is defined as the degree to which performance of 
the behavior is positively or negatively valued. Subjective norm is the perceived 
social pressure to engage or not to engage in a behavior. And perceived 
behavioral control refers to people's perceptions of their ability to perform a 
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given behavior. Intention to behavior is a person's readiness to perform a given 
behavior259 260. Behavior is a function of compatible intentions and perceptions 
of behavioral control. Perceived behavioral control moderates the effect of 
intention on behavior, such that a favorable intention produces the behavior 
only when perceived behavioral control is strong.  
  
Table 3.4.1. Demographic data and clinical characteristics of the study participants. 
 n (%) Mean (SD) Range 
Women     
   Age (years) 
 
36  32.7 (4.5) 22 -41 
   Ethnicity 
      Caucasian 
      African 
      Asian 
 
 
22 
8 
6 
 
(60.1%) 
(22.2%) 
(16.7%) 
 
 
 
   Educational level 
      Primary school 
      Secondary school 
      Higher education 
 
 
5 
15 
14 
 
(14.7%) 
(44.1%) 
(41.2%) 
 
 
 
 
   Smoking 
      Yes 
 
 
3 
 
(8.3%) 
 
 
 
   Body mass index  
       25-30 
        30 
 
 
12 
4 
 
(36.4%) 
(12.1%) 
24.8 (4.9) 
 
 
17.1-39.3 
   Parity 
        Nulliparous 
        Multiparous 
 
 
18 
18 
 
(50%) 
(50%) 
  
   Pregnancy complication 
       Preeclampsia  
       Intrauterine growth restriction 
       Gestational diabetes   
       Preeclampsia and intrauterine growth 
                                                    restriction  
 
21 
4 
5 
6 
 
(16.7%) 
(58.3%) 
(11.1%) 
(13.9%) 
  
     
Offspring     
   Birth weight (g) 36  2352 (1155) (690-4360) 
   Gestational age at delivery (days) 36  246 (4.9) (184- 290) 
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Analysis  
Ethnicity was classified according to Heart and Stroke Foundation 
criteria261. Educational level was assessed by the highest completed education 
and reclassified into three categories: primary school, secondary school and 
higher education262. Self-reported weight and height was used to calculate body 
mass index (BMI); a BMI of 25 or higher was defined as overweight, and 30 or 
higher as obesity. Birth weight and gestational age at delivery were retrieved 
from hospital records. 
Focus groups were audio taped, transcribed verbatim and checked for 
accuracy. After transcripts were made, a qualitative data analysis program (the 
software package QSR Nvivo, version 7) was used to analyze the transcripts in 
accordance with content analysis principles249 263. Content analyses is a 
methodology to systematically analyze the content of communication. It’s 
commonly used to analyze recorded transcripts of interviews. Discussion topics 
were identified, sorted and labeled according to the technique of content 
analysis. Discussion topics were examined across groups and for all groups 
combined. 
RESULTS  
Participants 
Recruitment rate was 19.8%. Of the 36 women that participated in the 
focus group interviews, 21 had preeclampsia, 4 intrauterine growth restriction, 
5 gestational diabetes, and 6 women had both preeclampsia and intrauterine 
growth restriction. The number of participants per group ranged from 4 to 10 
(average 6). Women were 5.8 to 19.0 months postpartum at the time of the 
focus groups. Demographic data and clinical characteristics of the participants 
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are shown in table 3.4.1.  
Attitude and intention 
Women considered the main components of a healthy lifestyle to be a 
healthy diet, sufficient physical activity, no smoking, limited alcohol use, little 
stress, and a healthy environment to live in. All participants expressed the desire 
for living a healthy postpartum lifestyle, and most stated that they had the 
intention to adopt a healthy lifestyle shortly after delivery.  
Motivators and subjective norm 
After their complicated pregnancy, women felt that they were more aware 
of the vulnerability of their health condition, the importance of being in good 
health, and of the importance of a healthy lifestyle: “I’ve never been so conscious 
of my health as after my pregnancy.” A healthy lifestyle after delivery was 
perceived as important, desirable, and a way of taking good care of themselves 
and their children. By adopting a healthy lifestyle women expected to promote 
both their physical and psychological health condition and to feel more 
energetic. The desire to be a good role model for their children also motivated 
them to adopt a healthy lifestyle. Women who were breastfeeding stated that a 
healthy diet was considered important because of the direct influence of their 
diet on the nutrition of their newborn. 
Promotion of a future health condition was also reported to be a 
motivator for adopting a healthy postpartum lifestyle. Women stated that they 
wanted to live a healthy lifestyle to prevent recurrence of the old complication: 
“If I want to have another baby in two years, I believe I have to improve my 
weight and physical condition - just in case it all goes wrong again, and I have 
another too small baby”. Furthermore, the majority said that their increased 
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cardiovascular and metabolic risk was an important reason for wanting to adopt 
a healthy postpartum lifestyle: “Because of the increased risk, I don’t eat too 
much fat, I avoid smoky places, and I have enough exercise. I’m aware of it - it’s 
not that I think: I’ll see what will happen in 10 years”. Furthermore, women 
perceived that a healthy lifestyle was also considered important and desirable 
by their partner, family, friends and their healthcare specialists.  
Barriers and perceived behavioral control 
The vast majority did not feel confident in their ability to be able to adopt 
a healthy lifestyle, and perceived it as difficult to achieve. Most women reported 
that they did not succeed in adopting a healthy postpartum lifestyle; this also 
applied to those who were living a healthy lifestyle prior to their pregnancy. 
All women characterized their postpartum physical and psychological 
health condition as being worse than that prior to their pregnancy. This was 
more pronounced in women who had experienced a severe complication: “After 
delivery, I’ve never had the feeling of being my old self again”. Frequently 
reported complaints were fatigue, forgetfulness, low mood, sleep disturbance, 
emotional lability, and reliving events surrounding their complicated pregnancy. 
Women felt they were not yet recovered from their pregnancy, both physically 
and psychologically. This was reflected in the complaints they reported, even up 
to 19 months after delivery. This reported lack of recovery from their 
complicated pregnancy was mentioned to be the main barrier to adopt and 
maintain a healthy lifestyle. This was more often the case among women who 
had experienced preeclampsia compared with women who experienced 
gestational diabetes, since women who had experienced preeclampsia more 
often reported postpartum complaints and lack of recovery form their 
pregnancy: “It was a battle to get out of bed, let alone thinking about eating two 
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pieces of fruit and two ounces of vegetables a day.” The pregnancy complications 
and their consequences were experienced as stressful life events, and the 
processing of and coping with these life events contributed to lack of recovery. 
In particular, the burden of emotional damage and the importance of 
psychological recovery were mentioned. Women also reported feelings of loss 
of control over their own body, and feelings of loss of confidence in their own 
body. Women reported that the recovery process as well as the adoption of a 
healthy postpartum lifestyle was hindered by a lack of postpartum support from 
health care providers, lack of knowledge, and lack of understanding about the 
pregnancy complication and its consequences: “That’s something I’ve missed, 
women who have been through the same thing to share experiences with, to be 
able to process my experiences.” “Nobody around me indicated what had 
happened to me, what I could expect to happen after delivery, and what kind of 
help could be offered to me when needed.” 
Compared with women who experienced preeclampsia and intrauterine 
growth restriction, women with gestational diabetes struggled with a healthy 
postpartum diet for different reasons. Whereas maintaining the diet prescribed 
by a dietician was associated with feelings of solitude, dullness, and isolation 
from their family or friends among women who had gestational diabetes, 
women who had preeclampsia and intrauterine growth restriction generally 
struggled with a healthy diet because of lack of recovery. 
Other perceived barriers included lack of time and energy caused by daily 
demands such as taking care of their offspring, housekeeping, working, and 
frequent hospital visits. “I was already very pleased that I could run my 
household and to go to work. And that was all I could cope with at the time. For 
nine months I was worn out just by doing that”. Frequent hospital visits were a 
particular challenge for women who had had intrauterine growth restriction, 
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since their offspring had more frequently been admitted to a neonatal care 
facility.  
DISCUSSION  
Our results show that even though most women reported that they had 
the intention, the majority did not succeed in adopting a healthy lifestyle. 
Barriers included poor postpartum physical and psychological recovery, and lack 
of postpartum medical and psychological support from their healthcare 
specialists. This suggests that there is a need for professional support in the 
adoption of a healthy lifestyle after pregnancies complicated by preeclampsia, 
intrauterine growth restriction and/or gestational diabetes. Professional support 
should focus on provision of knowledge about the pregnancy complications, 
their consequences, and what to expect after delivery. 
The finding that poor postpartum recovery is a barrier to live a healthy 
lifestyle confirms previous research148 264. According to the participants in the 
present study, after delivery more information is needed about the complication 
and its consequences, about what to expect regarding its course, and how to 
deal with the complication and postpartum recovery. This is especially the case 
in severe complications. Women also prefer to receive more psychological and 
physical guidance to support their recovery, and would like to be guided in 
adopting a healthy lifestyle. They expect such information and guidance from 
their healthcare specialists. Healthcare specialists could be assisted and 
exonerated in the application of a lifestyle intervention directly after delivery, as 
previously proposed by Sattar et al1.  
It has been suggested that pregnancies complicated by preeclampsia, 
intrauterine growth restriction, and/or gestational diabetes may provide a 
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window of opportunity to apply a lifestyle intervention shortly after delivery1. 
Our study provides a list of motivators and barriers of postpartum lifestyle. This 
list can be used to develop a lifestyle intervention aimed at women who have 
experienced these pregnancy complications. However, the reported findings are 
descriptive and provide information that should be further evaluated in 
quantitative research in representative samples. Further quantitative research is 
needed to be able to determine the prevalence and the relative importance of 
the reported benefits and barriers. In addition, research should be focused on 
the determinants of participation in health promotion programs and preferred 
program characteristics in order to develop an effective evidence-based lifestyle 
intervention for implementation in this high-risk group 
Study limitations and strengths 
Selection bias might have occurred, as only patients who gave birth in the 
Erasmus University Medical Center (a tertiary referral hospital) were invited to 
participate. Patients who are admitted to this university hospital generally 
experience more severe complications compared to other hospitals in the 
surrounding area. Despite efforts to prevent bias (e.g. by having random, 
consecutive participant selection), a volunteer bias could have occurred. There 
was a low recruitment rate. Reasons for non-participation included insufficient 
understanding of the Dutch language and inability to be present at the time of 
the focus group interviews.  
In addition, an investigator bias may have arisen. Although using more 
than one analyst might have improved the consistency or reliability of the 
analyses, the appropriateness of the inter-rater reliability concept in qualitative 
research is still debated249 265.  
 Our finding that women did not succeed in living a healthy lifestyle, 
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despite their positive attitude, their motivation to comply to the beliefs of 
important referents, and their favorable intention, can be explained by applying 
the Theory of Planned Behavior. According to this theory, these women did not 
achieve a healthy postpartum lifestyle because of their low perceived behavioral 
control. This suggests that a healthy lifestyle can be promoted in these women 
by improving their perceived behavioral control. Perceived behavioral control 
might be increased by lowering or removing perceived barriers, such as lack of 
postpartum guidance, and poor physical and psychological recovery. Thus, a 
healthy postpartum lifestyle may be promoted by supporting postpartum 
recovery and by providing better postpartum guidance.  
 
 
  
Table 3.4.2. Discussion guide to explore women’s perceptions of postpartum lifestyle after 
a pregnancy complicated by preeclampsia, gestational diabetes, and/or intrauterine 
growth restriction  
Opening questions 
 What comes to mind when you think of a healthy lifestyle? 
 What do you consider to be a healthy lifestyle? 
Attitude 
 To what extend is the adoption of a healthy lifestyle important to you? 
 What makes a healthy lifestyle important to you? 
 To what extent do you want to adopt a healthy lifestyle? 
Intention 
 To what extent do you intent to adopt a healthy lifestyle? 
Motivators 
 What motivates you to adopt a healthy lifestyle? 
 What would be the reason for you to adopt a healthy lifestyle? 
 To what extent does your social environment motivate you to adopt a healthy 
lifestyle (subjective norm)? 
Barriers 
 To what extent wo you think you are able to adopt a healthy lifestyle (perceived 
behavior control)? 
 Why do you think you may not be able to adopt a healthy lifestyle? 
 To what extent does your social environment not allow you to adopt a healthy 
lifestyle (subjective norm)? 
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ABSTRACT 
Objectives To evaluate the feasibility and effectiveness of a postpartum lifestyle intervention 
after pregnancies complicated by preeclampsia, fetal growth restriction (FGR) and/or 
gestational diabetes mellitus (GDM) to improve maternal risk factors for future 
cardiometabolic disease. 
Design A specific pre-post controlled design. 
Setting One tertiary care hospital and three secondary care hospitals (intervention group); one 
secondary care hospital (control group). 
Participants Two hundred and six women six months postpartum following a pregnancy 
complicated by preeclampsia, FGR or GDM. 
Intervention Lifestyle intervention program, consisting of a computer-tailored health education 
program in combination with three individual counselling sessions during seven months. 
Main outcome measures Primary outcome measure of feasibility was the proportion of eligible 
women who complied with the intervention. Primary outcome measure of effectiveness was 
weight change during the intervention. 
Results The proportion of eligible women who complied with the intervention was 23%. Major 
barrier was lack of time. Adjusted weight change attributed to lifestyle intervention was -1.9 
kg (95%-CI -4.3 to -0.3). Further significant changes were observed in BMI (-0.9 kg/m2 (95%-CI 
-1.4 to -0.3)), waist-to-hip ratio (-0.04 cm/cm (95%-CI -0.06 to -0.03)), blood pressure 
medication use (19% (95%-CI 9% to 28%)), HOMA2-score (59 %S (95%-CI 18 to 99)) and total 
fat intake (-2.9 gr (95%-CI -4.6 to -1.2)). 
Conclusions The results support feasibility and effectiveness of a lifestyle intervention after 
complicated pregnancies to improve maternal cardiometabolic risk factors. The proportion of 
eligible women who complied with the intervention was twice as high as in other primary 
lifestyle intervention studies. Further randomized controlled studies are needed with longer 
follow-up to confirm our findings and evaluate durability. In the meantime, we suggest health 
care professionals to offer lifestyle interventions to women after complicated pregnancies.  
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INTRODUCTION 
After pregnancies complicated by preeclampsia, fetal growth restriction 
and/or gestational diabetes mellitus, women are at an increased risk to develop 
cardiometabolic disease in later life. Women with a history of preeclampsia 
suffer from a two-fold increased risk of ischemic heart disease and stroke80. This 
increased risk may be due to shared risk factors, or an independent association 
between preeclampsia and cardiometabolic disease in later life1. Women with 
fetal growth restriction have an up to three-fold increased risk of future 
cardiovascular disease if it was the only pregnancy complication and an up to 
seven-fold increased risk in combination with preeclampsia3 11 14 16. Women with 
a history of gestational diabetes mellitus have a 20-60% risk of developing 
diabetes mellitus 5 to 10 years later266. 
Based on these observations pregnancy could be interpreted as a stress-
test for cardiometabolic health1. As stress-test, pregnancy could identify young 
women with a high risk of future cardiovascular disease. So far, the scientific 
focus has been to examine differences in cardiometabolic risk factors between 
women with a history of complicated pregnancies and those with uncomplicated 
pregnancies17. 
As a stress-test for cardiometabolic health, a complicated pregnancy could 
identify ‘high-risk’ women at a young age. This provides opportunities to prevent 
future cardiometabolic disease. In addition, the complicated pregnancy might 
boost a woman’s motivation to prevent future disease, thus providing a window 
of opportunity for starting a lifestyle intervention program4. 
Focus group studies have confirmed that women are willing to participate 
in a lifestyle intervention after pregnancy complications186 206 267. However, 
lifestyle interventions after pregnancies complicated by preeclampsia or fetal 
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growth restriction have not been evaluated yet204. 
The primary aim of this study is to evaluate the feasibility of a lifestyle 
intervention program after complicated pregnancies associated with an 
increased risk of future cardiometabolic disease by comparing the proportion of 
eligible women who completed the intervention to other lifestyle intervention 
programs. Secondary aim is to test effectiveness of this intervention in improving 
maternal cardiometabolic risk factors by analysing change in weight and other 
cardiometabolic risk factors before and after the intervention. 
MATERIALS AND METHODS 
The Postpartum Rotterdam Appraisal of Cardiometabolic health and 
Tailored Intervention (PRo-ACTIve) study is a feasibility study to develop and 
evaluate a postpartum lifestyle intervention program. It was designed as a 
multicentre, specific pre-post controlled study268 to develop and evaluate the 
lifestyle intervention. During the first year of the study a control cohort was 
considered to be a vital part of the effect evaluation of the intervention. 
Women with pregnancies complicated by preeclampsia, fetal growth 
restriction and/or gestational diabetes mellitus were included between February 
2007 and September 2010. Preeclampsia was defined according to ISSHP-
criteria5: blood pressure of 140/90 mmHg or higher and proteinuria of at least 
300 mg/day after a gestational age of at least 20 weeks. Severe preeclampsia 
was defined according to ACOG-criteria83: a blood pressure of 160 mmHg systolic 
or higher or 110 mmHg diastolic or higher; proteinuria of 5 gram or more in a 24-
hour urine specimen or dipstick urinalysis of 3+ or greater in two random urine 
samples collected at least 4 hours apart; cerebral or visual disturbances; elevated 
liver enzymes; thrombocytopenia; fetal growth restriction. Fetal growth 
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restriction was defined according to ACOG-criteria269: fetal abdominal 
circumference < 5th percentile and umbilical artery Doppler with a pulsatility 
index ≥ 95th percentile and/or absent or reversed end-diastolic flow on last 
ultrasonic examination before delivery. Gestational diabetes mellitus was 
defined according to the 2003 report of the international expert committee of 
the American Diabetes Association on the diagnosis and classification of diabetes 
mellitus243: a fasting glucose > 6.1 mmol/L or a 2-hour glucose > 7.8 mmol/L after 
a 75-grams oral glucose tolerance test. Other inclusion criteria were age ≥ 18 
years at time of inclusion, Dutch, Turkish or Moroccan ethnicity and mastery of 
the Dutch language. Women with pre-pregnancy cardiovascular and/or 
metabolic conditions, like renal insufficiency, pre-existent hypertension or 
diabetes mellitus were excluded. Cases of fetal growth restriction due to intra-
uterine infection, congenital anomalies or abnormal fetal karyotype were also 
excluded. 
At the Erasmus University Medical Center in Rotterdam (tertiary care 
hospital) and three secondary care hospitals (Sint Franciscus Hospital, 
Rotterdam, Maasstad Hospital, Rotterdam and Sint Elisabeth Hospital, Tilburg) 
women were screened for eligibility and asked to participate in the lifestyle 
intervention program. At the Amphia Hospital, Breda (secondary care hospital) 
women were screened for eligibility and subsequently served as the control 
group. At 5 months postpartum all eligible women were given or sent 
information about the study together with a letter of invitation to participate. If 
no response was received within two weeks, women were called on different 
weekdays. If twice unanswered, women were registered as unable-to-contact. 
Interested women were invited for a first visit six months postpartum. If during 
this visit informed consent was obtained, they were registered as participants. 
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Study planning 
The time-schedule of the study is shown in figure 3.5.1. The first visit was 
scheduled at six months postpartum, because we aimed for minimal changes in 
the measured variables due to ongoing recovery after pregnancy202, and to 
minimize the chance that the women were going to be pregnant again during 
the study period. During the first visit, participants were extensively screened for 
cardiometabolic risk factors. Anthropometric measures included weight, height, 
waist- and hip circumference, blood pressure and heart rate. Weight was 
measured on a digital weighting scale in tenths of kilograms. Blood pressure and 
heart rate were measured according to the guideline of the British Hypertension 
Society (2004-BHS IV)270. Biochemical measures included high density 
lipoprotein (HDL) (HDL_Cholesterol plus 3rd generation (HDLC3), Cobas®, Roche 
Diagnostics), low density lipoprotein (LDL) (LDL-Cholesterol plus 2nd generation 
(LDL_C), Cobas®, Roche Diagnostics) and total cholesterol (Cholesterol Gen.2 
(CHOL2), Cobas®, Roche Diagnostics), HDL/total cholesterol ratio, triglycerides 
(Triglycerides (TRIGL), Cobas®, Roche Diagnostics), fasting glucose (Glucose HK 
Figure 3.5.1. Time-schedule of study in months after delivery 
 
 
 
Delivery 6 7 10 138.5
Cardiometabolic screening X X X
Lifestyle questionnaires X X
Lifestyle counselling* X* X* X*
Evaluation questionnaires* X*
Semi-structured interview* X*
*Lifestyle counselling, evaluation questionnaires and semi-structured interviews are only applicable to the intervention group
but not to the controls
Start End
(months)
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Gen.3 (GLUC3), Cobas®, Roche Diagnostics), fasting insulin (Insulin, Cobas®, 
Roche Diagnostics), the Homeostasis Model Assessment (HOMA)2-score271 as 
measure of insulin sensitivity and high-sensitive C-reactive protein (CRP) (C-
Reactive Protein Gen.3 (CRPL3), Cobas®, Roche Diagnostics). Lifestyle was 
evaluated by three questionnaires, i.e. for saturated fat-intake the Maastricht 
Fatlist272, for physical activity the International Physical Activity Questionnaire 
(IPAQ)273 and for smoking habits the short version of the questionnaire of 
STIVORO (the Dutch anti-smoking association, www.stivoro.nl). 
Three subsequent sessions with a trained lifestyle counsellor (MH) were 
scheduled between 7 and 10 months postpartum. The intervention consisted of 
a combination of individual counselling sessions based on the technique of 
motivational interviewing193 and the use of a computer-tailored Dutch health 
education program (www.gezondlevencheck.nl of the Dutch Heart Association). 
The counselling sessions were preferably face-to-face, but could be taken by 
telephone if the woman wanted. The computer-tailored health education 
program and the three questionnaires were completed by the participants 
before each counselling session. The program provided feedback on the 
individual scores on the questionnaires. Based on these scores, Individual 
tailored lifestyle advice was discussed during the sessions and used to set 
personal lifestyle goals. Progress on the individual goals was discussed, and if 
applicable adjusted, at each subsequent session.  
During the visit at 10 months postpartum the complete screening for 
cardiometabolic risk factors was repeated with exclusion of the lifestyle 
questionnaires. Women were encouraged to maintain their lifestyle program. 
The final visit of the study was scheduled 13 months postpartum. The 
complete screening for cardiometabolic risk factors was repeated again, 
including the lifestyle questionnaires. In addition, women who participated in 
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the lifestyle intervention program received questionnaires to evaluate the 
intervention program (tables 3.5.3-3.5.5), including the Patient Satisfaction 
Questionnaire (PSQ-18)274. The questions were based on the motivators and 
barriers reported in previous focus group studies 186 206. Additionally, a 
qualitative semi-structured interview was conducted among women in the 
intervention group (table 3.5.6). 
Statistical analysis 
Primary outcome of feasibility was the proportion of eligible women who 
completed the intervention. This best represents how many women who could 
receive lifestyle intervention were actually motivated to complete the 
intervention. The higher this proportion, the more feasible it would be to plan 
larger-scale studies to test effect of postpartum lifestyle intervention after 
complicated pregnancy and to offer lifestyle intervention – if effective - as usual 
care. The proportion of eligible women who completed the intervention was 
defined as: 
 
nCompleted study
nEligible
= 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 ∗ 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝐴𝐴𝐴𝐴ℎ𝑒𝑒𝑃𝑃𝑒𝑒𝑃𝑃𝑃𝑃𝑒𝑒 = 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 ∗ (1 − 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝐷𝐷𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝐷𝐷𝑃𝑃)
  
Participation rate was defined by the number of women who agreed to 
participate in the study divided by the total of women who were eligible for 
participation. Based on other studies in primary lifestyle interventions275 276, a 
participation rate of 15% was expected. Adherence was defined by the number 
of women who attended the 13-months visit divided by the number of women 
who agreed to participate in the study. Based on other studies in primary lifestyle 
interventions in fertile women60 an adherence of 75% was expected. Based on 
these numbers, the lifestyle intervention was found to be feasible if the 
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proportion of eligible women that completed the intervention was at least 11%. 
The primary outcome measure for effectiveness was change in weight 
before and after the intervention. If the lifestyle intervention would be effective 
in improving diet and exercise, it would result in weight loss. Weight, as part of 
Body Mass Index (BMI) is a major risk factor of cardiometabolic disease. A weight 
loss of 2.7 kg, corresponding with a risk reduction of 50% for diabetes mellitus 
after 4 years, was considered clinically relevant 58 277. With mean weight loss in 
the intervention group of 3.5 kg (SD 5.5), mean weight loss in the control group 
of 0.8 kg (SD 4.4)277, α 0.05 (2-sided), β 0.80 and a cases-to-control ratio of 2:1 
and an expected drop-out rate of 30% we calculated a sample size of 108 cases 
and 54 controls. Secondary outcome measures included the other 
anthropometrical, biochemical and lifestyle measurements. 
Based on the intention-to-treat principle, women who became pregnant 
during the study period were considered as drop-out. Their pregnancy would 
have had considerable influence on the outcome measures. Women who 
dropped out for other reasons were approached for the final visit at 13 months 
postpartum. 
Statistical analyses were performed using IBM SPSS Statistics, version 20, 
International Business Machines Corp©. The weight change between six months 
postpartum and the end of the study at 13 months postpartum was calculated 
for each participant in the intervention and control group. Using a linear 
regression model with weight change as outcome variable, we used the 
regression coefficient of the case group as effect of the intervention and thus 
adjusted for normal or ‘background’ change in the control group that would 
supposedly have occurred if lifestyle intervention had not been conducted 
(model 1). We also adjusted for known confounders (baseline weight measure 
at start at 6 months postpartum, duration of breastfeeding), and significantly 
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different demographic variables between the case and control group (model 2). 
This analysis was repeated for all secondary outcome measures, where the 
baseline weight measure was replaced by the baseline measure of the 
dependent variable. Results are presented as mean change and 95% confidence 
interval. 
During the study we experienced lower adherence in the control group 
than expected. To compensate, we multiple imputed the 13-month measures for 
participants who had attended the visits at 6 and 10 months postpartum. The 
imputation model was based on the mean and standard deviation of participants 
who attended all visits, with a random generated z-score. Sensitivity analysis was 
performed by comparing the findings with the analysis without imputation. 
Three random iterations of imputation were done. Significant findings were only 
reported, if all 3 iterations showed significant results. 
The study was funded by a research grant of ZonMw (61200024). Ethical 
approval was granted by the institutional review board of the Erasmus University 
Medical Centre (2006-164) and the participating secondary care hospitals. 
 
RESULTS 
Table 3.5.1 summarizes the demographics and baseline measures at 
enrolment. Significant differences between the intervention and control group 
were observed for ethnicity, marital status, birth weight, frequency of 
preeclampsia and severe preeclampsia and gestational age at delivery. 
Furthermore, the groups significantly differed in weight, systolic blood pressure 
and diastolic blood pressure at baseline measurement. 
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Feasibility 
The proportion of eligible women that completed the intervention was 
94/407 (23%). Figure 3.5.2 shows the inclusion, participation and adherence to 
the study. Of the eligible women 41% declined participation (43% in the 
Table 3.5.1. Baseline characteristics of the study participants (n=206) 
 Cases 
(n=144) 
Controls 
(n=62) 
p-value 
    
Age (years) 31.6±4.2 30.7±8.8 0.31 
Ethnicity   0.03 
   Dutch 94%(134) 97%(60)  
   Turkish 3%(5) -  
   Moroccan 3%(5) 3%(2)  
Education   0.05 
   Primary school 8%(12) 2%(1)  
   Secondary school 44%(63) 45%(28)  
   Higher education 44%(64) 48%(30)  
   Unknown 3%(5) 5%(3)  
Married 58%(84) 42%(26) 0.03 
Primiparous 70%(101) 71%(44) >0.99 
Twin pregnancy 8%(12) 5%(3) 0.56 
Birth weight (grams) 2209±1137 2947±868 <0.001 
Breastfeeding (days) 42(0-421) 33(0-465) 0.88 
Pregnancy complication    
   Preeclampsia 83%(120) 68%(42) 0.02 
      Severe (% of preeclampsia) 76%(91) 57%(24) 0.03 
   IUGR 24%(35) 24%(15) >0.99 
   Gestation diabetes mellitus 15%(21) 26%(16) 0.07 
      Insulin-dependent (% of gestational 
                                         diabetes mellitus) 
52%(11) 31%(5) 0.32 
Gestational age at delivery (days) 242±31 263±20 <0.001 
    
Baseline measures at start of study    
   Weight (kg) 81±20 75±16 0.02 
   BMI (kg/m2) 28.3±6.6 26.4±5.4 0.05 
   WHR (cm/cm)  0.83±0.06 0.82±0.06 0.14 
   Systolic blood pressure (mmHg) 120±12 112±13 <0.001 
   Diastolic blood pressure (mmHg) 77±10 71±9 0.001 
   Blood pressure medication  9%(13) 6%(4) 0.78 
Numbers in Mean ± SD, Median(Range) or %(n), significance is calculated with ANOVA (means), 
Mann-Whitney-U(medians) or Chi-Square(%). 
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intervention group, 39% in the control group). The main reported reason for 
declining participation was lack of time. An additional 27% of the eligible women 
could not be contacted (21% in the intervention group, 37% in the controls).  
Of the 144 women who participated in the intervention group, 28% 
dropped out between 6 and 10 months postpartum, compared to 18% in the 
controls. The main reason was again lack of time. An additional 7% drop-out in 
the intervention group was observed between 10 and 13 months postpartum 
compared to 31% in the controls. The main reason for drop-out at this time was 
a next pregnancy. 
Evaluation questionnaires were completed by 99% of the women who 
completed the intervention, but by none of the women who dropped out. 
Reported values are percentages of the responders. The questionnaires and 
their scores are shown in tables 3.5.3 to 3.5.5. 
Figure 3.5.2. Flowchart of inclusion, participation and compliance 
   
Intervention group Controls
Screened for eligibility n=854
Eligible n=407 (48%)
Excluded n=446 (52%)
Declined n=176 (43%)
Unable to contact =87 (21%)
Informed consent n=144 (35%)
Screened for eligibility n=284
Eligible n=249 (88%)
Excluded n=35 (12%)
Declined n=96 (39%)
Unable to contact n=91 (37%)
Informed consent n=62 (25%)
Drop-out between 6-10 months:
Lack of time n=30 (21%)
Unknown = 10 (7%)
Drop-out between 10-13 months:
Lack of time n=7 (5%)
New pregnancy n=3 (2%)
Completed study n=94 (65%)
Drop-out between 6-10 months:
Lack of time n=7 (11%)
Unknown = 4 (6%)
Drop-out between 10-13 months:
Lack of time n=1 (2%)
New pregnancy n=18 (29%)
Completed study n=32 (52%)
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A strong motivator to participate in the lifestyle intervention was the 
experienced morbidity in the pregnancy (85%). Other motivators were the 
perceived increased risk of future disease (60%), risk of recurrence in a next 
pregnancy (58%) and the possibility to improve personal health (60%). A majority 
of the responders reported that feedback on their risk profile made them aware 
of their risk of future disease (80%) and empowered them to improve their 
lifestyle (84%). 
Satisfaction with the lifestyle intervention was high (86%). A majority of 
the responders was satisfied with the counselling sessions (89%) and use of the 
computer-tailored health education program (61%). Perceived barriers to 
participate in the lifestyle intervention were travel distance (33%) and travel 
time (35%) to the hospital, although 76% thought the hospital to be a good 
setting for the counselling sessions. A total of 65% agreed that counselling 
sessions conducted by telephone were a good alternative for face-to-face 
counselling. 
Preferred time between counselling sessions was eight weeks (range 4-16) 
and preferred average duration of the intervention program was 12 months 
(range 2-72). Preferred time to start with lifestyle intervention was at three 
months postpartum (range 0-26). 
Effectiveness 
Based on the differences in demographic and baseline measurements in 
table 3.5.1, we introduced prevalence of preeclampsia and severe preeclampsia, 
as well as gestational age at delivery into the adjustment model for the effect 
analysis. 
Table 3.5.2 shows the changes in the intervention group after lifestyle 
intervention. Weight was significantly decreased by 4 kg in the intervention 
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group. After adjustment for the change in controls, baseline weight, duration of 
breastfeeding, preeclampsia and severity of preeclampsia and gestational age at 
delivery, a significant decrease of 1.9 kg (0.3 to 3.4) could still be attributed to 
the lifestyle intervention. BMI and waist-to-hip ratio also significantly decreased, 
which remained after adjustment. Total and LDL-cholesterol changed 
significantly in the intervention group. However, after adjustment for the 
mentioned confounders this change was no longer significant. The change in 
HOMA2-score in the intervention group became significant after adjustment for 
the mentioned confounders. Lifestyle habits all showed favourable trends in the 
Table 3.5.2. Effect of lifestyle intervention program 
Parameter Unit Intervention group (n=144) 
  6 months 13 months p-value 
Weight kg 81±20 77±19 <0.001 
BMI kg/m2 28±7 27±6 <0.001 
Waist-to-hip ratio cm/cm 0.83±0.06 0.81±0.07 <0.001 
Systolic blood pressure mm Hg 120±12 117±12 0.09 
Diastolic blood pressure mm Hg 77±10 75±8 0.10 
Blood pressure medication % 9% 16% 0.02 
Heart rate bpm 75±11 71±8 <0.01 
     
Total cholesterol mmol/L 5.0±0.9 4.6±0.8 <0.001 
LDL-cholesterol mmol/L 3.1±0.8 2.9±0.7 <0.001 
HDL-cholesterol mmol/L 1.4±0.3 1.3±0.4 0.50 
HDL/total cholesterol ratio mol/mol 3.9±1.2 3.7±1.2 0.08 
Triglycerides mmol/L 1.3±0.9 1.2±1.0 0.07 
Fasting glucose mmol/L 4.9±0.6 4.9±0.9 0.31 
75 gr-OGTT 2-hour value mmol/L 5.2±1.2 5.0±1.7 0.54 
Abnormal glucose (DM-2) % 14% 12% 0.45 
HOMA2-score %S 130±106 144±111 0.57 
CRP mmol/L 5.7±9.4 5.7±8.1 0.76 
Urinary protein/creatinine ratio g/mol 12±23 12±23 0.40 
Total protein in 24-hour urine g/24h 113±207 116±159 0.58 
     
Smoking % 15% 14% 0.74 
Physical activity MET 3672±6554 3830±4240 0.07 
Physical activity steps/day 8290±2508 8658±2099 0.47 
Fat intake total g/day 17.0±5.1 15.1±5.1 <0.001 
Fat intake snacks g/day 6.2±3.0 5.5±3.0 <0.01 
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intervention group after adjustment for the mentioned confounders except for 
total fat score, which decrease was significant.  
Figures 3.5.3a-c shows the unadjusted change over time in the 
intervention and the control groups. All anthropometrical measures (figure 
3.5.3b) show a rebound effect in the intervention group between the 10 and 13 
months visit after counselling visits were discontinued. An increase in the use of 
blood pressure medication was observed in the intervention group, compared 
to a decrease in the control group.  
  
 
Effect lifestyle intervention program at 13 months postpartum (95% CI) 
Model 1* Model 2# 
-1.8 (-3.2 to -0.3) -1.9 (-3.4 to -0.3) 
-0.8 (-1.3 to -0.3) -0.9 (-1.4 to -0.3) 
-0.04 (-0.06 to -0.03) -0.04 (-0.06 to -0.03) 
1.4 (-2.2 to 4.9) 0.7 (-3.1 to 4.4) 
1.2 (-1.4 to 3.8) 0.8 (-1.9 to 3.6) 
15% (4% to 25%) 19% (9% to 28%) 
-2.9 (-5.6 to 0.6) -0.7(-4.1 to 2.7) 
  
-0.2 (-0.4 to 0.1) -0.2 (-0.4 to 0.1) 
-0.1 (-0.3 to 0.1) -0.1 (-0.3 to 0.2) 
0.1 (-0.02 to 0.2) 0.1 (-0.02 to 0.2) 
-0.1 (-0.3 to 0.1) 0.1 (-0.3 to 0.2) 
-0.04 (-0.2 to 0.1) -0.02 (-0.2 to 0.2) 
0.1 (-0.2 to 0.3) 0.01 (-0.3 to 0.4) 
0.1 (-0.7 to 0.9) 0.1 (-0.9 to 1.0) 
-13% (-39% to 12%) -22% (-45% to 1%) 
71 (-12 to 154) 59 (18 to 99) 
0.2 (-2.6 to 2.9) 0.9 (-2.2 to 4.1) 
2 (1 to 4) 2 (0.1 to 4) 
27 (-12 to 66) 29 (-3 to 60) 
  
-5% (-17% to 7%) -5% (-16% to 7%) 
2251 (329 to 4174) 844 (-945 to 2634) 
452 (-695 to 1599) 302 (-1373 to 770) 
-2.9 (-4.8 to -1.0) -2.9 (-4.6 to -1.2) 
-0.8 (-2 to -0.4) -1.0 (-2.0 to 0.04) 
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Figure 3.5.3b. Anthropometric changes during the study period 
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Figure 3.5.3a. Lifestyle changes during the study period 
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Figure 3.5.3c. Biochemical changes during the study period 
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DISCUSSION 
We found a high proportion of eligible women who complied with the 
intervention, and women had a significant weight loss after the intervention, 
supporting feasibility and effectiveness of lifestyle intervention to improve 
maternal cardiometabolic risk factors. 
Feasibility 
The proportion of eligible women who complied with the intervention was 
23%, twice the percentage we assumed (11%). Participation rate in the 
intervention group was 35%, which was higher than the expected 15%. On the 
other hand, adherence in the intervention group was 65%, which was lower than 
the expected 75%.  
Participation rate in our study was twice as high as in other primary 
lifestyle interventions275 276. We showed that the pregnancy complication, the 
perceived increased risk of future disease and the risk of recurrence in a next 
pregnancy were strong motivators to comply with the study. This supports the 
idea that a complicated pregnancy opens a window of opportunity for lifestyle 
intervention. Adherence to the intervention (65%) was lower than expected. The 
main reason for drop-out was lack of time and was 4 times higher in the first half 
of the follow-up compared to the second half. Prior research showed that 
women generally prefer the location of the counselling close to home186, 
suggesting that offering the lifestyle intervention in a primary health care setting 
might increase participation and adherence. 
Only two recent studies on lifestyle interventions after metabolic 
complicated pregnancy reported participation and adherence rates. Both studies 
aimed to reduce the risk of type 2 diabetes mellitus in women with a history of 
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gestational diabetes mellitus. The proportions of eligible women that completed 
the intervention were 43%278 (intervention was initiated at seven to eight weeks 
postpartum with a follow-up of 12 months) and 24% respectively (women were 
recruited within one to three years after their pregnancy with a follow-up of two 
years)279. This might indicate that the window of opportunity for lifestyle 
intervention after a complicated pregnancy is most present shortly after delivery 
and disappears over time. Offering lifestyle intervention six weeks after delivery 
might lead to a higher proportion of women complying to lifestyle intervention. 
Of all eligible women in the intervention group, 21% could not be traced. 
Other postpartum lifestyle studies report similar percentages up to 35%279. 
Traceability might be improved shortly after delivery, when women are still in 
contact with their gynaecologist or midwife. 
We used a health education program with tailored advice, already on-line 
available by the Dutch Heart Foundation. The women in our study liked the 
possibility to complete the computer-tailored health education online in their 
own time and found its advice easy to understand. It was, however, not 
specifically tailored to postpartum women and therefore the advice was not 
always readily applicable. During the counselling sessions, we tailored the advice 
to the personal situation. New developments like web-based tailored advice for 
postpartum women278 as well as the use of new media like smartphones280 281 
are promising new ways to challenge low participation and adherence in 
postpartum lifestyle interventions. 
Tailoring the start of the intervention to the woman’s need might increase 
participation and adherence rates. Some women who completed the study 
would in retrospect have preferred to start with the intervention several weeks 
postpartum. In our study, women were informed at a fixed moment (five months 
postpartum). 
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We used the proportion of eligible women who complied with the 
intervention as measure of feasibility. Other studies focus on dropout rate60. 
However, dropout rate is biased by the motivation of participants and thus by 
the process of inclusion. By comparing studies by the proportion of eligible 
women who complied with the intervention, this bias is eliminated.  
Effectiveness 
Women in the intervention group had a significant weight loss that could 
be attributed to the lifestyle intervention. Also, the secondary outcomes BMI, 
waste-to-hip ratio, HOMA2-score and total fat score significantly improved. 
Blood pressure medication was significantly more prescribed in the 
intervention group than in the control group. An explanation might be that the 
intervention group more often had preeclampsia and severe preeclampsia, 
leading to a longer recovery time and a longer need for blood pressure 
medication up to two years202. This was also expressed in a significantly higher 
baseline blood pressure in the intervention group. However, after adjustment 
for these variables the difference remained significant. 
The effect of improved cardiometabolic risk factors was achieved between 
6 and 10 months. Between 10 and 13 months a loss of effect was observed. 
Similar rebound effects were observed in other lifestyle intervention studies154. 
There are currently no strategies that effectively address the challenge of 
promoting sustained long-term behavioural change282. Studies with longer 
follow-up and on-going counselling with promising new strategies280 281 must 
show if and how the improved cardiometabolic risk status by postpartum 
lifestyle intervention can be sustained. 
The potential reduction in risk of recurrence of the sustained pregnancy 
complication was an important motivator for the women participating in the 
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intervention. Lifestyle interventions before or during pregnancy are known to be 
effective in improving obstetrical outcome283 284. If started shortly after a 
complicated pregnancy, lifestyle intervention might give a larger reduction of the 
risk of recurrence in the next pregnancy than starting at a next pregnancy or 
when a next pregnancy is intended. Further studies are needed to evaluate this 
hypothesis. 
We used weight loss as proving effectiveness of lifestyle intervention. 
Although used as primary outcome variable to test effectiveness by many other 
intervention studies, recently the Look AHEAD study showed that during the 
years after intervention weight was regained285. However, weight remained 
slightly but significantly lower, even years after the intervention, compared to 
women who did not have had intervention. 
Strengths and weaknesses of the study 
A major strength of this study is that it addresses a topic that is frequently 
being mentioned in preeclampsia research, but has never been studied before. 
Another strength of this study is that we used validated questionnaires to 
evaluate lifestyle habits and tailored them to individual goals in the counselling 
sessions to make them easily applicable. Finally, we had a high participation rate 
as compared to other primary lifestyle studies, adding to the generalisability of 
our results. Although selection bias can never be totally eradicated in primary 
lifestyle intervention studies, our non-randomized study design and still low 
participation and adherence rates contributed to this bias. 
Some other factors limit generalisability of our results. First we did not 
have information about the women who declined participation or could not be 
traced. Whether our results are applicable to these women, is unclear. Second, 
the majority of the women in the study were Dutch. Whether our results are 
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applicable to other than Dutch women, is unclear. Third, a major part of the 
women had received tertiary care. Whether our results are applicable to all 
women with complicated pregnancies, is unclear. 
The criteria we used for gestational diabetes mellitus were based on the 
2003 report of the expert committee on the diagnosis and classification of 
diabetes mellitus243. In 2010 new criteria for gestational diabetes mellitus were 
presented after completion of the HAPO-study286. Compared to the inclusion 
criteria of our study, the fasting glucose threshold is lower (5.1 mmol/l) and the 
2-h glucose threshold after a 75-grams oral glucose tolerance test is higher (8.4 
mmol/l). This might limit generalizability of our results to women who have been 
diagnosed with gestational diabetes mellitus based on other criteria than the 
ones we used. 
Meaning of the study: possible explanations and implications for clinicians and 
policymakers 
This study supports the feasibility and effectiveness of a lifestyle 
intervention after complicated pregnancies. We suggest that clinicians should 
discuss the possible beneficial effects of lifestyle intervention with women who 
experienced a cardiometabolic complicated pregnancy at the regular visit 6 
weeks postpartum. If women are willing to comply, lifestyle intervention 
programs should be made available, preferably close to home in a primary health 
care setting. 
Current guidelines recommend lifestyle modification and early evaluation 
for the most high-risk women287, the provision of information to patients and 
primary care clinicians about increased risks in later life288, assessment of 
traditional risk factors and to pursue a healthy lifestyle289, counselling about 
beneficial effects of a healthy lifestyle and regular (1-5 yearly) cardiovascular 
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assessments290 or counselling for a healthy lifestyle and cardiovascular 
assessment at menopause291. Our study provides support to recommend the 
availability of postpartum lifestyle intervention in these guidelines. 
Unanswered questions and future research 
We suggest randomized controlled trials, to decrease selection bias, in 
varied populations with a follow-up period of several years to confirm efficacy 
and durability of postpartum lifestyle intervention after complicated 
pregnancies. Varied populations will help to increase generalisability of the 
results. A longer follow-up is needed to evaluate the durability of the effects on 
cardiometabolic risk factors. The ideal primary outcome of these studies would 
be cardiometabolic events, although the low prevalence of these events needs 
large cohorts. To further decrease selection bias, more research is needed on 
motivators and barriers of women to increase participation and adherence to 
lifestyle intervention.   
Table 3.5.3. Response to process evaluation at 13 months postpartum, questionnaire A: 
General Questions (response 93/144=65%) 
  Totally Agree  Absolutely 
Not Agree 
       
1 The intervention program was well adapted to 
women with a history of preeclampsia, foetal 
growth restriction of gestational diabetes 
mellitus 
13% 56% 24% 8% - 
2 The intervention program was difficult to 
integrate into daily life 
2% 7% 25% 47% 18% 
3 The increased risk of recurrence in a next 
pregnancy was an important motivator to 
participate in the study 
23% 35% 21% 16% 4% 
4 The increased risk of future disease was an 
important motivator to participate in the study 
23% 47% 11% 15% 3% 
5 An important motivator to participate with the 
study was to improve my health 
13% 47% 14% 22% 3% 
6 The course of my pregnancy was an important 
motivator to participate in the study 
25% 60% 4% 11% 1% 
 
 
Table 4.1. International guidelines on postpartum follow-up and lifestyle intervention after 
preeclampsia 
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Table 3.5.3. Continued 
  Totally Agree  Absolutely 
Not Agree 
       
7 It was my own choice to improve my lifestyle, I 
did not feel forces by the counsellor 
39% 45% 9% 7% - 
8 The counselling sessions helped me to improve 
my lifestyle 
11% 39% 30% 20% - 
9 The counselling sessions were a valuable 
addition to the computer-tailored health 
education program 
10% 54% 23% 13% - 
10 offsetting behavioural goals helped me to 
improve my lifestyle 
7% 35% 40% 12% 1% 
11 Feedback on my personal risk profile for future 
disease provided me with new information 
2% 30% 35% 30% 4% 
12 Feedback on my personal risk profile was an 
important motivator to change my lifestyle 
2% 37% 35% 22% 3% 
13 Feedback on my personal risk profile made me 
realise my risks of future disease 
20% 60% 22% 8%  
14 Travel distance to the location of the 
counselling sessions was a barrier to comply 
with the intervention program 
3% 14% 16% 45% 22% 
15 Time to travel to the location of the counselling 
sessions was a barrier to comply with the 
intervention program 
3% 16% 16% 41% 24% 
16 The hospital is a good setting for counselling 
sessions 
17% 59% 18% 3% 2% 
17 Counselling sessions could be done by phone 11% 34% 20% 31% 4% 
18 The recurrent counselling sessions helped me 
to comply with a healthier lifestyle 
4% 48% 32% 14% 2% 
       
  Too Short  Too Long 
       
19 The use of the registration form to register my 
progress helped me to achieve my personal 
goals 
2% 28% 47% 22% 2% 
20 The time between the counselling sessions (6 
weeks) was 
- 4% 84% 12% - 
21 The total time of the intervention program (3 
months) was 
2% 13% 66% 17% 2% 
22 The total time I spent to the intervention 
program was 
- 5% 71% 23% 1% 
23 The duration of each counselling session was - 2% 90% 7% 1% 
       
  Too Low  Too High 
       
24 The frequency of the counselling was  11% 72% 17% - 
Continues on next page 
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Table 3.5.3. Continued 
  Too Early  Too Late 
       
25 I found the time the intervention program 
started after my delivery 
4% 11% 77% 9% - 
   
26 For me the optimal time between the counselling 
sessions would be 
8 weeks (4-16) 
27 For me the optimal total of counselling sessions 
would be 
4 (2-12) 
28 For me the optimal time after delivery to offer an 
intervention program would be 
3 months (0-26) 
29 For me the optimal duration of an intervention 
program would be 
12 months (2-72) 
 
Table 3.5.4. Response to process evaluation at 13 months postpartum, questionnaire B: 
Computer-tailored health education program (response 93/144=65%) 
  Totally 
Agree 
 Absolutely 
Not Agree 
       
1 Completing the computer-tailored health 
education program took too much time 
4% 25% 25% 41% 4% 
2 Completing the computer-tailored health 
education program was easy 
13% 70% 9% 7% 2% 
3 The tailored advice provided by the computer-
tailored health education program easy to 
understand 
17% 71% 8% 3% 1% 
4 I liked completing the computer-tailored health 
education program on-line 
20% 57% 13% 6% 4% 
5 Completing the computer-tailored health 
education program was a good way to be 
informed about my lifestyle 
12% 59% 20% 8% 1% 
6 Completing the computer-tailored health 
education program was a good way to get 
personal advice 
10% 57% 23% 10% 1% 
7 Log-in to the computer-tailored health education 
program was difficult 
7% 9% 13% 53% 19% 
8 I liked the fact that my personal lifestyle data 
could be viewed by the counsellor 
11% 64% 24% 1%  
9 The provided tailored advice was applicable to my 
personal situation 
6% 42% 33% 17% 3% 
10 The provided tailored advice was complete 3% 37% 33% 20% 6% 
11 The provided tailored advice was applicable to 
women like me 
7% 45% 34% 11% 3% 
12 The provided tailored advice was important to me 5% 33% 34% 25% 3% 
Continues on next page 
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Table 3.5.4. Continued 
  Totally Agree  Absolutely 
Not Agree 
       
13 The provided tailored advice provided me with 
new information 
1% 24% 35% 32% 9% 
14 The provided tailored advice was applicable to 
women with a history of preeclampsia, IUGR or 
gestational diabetes mellitus 
4% 30% 40% 21% 6% 
15 The provided tailored advice was applicable to 
women 7 to 10 months after delivery 
- 30% 47% 22% 1% 
16 Repeatedly completing the computer-tailored 
health education program helped me to 
improve my lifestyle 
2% 31% 39% 25% 3% 
17 I liked the fact that I could complete the 
computer-tailored health education program 
when it suited me 
20% 75% 3% 2% - 
18 The direct feedback on my lifestyle scores made 
me more aware of my lifestyle 
7% 59% 23% 10% 2% 
19 Completing the registration form of the 
computer-tailored health education program 
helped me to absorb the information 
3% 37% 37% 20% 3% 
20 The direct feedback of my lifestyle scores was a 
motivator to improve my lifestyle 
4% 41% 40% 12% 2% 
21 Completing the registration form of the 
computer-tailored health education program 
took too much time 
1% 17% 29% 39% 14% 
 
Table 3.5.5. Response to process evaluation at 13 months postpartum, questionnaire C: 
Satisfaction (questions 5-22 are the PSQ-18) (response 93/144=65%) 
  Very 
unsatisfied 
 Very 
satisfied 
       
1 How satisfied are you with the intervention 
program? 
- 3% 11% 57% 29% 
2 How satisfied are you with the result of the 
intervention program? 
- 1% 34% 46% 18% 
3 How satisfied are you with the counselling 
sessions? 
- 1% 10% 41% 48% 
4 How satisfied are you with using the computer-
tailored health education program? 
2% 14% 23% 44% 17% 
Continues on next page 
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Table 3.5.5. Continued 
  Totally 
Agree 
 Absolutely 
Not Agree 
       
5 The counsellor gave good information about the 
need of the counselling sessions 
18% 72% 5% 2% 2% 
6 Everything needed for a complete intervention 
program was available 
14% 63% 14% 7% 2% 
7 The provided counselling could not have been 
better 
9% 45% 32% 14% - 
8 Sometimes I question myself if I got the 
appropriate counselling 
- 7% 18% 59% 16% 
9 I am confident that the counselling I needed was 
provided to me without getting me into financial 
problems 
28% 51% 18% 1% 2% 
10 The counsellor was well prepared to the 
counselling sessions 
10% 46% 37% 5% 1% 
11 The counselling sessions costed met more than I 
could afford 
- 4% 20% 47% 29% 
12 If needed, I could easily get in contact with my 
counsellor 
14% 37% 38% 9% 2% 
13 If urgently needed, It was difficult to get in contact 
with my counsellor 
- 4% 46% 29% 21% 
14 The counsellor was too impersonal 1%  5% 48% 45% 
15 The counsellor was friendly and polite 29% 38% 1% 2% - 
16 The counsellor sometimes was in a haste - - 7% 46% 47% 
17 Sometimes I doubted the competence of the 
counsellor 
2% 3% 10% 39% 46% 
18 I sometimes felt that the counsellor did not listen 
to me 
1% - 5% 43% 51% 
19 The counsellor spend enough time to the visits 53% 43% 2% - 2% 
20 It was difficult to make an appointment on a short 
notice 
1% 4% 33% 29% 31% 
21 I am dissatisfied about certain aspects of the 
counselling sessions 
1% 9% 8% 42% 40% 
22 If needed, counselling could be provided to me 23% 31% 39% 4% 3% 
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This thesis should make us rethink on how cardiometabolic complications 
of pregnancy should be interpreted. It shows that cardiovascular recovery after 
preeclampsia could take as long as 2 years after delivery. It also presents 
preeclampsia not only as a marker, but as an independent risk factor of future 
cardiovascular disease. Finally, it describes a complicated pregnancy as a unique 
opportunity by using pregnancy as a stress-test to identify women at increased 
risk of future cardiometabolic disease. Women with a complicated pregnancy 
often struggle with their newly acquired motherhood, physical and psychological 
complaints and feelings of guilt, anxiety and worry for the health of their 
newborn and their own. This thesis proves lifestyle intervention as a feasible and 
probably effective way to offer these women a chance of a healthier future. 
Postpartum recovery after preeclampsia 
Recovery of hypertension and proteinuria can last until 2 years after 
preeclampsia. Severity and duration of preeclampsia affect postpartum 
recovery. The more severe the preeclampsia is and the longer it is prolonged, 
the longer it takes to recover which can take up to 2 years after delivery. At the 
regular check-up at 6 weeks postpartum, the gynecologist and midwife have a 
unique opportunity to identify women who are not fully recovered and need 
close cardiometabolic follow-up. 
If hypertension or proteinuria persist at 6 to 12 weeks postpartum, the 
chance of resolving is still 50-85%. The chance of persistent hypertension after 2 
years is 18%. And although persistent proteinuria at 2 years postpartum is rare 
(2%), identification of persistent disease could initiate proper treatment and 
limit progression of cardiometabolic disease over time. Moreover, persistent 
hypertension or proteinuria should initiate broad cardiometabolic screening for 
other traits, like dyslipidemia or impaired glucose intolerance. 
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The NICE guideline (2011)288 does not address postpartum 
cardiometabolic screening yet. However, more recent developed guidelines do 
address this need of postpartum cardiometabolic screening after preeclampsia, 
but in various ways due to low-level evidence on screening strategies (cohorts or 
case-control studies or expert opinions). The variations are explicated in table 
4.1. Explicit follow-up on hypertension and proteinuria are mostly not 
mentioned. Only one guideline (SGOC289) mentions a timeframe when to screen 
or act and one other guideline (ACOG287) takes severity of preeclampsia into 
account. 
The Dutch guideline is most conservative regarding cardiometabolic 
screening, recommending only to start at the age of 50291. In case hypertension 
and proteinuria resolve within 2 years postpartum, this is a good 
recommendation, given the lack of evidence on the effect on future 
cardiometabolic events of routine postpartum extensive cardiometabolic 
screening. 
 More evidence is needed to uniform best practice of postpartum 
follow-up and screening after preeclampsia. Studies should focus on the chance 
of finding (1) modifiable risk factors, (2) treatable risk factors and (3) on the 
reduction of cardiovascular risk. Screening should not start before 2 years 
postpartum to reduce the risk of over-treatment when spontaneous recovery is 
still at hand. 
Preeclampsia as risk factor of future cardiovascular disease 
This thesis shows that preeclampsia is not just a marker, but an 
independent risk factor for future cardiovascular risk. Modelled odds-ratios for 
cardiovascular risk, based on differences in cardiometabolic health between 
formerly preeclamptic women and women with an uncomplicated pregnancy, 
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still leave a significant gap with observed odds-ratios.  
The model we used to estimate the independent risk of preeclampsia for 
future cardiovascular disease had limitations that could have overestimated the 
Table 4.1. International guidelines on postpartum follow-up and lifestyle intervention 
after preeclampsia 
Guideline Year Follow-up 
hypertension 
Follow-up 
proteinuria 
Cardiometabolic 
screening 
Advice on 
lifestyle 
NICE288 
(England)  
2011 None None None Inform women 
about increased 
risk, 
intervention not 
mentioned 
 
ACOG287 
(USA) 
2013 None None Yearly extensive 
screening if 
delivery <37 
weeks 
 
Recommend 
lifestyle 
modification 
SGOC289 
(Canada) 
2014 Until well 
controlled, if 
difficult to 
control: 
referral to 
internal 
medicine 
 
If persistent 
at 3-6 
months 
postpartum: 
referral to 
nephrology 
Once at least 
6 weeks 
postpartum 
extensive 
screening 
Women should 
pursue a 
healthy lifestyle 
SOMANZ290 
(Australia, 
New-
Sealand) 
2014 None None Yearly blood 
pressure 
5-yearly 
extensive 
screening 
Counsel women 
that they will 
benefit from a 
healthy lifestyle 
 
DSOG291 
(Netherlands) 
2014 Until 
normotensive 
None Extensive 
screening at the 
age of 50 years 
Counsel women 
to maintain a 
healthy lifestyle 
NICE = The National Institute for Health and Care Excellence 
ACOG = American Congress of Obstetricians and Gynecologists 
SGOC = The Society of Obstetricians and Gynecologists of Canada 
SOMANZ = Society of Obstetric Medicine of Australia and New Zealand 
DSOG = Dutch Society of Obstetrics and Gynecology 
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independent effect of preeclampsia. However, another study that support the 
conclusion that preeclampsia is an independent risk factor is the HUNT-trial. It is 
a longitudinal prospective follow-up program in Norway, measuring 
cardiometabolic risk factors in women every decade207. A cohort was defined 
that had given birth between the 1985 and 1995 check-up. Compared to women 
with a non-hypertensive pregnancy, women after hypertensive disorder in 
pregnancy (including preeclampsia) had a 0.8 kg/m2 increase in BMI, 6.2 mmHg 
increase in systolic blood pressure and 3.5 mmHg increase in diastolic blood 
pressure, adjusted for age at follow-up and pre-pregnancy values of BMI, systolic 
and diastolic blood pressure. While parity in general decreases risk of 
cardiovascular disease292, this confirms our finding that preeclampsia 
independently and irreversibly decreases cardiovascular health and thus 
increases the risk of future cardiovascular disease.  
Lifestyle intervention after complicated pregnancy 
Lifestyle intervention after complicated pregnancy is feasible and effective 
in improving cardiometabolic health. Participation rate in our study was twice as 
high as in other primary lifestyle interventions275 276. Compliance was fair with a 
drop-out rate of 29%60, but could be improved by offering lifestyle intervention 
closer to home or by phone. 
Informing women of their risk profile made them more aware of their risk 
of future cardiometabolic disease. This was a good motivator to improve 
cardiometabolic health. However, women after a complicated pregnancy are 
having difficulties in finding time to invest in their own recovery. Caring duties 
for their, sometimes, prematurely or growth-restricted newborn take a lot of 
time. They perform worse on physical and psychological tests compared to 
women after an uncomplicated pregnancy149. Major determinants are NICU-
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admission or death of their newborn293-295. Other determinants were a younger 
age, severity of preeclampsia, cesarean section and low gestation age293. 
When they need to go back to work at 10-12 weeks after delivery, they 
generally do not feel fully recovered. We started our intervention program at 6 
months postpartum. Some women expressed their wish to participate, but had 
lack of time. Tailoring the moment to start with lifestyle intervention after 
complicated pregnancy can improve participation rates. 
Gynecologists, midwifes and primary health care physicians should 
identify women at risk of future cardiometabolic disease at 6 weeks postpartum 
and inform them about their risk profile and risk of future cardiometabolic 
disease. They should initiate a lifestyle intervention program in combination with 
psychological counselling. The latter especially for those who have risk factors 
for post-traumatic stress, like younger maternal age and previous severe 
preeclampsia, cesarean section, fetal death, extreme prematurity and NICU-
admission. 
A strong recommendation based on this thesis is that gynecologists and 
midwifes should be responsible for the identification of these ‘high risk’ women 
and that primary health care physicians should be responsible for initiating a 
lifestyle intervention program and psychological counselling. The physician 
should refer to a trained lifestyle coach/counsellor, who has the time to listen 
and could help the women to set and reach their lifestyle goals. The 
coach/counsellor should guide these women at least 5 to 10 years, but probably 
lifelong. 
However, more knowledge is still needed on the effects of lifestyle 
intervention after complicated pregnancy. Future research should include (1) 
randomization between different intervention strategies and (2) long-term 
maternal cardiometabolic follow- up. 
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Scientific implications 
The way this thesis changes our view on cardiometabolic complications of 
pregnancy is summarized in figure 4.1. The finding that cardiovascular recovery 
after preeclampsia could take as long as 2 years after delivery is presented in a 
less steep slope of the curve toward cardiometabolic recovery after a 
cardiometabolic complicated pregnancy. The finding that cardiometabolic 
complicated pregnancy is an independent risk factor of future disease is 
displayed by cardiometabolic health not returning to the ‘base curve’ after 
complicated pregnancy. Finally, the finding that lifestyle intervention is a feasible 
and might be an effective way to offer a chance of a healthier future is presented 
in the dotted line after cardiometabolic complicated pregnancy. 
 
 
 More knowledge is needed on the costs and benefits of postpartum 
screening strategies for cardiovascular traits. 
Our study was not designed to prove the effect of lifestyle intervention, 
nor to do a cost-benefit analysis. Our findings on the effect of lifestyle 
intervention after cardiometabolic complicated pregnancy need to be confirmed 
in randomized controlled trials, comparing different intervention strategies. 
Inclusion criteria can be the same as in our Pro-Active study. More ethnicities 
should be included, offering them written material, questionnaires and 
counselling session in their native language. Lifestyle intervention could be 
initiated as early as 6 weeks postpartum, but start of the program must be 
tailored to the individual needs of the woman. Lifestyle intervention should be 
organized close to home by involving gynecologists and midwifes (responsible 
for the identification of women) primary health care physicians (responsible for 
organizing the initiation of lifestyle intervention) and trained 
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coaches/counsellors. Follow-up should be at least 5 years, but preferably up to 
10 years or longer and could be combined with a study on cardiometabolic 
screening strategies, e.g. yearly versus 5-yearly screening. 
Primary outcome should ideally be the prevalence of cardiometabolic 
disease. However, intermediate cardiometabolic risk factors could be used, like 
weight, blood pressure, cholesterol and triglyceride-levels and exercise and fat 
intake.  
Another interesting secondary outcome to study would be the risk of 
recurrent disease in a subsequent pregnancy. Preconceptionally initiated 
lifestyle intervention for weight reduction to reduce the risk of recurrent 
preeclampsia has not been studied yet296, but is suggested by a risk reduction if 
initiated during pregnancy284. Lifestyle intervention to increase physical activity 
has no effect on risk of preeclampsia if initiated during or before pregnancy297. 
Figure 4.1. Possible effect of lifestyle intervention after complicated pregnancy on 
cardiometabolic health and future disease (adapted from Sattar and Greer, 20021) 
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This might be a power-problem, since pre-pregnancy lifestyle interventions are 
scarce. It might be hypothesized that lifestyle intervention might be more 
effective if offered for a longer period, starting shortly after complicated 
pregnancy. 
Another interesting secondary outcome would be psychological well-
being during lifestyle intervention. Psychological burden might be an 
undervalued but important independent risk factor for cardiometabolic disease 
in women52, and might offer a new terrain of prevention of cardiometabolic 
disease in women’s health.  
Clinical implications and current guidelines 
Current guidelines differ in their advice what to do after a complicated 
pregnancy like preeclampsia (table 4.1). The newest guidelines recommend 
counselling of women that they will benefit from a healthy lifestyle. The 
somewhat older NICE guideline288 does not mention lifestyle intervention, but 
advises to inform women about their increased risk of future disease. However, 
guidelines do not guide in the organization of lifestyle interventions.   
Caution must be taken to advise for routine extensive cardiometabolic 
screening without proper studies on best practice. Benefits might be low, since 
risk profiles might be too low to start treatment. Although positive effects of 
lifestyle intervention could be observed, they might be small and therefore 
might have discouraging effects on compliance. Also the absence of classical risk 
factors for future disease could falsely reassure women that they already have a 
healthy lifestyle, leaving a risk for drop out of lifestyle coaching. 
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Recommendations for current practice 
Gynecologist and midwife: 
1. At the 6-weeks postpartum check-up after preeclampsia measure blood pressure and 
proteinuria. If still present, inform the primary health care physician by writing to take 
over follow-up. Advice to refer to a nephrologist if proteinuria is still present after 2 
years or progresses. Advice for an extensive cardiometabolic screening if hypertension 
is still present after 2 years. 
2. At the 6-weeks postpartum check-up after cardiometabolic complicated pregnancy, 
inform the woman about their increased future risk and the beneficial effect of a 
healthy lifestyle. Refer to primary health care physician (by writing) for lifestyle 
intervention. 
3. Emphasis the need for a pre-conception consultation in case the woman wants to 
become pregnant again in the future. During pre-conception consultation focus on 
lifestyle and modifiable and treatable cardiometabolic risk factors. If applicable, 
counsel the woman that she will benefit from a healthier lifestyle. 
Primary health care physician: 
4. During follow-up after preeclampsia refer to a nephrologist if proteinuria is still 
present and perform an extensive cardiometabolic screening if hypertension is still 
present after 2 years. 
5. Counsel a woman after cardiometabolic complicated pregnancy that she will benefit 
from a healthier lifestyle. If she wants to, refer her to a lifestyle coach/counsellor. The 
latter especially if she has risk factors for post-traumatic stress, like younger age, 
severe preeclampsia, cesarean section, fetal death, extreme prematurity and NICU-
admission. 
6. If a woman expresses the wish for a new pregnancy, refer her to a gynecologist for a 
pre-conception consultation. 
Gynecologist, midwife and primary health care physician: 
7. Write a local protocol describing (the organization of) follow-up, cardiometabolic 
screening and lifestyle intervention after complicated pregnancies. 
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SUMMARY 
Women with a history of cardiometabolic complicated pregnancy are at 
increased risk for future disease. The metabolic syndrome may represent a 
pathophysiological link between a complicated pregnancy and future 
cardiometabolic risk. However, since studies focus on women after their 
pregnancy, it remains unclear whether pregnancy complications themselves 
(irreversibly) affects cardiometabolic health. The answer to this question does 
not alter the fact that a complicated pregnancy uniquely identifies these women 
at a young age as high risk for future disease. This represents a unique possibility 
for primary lifestyle intervention. However, although it is difficult to reach and 
motivate the eligible people to change their lifestyle, the experience of having 
had a complicated pregnancy might open up a window of opportunity to guide 
these women to a healthier future. 
The introduction and outline of this thesis are presented in part 1. The 
general aim of this thesis is to develop and evaluate a postpartum program 
appraising cardiovascular health and offering lifestyle intervention after 
complicated pregnancy to reduce future cardiometabolic risks. 
Lot of research is being performed on cardiovascular health after 
preeclampsia. Part 2 describes our findings that contribute to the appraisal of 
cardiovascular health after complicated pregnancy. In chapter 2.1 a historical 
prospective cohort is used to test how time to resolution correlate with the levels 
of blood pressure and proteinuria during preeclampsia and the prolongation of 
pregnancy after the development of preeclampsia. We showed that maximal 
blood pressure and prolongation of pregnancy were significantly correlated with 
time of postpartum recovery of hypertension. Every day that preeclampsia was 
prolonged added 4% more time to recovery of hypertension. This suggests that 
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preeclampsia exhibits a direct effect on postpartum cardiovascular health. In 
chapter 2.2 we used a retrospective cohort to test the hypothesis that different 
phenotypes of preeclampsia are associated with thrombophilia factors. We also 
provide an overview of the literature. We conclude that only anti-phospholipid 
antibodies are associated with (severe) preeclampsia. 
The development and evaluation of a lifestyle intervention program after 
cardiometabolic complicated pregnancy is described in part 3. In Chapter 3.1 we 
provide a review of the literature (until May 2010) to identify potential 
intervention strategies. We found no studies on postpartum lifestyle 
interventions after cardiometabolic complicated pregnancies. We included 21 
studies on postpartum lifestyle intervention on unselected women on the basis 
of pregnancy complications. Six of 8 weight loss interventions, 4 of 5 smoking 
cessation interventions, and 4 of 8 smoking relapse prevention interventions 
were shown to be effective. In chapter 3.2 we estimate the effects of lifestyle 
intervention after preeclampsia on the risk of cardiovascular disease. First, the 
differences in cardiovascular risk factors after preeclampsia compared to an 
uncomplicated pregnancy were estimated. Second, the effects of lifestyle 
interventions on cardiovascular risk factors were estimated. Validated risk 
prediction models were used to translate these results into an effect on 
cardiovascular risk. We estimated the odds-ratio of cardiovascular disease after 
lifestyle interventions on a combination of exercise, dietary habits and smoking 
cessation to be 0.91 (0.87-0.96). Since lifestyle intervention in this model does 
not completely ameliorate the risk of cardiovascular disease, we also conclude 
that preeclampsia may represent an independent risk factor for cardiovascular 
disease. 
In chapter 3.3 and chapter 3.4 we describe our focus group studies on 
women after complicated pregnancies. With regard to women’s preferences for 
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postpartum lifestyle counseling (chapter 3.3) we found that all women 
expressed a need for participation in postpartum lifestyle counseling. They 
preferred participation to be tailored to individual preferences. A combination 
of face-to-face counseling supported by computer-tailored lifestyle advice 
appealed to them. With regard to motivators and barriers to the adoption of a 
healthy postpartum lifestyle (chapter 3.4) we found that although women 
expressed that they intended to live a healthy postpartum lifestyle, it was 
generally not achieved. Motivators included improving their own current health 
condition as well as modeling a healthy lifestyle for their children. Important 
barriers were reported to be lack of knowledge, poor post-pregnancy recovery 
and lack of professional support after delivery. 
Chapter 3.5 describes the Pro-Active study: a specific pre-post controlled 
designed study to evaluate the feasibility and effectiveness of a postpartum 
lifestyle intervention after complicated pregnancies to improve maternal risk 
factors for future cardiometabolic disease. Our results support feasibility and 
effectiveness of a lifestyle intervention after complicated pregnancies to 
improve maternal cardiometabolic risk factors. The proportion of eligible women 
who complied with the intervention was twice as high as in other primary 
lifestyle intervention studies, supporting the window of opportunity for lifestyle 
intervention after a complicated pregnancy. We also conclude that further 
randomized controlled studies are needed with longer follow-up to confirm our 
findings and evaluate durability. In the meantime, we suggest health care 
professionals to offer lifestyle interventions to women after complicated 
pregnancies. 
Part 4 provides the general discussion on how the results of this thesis 
should make us rethink the interpretation of cardiometabolic complications of 
pregnancy. It presents preeclampsia as an independent risk factor of future 
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cardiovascular disease. It also proves lifestyle intervention as a feasible and 
probably effective way to offer these women a chance of a healthier future. It 
gives an overview of scientific implications by describing further research to 
better test the effects of lifestyle interventions. Regarding clinical implications, 
it reflects on the current international guidelines and gives recommendations for 
current practice. 
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SAMENVATTING 
Vrouwen met in de voorgeschiedenis een cardiometabool gecompliceerde 
zwangerschap hebben in de toekomst een verhoogd risico op vergelijkbare 
ziekten. Het metabool syndroom kan dienen als pathofysiologische link tussen 
een gecompliceerde zwangerschap en toekomstige cardiometabool risico. 
Doordat studies zich richten op vrouwen na hun zwangerschap, blijft het echter 
de vraag of de gecompliceerde zwangerschap zelf (irreversibel) effect heeft op 
cardiometabole gezondheid. Het antwoord op deze vraag laat echter onverlet 
dat een gecompliceerde zwangerschap vrouwen op jonge leeftijd identificeert 
meteen verhoogd risico op toekomstige ziekte. Dat betekent een unieke kans 
voor primaire leefstijl interventie. Terwijl het lastig is om deze groep mensen in 
het algemeen te bereiken en te motiveren hun leefstijl aan te passen, zou het 
doormaken van de gecompliceerde zwangerschap een ‘window of opportunity’ 
kunnen zijn, waarin deze vrouwen open staan voor leefstijlaanpassingen. 
De introductie en uiteenzetting van dit proefschrift worden beschreven in 
deel 1. Het belangrijkste doel van dit proefschrift is het ontwikkelen en evalueren 
van een postpartum programma voor het beoordelen van cardiovasculaire 
gezondheid en begeleiden van leefstijl aanpassingen om te komen tot verlaging 
van het risico op toekomstige cardiometabole ziekte.  
Er is veel onderzoek verricht naar cardiovasculaire gezondheid na pre-
eclampsie. Deel 2 beschrijft onze bevindingen die bijdragen aan het inschatten 
van de cardiovasculaire gezondheid na een gecompliceerde zwangerschap. In 
hoofdstuk 2.1 wordt aan de hand van een historisch prospectief cohort getest 
hoe het postpartum herstel van bloeddruk en proteïnurie correleert met de 
bloeddruk en proteïnurie tijdens de pre-eclampsie en de tijdspanne tussen het 
stellen van de diagnose pre-eclampsie en de bevaldatum. We laten zien dat 
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zowel de maximale bloeddruk als het tijdsbestek tussen de diagnose pre-
eclampsie en bevalling beide significant gecorreleerd zijn met het postpartum 
herstel van de hypertensie. Elke dag dat de vrouw met pre-eclampsie langer 
zwanger blijft, voegt 4% toe aan de tijd die nodig was voor herstel van de 
hypertensie. Deze bevinding suggereert dat pre-eclampsie een direct effect 
heeft op postpartum cardiovasculaire gezondheid. In hoofdstuk 2.2 gebruiken 
we een retrospectief cohort waarin we de hypothese testen dat verschillende 
fenotypes van pre-eclampsie geassocieerd zijn met trombofilie factoren. We 
geven ook een literatuuroverzicht. We concluderen dat alleen antifosfolipide 
antistoffen geassocieerd zijn met (ernstige) pre-eclampsie. 
De ontwikkeling en evaluatie van een leefstijl interventie programma na 
cardiometabool gecompliceerde zwangerschap wordt beschreven in deel 3. In 
hoofdstuk 3.1 geven we een overzicht van de literatuur (tot mei 2010) om 
potentiele strategieën te identificeren. Studies over leefstijl interventie 
programma’s na cardiometabool gecompliceerde zwangerschap konden we 
echter niet vinden. Om toch een idee te krijgen van de effectiviteit van leefstijl 
interventie programma’s includeerden wij 21 studies over leefstijl interventie na 
zwangerschap van een groep ongeselecteerde vrouwen. Zes van de 8 
interventies op gewichtsverlies, 4 van de 5 op stoppen-met-roken en 4 van de 8 
voorkomen-opnieuw-te-gaan-roken laten een significant effect zien. In 
hoofdstuk 3.2 maken wij een schatting van het effect van leefstijl interventie na 
pre-eclampsie op het risico op hart- en vaatziekten. Eerst schatten wij de 
verschillen in risicofactoren voor hart- en vaatziekten tussen vrouwen na pre-
eclampsie in vergelijking met vrouwen na een ongecompliceerde zwangerschap. 
Vervolgens schatten wij het effect van leefstijl interventies op de risicofactoren 
voor hart- en vaatziekten. Tot slot gebruikten wij gevalideerde predictie 
modellen om deze bevindingen te vertalen naar een verschil in het risico op hart- 
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en vaatziekten. Dit resulteerde in een odds-ratio voor hart- en vaatziekten na 
leefstijl interventie op een combinatie van bewegen, eetgewoonten en stoppen-
met-roken van 0,91 (0,87-0,96). Aangezien leefstijl interventie het toegenomen 
risico op hart- en vaatziekten na pre-eclampsie niet volledig doet verdwijnen, 
concluderen wij tevens dat pre-eclampsie kan worden beschouwd als een 
onafhankelijke risicofactor voor hart- en vaatziekten. 
In hoofdstuk 3.3 en hoofdstuk 3.4 beschrijven we 2 focusgroep studies 
met vrouwen na een gecompliceerde zwangerschap. Met betrekking tot hun 
voorkeur voor postpartum counseling over leefstijl (hoofdstuk 3.3) zien wij dat 
alle deelnemende vrouwen de behoefte hadden om postpartum te worden 
geïnformeerd over het belang van een goede leefstijl. Ze gaven de voorkeur aan 
informatie die specifiek op hen van toepassing was. Een combinatie van face-to-
face counseling, ondersteund door computergestuurde, specifieke leefstijl 
adviezen vonden ze een aantrekkelijke strategie. Met betrekking tot 
motiverende en remmende factoren voor het postpartum aannemen van een 
gezonde leefstijl (hoofdstuk 3.4) zien wij dat ondanks dat vrouwen zich dat wel 
voornamen, het hen over het algemeen niet lukte om dat te bereiken. 
Motiverende factoren waren onder andere het verbeteren van hun gezondheid 
en een rolmodel zijn voor hun kinderen. Belangrijke remmende factoren waren 
gebrek aan kennis, langzaam herstel postpartum en gebrek aan professionele 
ondersteuning. 
Hoofdstuk 3.5 beschrijft de Pro-Active studie: een specifiek pre-post 
gecontroleerde studie voor het testen van de haalbaarheid en effectiviteit van 
een postpartum leefstijl interventie na gecompliceerde zwangerschap op het 
verbeteren van risicofactoren van toekomstige cardiometabole ziekten. Onze 
resultaten ondersteunen de haalbaarheid en effectiviteit van een postpartum 
leefstijl interventie op het verbeteren van risicofactoren. Het aantal vrouwen dat 
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tot het einde bij de interventie betrokken bleef, was 2 keer zo hoog in 
vergelijking met andere primaire leefstijl interventie programma’s. Daarmee 
wordt de ‘window of opportunity’ na een gecompliceerde zwangerschap 
onderschreven. We concluderen eveneens dat gerandomiseerde, 
gecontroleerde studies, met een langere follow-up dan onze studie, nodig zijn 
om onze bevindingen te bevestigen, met name ook de houdbaarheid van het 
effect van leefstijl interventie. Voor de tussenliggende tijd suggereren we dat 
zorgverleners aan vrouwen na een gecompliceerde zwangerschap leefstijl 
interventies aanbieden. 
Deel 4 betreft de algemene discussie over hoe dit proefschrift ons de 
interpretatie van cardiometabole complicaties van de zwangerschap doet 
heroverwegen. Pre-eclampsie wordt gepresenteerd als onafhankelijk 
risicofactor voor toekomstige hart- en vaatziekten. Leefstijl interventie wordt als 
een haalbare en waarschijnlijk effectieve manier gezien om vrouwen de kans te 
geven op een gezondere toekomst. Het geeft een overzicht over de 
wetenschappelijke implicaties, waarbij toekomstig onderzoek wordt beschreven 
waarin het effect van leefstijl interventie kan worden getoetst. Met betrekking 
tot klinische implicaties wordt een reflectie gegeven op de huidige internationale 
richtlijnen en worden aanbevelingen gedaan voor de praktijk. 
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DANKWOORD
Wat zit het leven steeds weer vol verassingen. Het is mei 2005 als ik begin
als 3de-jaars AIOS gynaecologie in het Erasmus MC. Net droog achter de oren
van alle liters vruchtwater van 2 jaar werken in een drukke periferie is overmoed
mij niet vreemd. Wat valt er nog te leren? Alle verloskundige instinkers zijn
immers bekend, geen probleem te groot of het is oplosbaar, geen dienst te druk
of je ontmoet als vanzelf de eerste zonnestraal van een nieuwe dag – soms de
voorbode  van  een  lekker  glaasje  whiskey.  En  ja,  soms  gebeurt  er  iets
‘onverklaarbaars’ of ‘onvermijdelijks’, maar zeg toch zelf, daar weet toch
niemand een antwoord op?
Na amper 2 maanden academie zit ik in mijn steilste leercurve ooit. Het is
oktober 2005 als Hans Duvekot, Chef de Clinique van de afdeling verloskunde,
mij vraagt op zijn kamer te komen om ‘iets te bespreken’. Oh nee, wat heb ik
gemist? Het ging toch juist zo lekker? Waarom doet hij zo vriendelijk? Het moet
vast iets héél ernstigs zijn. Op weg naar zijn kamer denk ik snel aan de afgelopen
weken op zoek naar een aanwijzing waar dit gesprek over zou kunnen gaan. Niets
schiet me te binnen en plots zitten we daar. Een plek die toen nog als onwennig
aanvoelde. Raar eigenlijk om daaraan terug te denken. Nu is het vaak de eerste
kamer waar ik naar toe loop, als ik op bezoek ben in het Erasmus MC. En ben ik
teleurgesteld als de deur op slot blijkt.
‘Wat zou je ervan vinden om promotieonderzoek te gaan doen naast je
opleiding?’ Ik moet wel héél schaapachtig hebben gekeken, want na een korte
pauze voegt hij eraan toe: ‘Eric en ik hebben het erover gehad dat jij echt iemand
bent voor dit onderzoek.’ 2 Weken later ben ik AGIKO en 1 maand later begin ik
aan mijn eerste jaar fulltime onderzoek.
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Beste Hans en Eric, het was geen gemakkelijk onderzoek: veel werd ons
pas gaandeweg duidelijk. En daarmee ontdekten we een schat aan waardevolle
informatie en weer nieuwe vragen. Ik was geen gemakkelijke promovendus. Met
mijn eigen wijs zocht ik mijn weg in dit onderzoek. En dat ging niet altijd even
snel als dat we hadden gewild. Gaandeweg werd het onderzoek een deel van
mijzelf en van ons. Pro-Active verwerd van een acroniem tot een entiteit. Een
entiteit die garant stond voor nieuwsgierigheid, passie, vernieuwing en
verbinding. Daarom dat dit proefschrift, naast de bekroning op een geweldig
project dat we met elkaar hebben neergezet, ook een –zachte – ondertoon heeft
van verdriet. Het confronteert met de eindigheid van mooie dingen. Mijn lijntje
met de bruisende en verslavende Academie, waar altijd iets gebeurt en mensen
zitten die van zich verwonderen hun vak hebben gemaakt, houdt hier op. Maar
ja, alsof ik tijd heb om daarbij stil te staan. De nieuwe uitdagingen struikelen al
over elkaar heen, wachtend om opgepakt te worden. Enthousiasme en Passie,
en vooral ook het doorzettingsvermogen om te blijven verwonderen en te
zoeken naar wat mogelijk is, heb ik van jullie beiden af mogen kijken. Ik heb daar
diep bewondering voor, jullie zijn daarin mijn grote voorbeeld. Ik ben jullie
onmetelijk dankbaar voor het vertrouwen dat jullie mij destijds in 2005 en alle
jaren daarna hebben gegeven en de passie en toewijding waarmee jullie mij
hebben besmet.
Beste Hein, wat hebben ook wij samen gezocht naar de weg in dit project.
Jij was voor mij iets meer op afstand, maar jouw deur stond altijd open. Altijd
bereid om mee te denken in weer eens een moeilijk dilemma. En wat heb ik
daarin veel van je geleerd. Jij hielp mij en destijds ook Meeke zelf zoeken naar
oplossingen, maar had altijd een slim idee als het écht even niet ging. Iemand in
zijn kracht zetten kan jij als geen ander. Heel hartelijk dank daarvoor!
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Beste Arie, eigenlijk voel ik me naar jou altijd een beetje schuldig. Jij hebt
destijds het onderzoeksproject geschreven, samen met Hein, maar toen ging je
weg en moest je dit onderzoek achterlaten in het Erasmus MC. Gelukkig bleef er
contact bestaan via deelname van het St. Elizabeth ziekenhuis in Tilburg aan het
project. Ik voel me dan ook zeer vereerd dat je vandaag in de commissie zit.
Beste overige commissieleden en in het bijzonder Joline, Eric en
Christianne, ik wil jullie hartelijk danken voor jullie interesse in het proefschrift
en de bereidheid deze kritisch te lezen. Ik voel me vereert dat ik dit proefschrift
aan jullie mag voorleggen.
Beste Meeke, eindelijk heb ik die eindstreep ook gehaald! Jij begon iets
later en was veel eerder klaar.  Wat had ik je toen graag nagedaan. Hoe jij  dat
destijds voor elkaar hebt gekregen met een klein kind en heen en weer reizend
tussen Tilburg en Rotterdam, is me nog altijd een raadsel. Ondanks dat we ons
soms ingegraven voelden door allemaal papieren die allemaal ongeveer even
belangrijk waren, vonden we toch altijd weer onze weg. En die weg ging altijd
vóóruit. Ik ben ongelofelijk trots dat wij dit project samen hebben neergezet en
ben je heel dankbaar voor de tijd waarin we samen weg van de Pro-active
hebben bewandeld.
En natuurlijk zijn er nog velen anderen die ik dank verschuldigd ben.
Allereerst natuurlijk alle vrouwen die aan de studie hebben deelgenomen.
Zonder hen was dit project nooit geslaagd. Dat geldt ook voor Mirjam, Robbert,
Sarah, en Meike. Dank jullie hartelijk voor het meedraaien in de poli-spreekuren.
Mark, dank voor de ondersteuning in Access. Wie had gedacht dat ik daar ook
een passie in zou vinden. Een passie die zijn vruchten af heeft geworpen en ook
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nu  nog  afwerpt.  Joke,  Wilma  en  Titia,  dank  voor  het  verwerken  van  de
labsamples en natuurlijk de gezelligheid. Collega’s in het Erasmus MC, Sint
Franciscus Gasthuis en het Westfriesgasthuis voor de ruimte en tijd. Vrienden en
familie voor de nooit aflatende interesse in de voortgang van het project.
Een bijzondere vermelding voor jou Hajo. Hartelijk dank voor je continue
interesse en betrokkenheid. Niet alleen bij dit project, maar vooral ook op het
persoonlijk vlak en niet te vergeten, mijn carrière. Ik weet nog heel goed, volgens
mij was het september 2011, dat jij me een keer uitnodigde in het
Westfriesgasthuis te Hoorn. Nadat ik je al ettelijke malen voor gek had verklaard
– de afstand met Rotterdam was immers veel te groot – heb ik een dag
meegelopen. Ik was direct verkocht en ’s avonds heb je bij een hapje eten aan
de haven geholpen de logistieke oplossing te vinden. Jij zag dat ik in het team
gynaecologen paste en het team bij mij. Dat is jouw kracht: jij ziet dingen die
anderen (nog) niet zien. En in plaats van je te vervreemden, maak je anderen
deelgenoot van jouw visie, juist door interesse te tonen in de ander. Daarmee
heb je dingen kunnen bereiken die anderen nooit voor mogelijk hielden. Ik
bewonder dat in je en hoop tegen het einde van mijn carrière nog net zo jong
van geest te zijn als jij.
En natuurlijk De Sjôtelsplek: Marco, Marieke, Guy, Marion, Hèlen,
Dankert, Arjan, Mirjam, Marcel, Daniëlle, Nettie en Kees. Ooit in 1994 klein
begonnen in een vakantiehuisje in Schoorl en al snel uitgegroeid tot de
vriendclub die we nu zijn. Lief en leed hebben we gedeeld en verwerkt. Wie kan
nu zeggen dat hij met zijn studievrienden na 23 jaar nog elk jaar 2 keer een
weekend feestviert? Zonder jullie zou ik niet de persoon zijn die ik nu ben. Jullie
zijn mijn beste vrienden voor altijd.
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Beste Lyanne, ik ben zo blij dat jij samen met Alike mijn paranimf wilt zijn.
Jij kan als geen ander een situatie zó ontregelen dat er een geheel nieuw
perspectief ontstaat. Noem het humor, noem het je-kunnen-verwonderen.
Beide kernkwaliteiten die je doen realiseren dat het leven continue in beweging
is en vol verassingen zit. Met die basis voel ik me op 17 januari niet alleen staan,
maar staan we daar echt met z’n drieën en dat voelt bijzonder goed.
Tot slot is het doen van promotieonderzoek niet alleen iets wat je tijdens
werktijd doet. De soms lange dagen, de uren achter de computer, de weken weg
op congres zijn daar maar enkele voorbeelden van die anderen om je heen ervan
merken. Maar ook de minder tastbare dingen, zoals in gedachten zijn, omdat er
creatieve input nodig is voor een artikel. Of heel enthousiast vertellen dat het nu
écht bijna klaar is (de eerste keer was geloof ik zo’n 5 jaar geleden). Promoveren
doe je niet alleen, zeggen ze, en ze hebben gelijk.  Maar het is  iets waar je als
bijstander je soms onmachtig kan voelen. Kinderen beleven het anders dan
volwassenen. Die weten ook niet altijd beter. Ze hebben er ontzag voor dat hun
vader een eigen boek heeft geschreven, maar vinden het eigenlijk maar stom dat
het allemaal in het Engels is. Dan begrijpt toch niemand er iets van. Volwassenen
zien de offers die je soms moet brengen om het project in beweging te houden.
Wat dat betreft is het eigenlijk maar oneerlijk dat alleen mijn naam op het boekje
staat. Daarom hier de eer die jou toekomt. Dank je vanuit het diepst van mijn
hart voor alle tijd, geduld en ruimte die je me hebt gegeven om dit project waar
te maken. Alike, ik houd van je.
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CURRICULUM VITAE 
Durk Berks was born at home on the 3rd of May 1974 in Amsterdam, The 
Netherlands. He went to primary school on de Antonia Kleuterschool, following 
on the Dr Rijk Kramerschool in Amsterdam, continuing on De Scheepskameel 
after moving to Almere. He started his secondary school on Het Baken in Almere, 
The Netherlands. After moving to Nuenen, The Netherlands, he continued on het 
Eckhart College, where he graduated in 1992. Shortly after, he attended Medical 
School at the Rijksuniversiteit Limburg in Maastricht, The Netherlands, (now 
called Maastricht University) in 1992, from which he graduated in July 1999. 
From august 1999 until December 2000 he worked as a junior resident at the 
Department of Obstetrics and Gynecology at the Maaslandziekenhuis Sittard, 
The Netherlands (now called Orbis). In December 2000, he moved to Rotterdam, 
working as a fertility doctor in het Zuiderziekenhuis in Rotterdam, The 
Netherlands (now called Maasstad ziekenhuis) until May 2003, where he met his 
beautiful wife. In May 2003, he started his training in Obstetrics and Gynecology 
at the Sint Franciscus Gasthuis, Rotterdam, The Netherlands (now called 
Franciscus Gasthuis & Vlietland) and the Erasmus Medical Center, Rotterdam, 
The Netherlands. During his training, he started his PhD in December 2005. He 
worked as PhD-student from December 2005 until May 2007 and November 
2008 until November 2009. He graduated as Gynecologist in February 2012. He 
works as gynecologist in het Westfriesgasthuis Hoorn, The Netherland, with 
obstetrics and fertility as mean areas of expertise. He is member of the hospital’s 
Lean core-team and member of the Steering committee on integrated obstetric 
care. He lives in Rotterdam with Alike and their 3 beautiful daughters: Meike, 
Sophie and Jasmijn. 
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